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Summary 
 
Water scarcity is a global problem and pollution of this valuable resource is a growing 
concern. South Africa is no exception. As part of an on-going study aimed at developing 
decentralized water treatment systems based on biomimicry design, this project aimed to 
evaluate and optimize analytical methods that can be used to evaluate the efficiency of 
these systems in removing compounds with endocrine disrupting properties. In addition, 
this project also aimed to show the possible consequences if pollutants are not removed 
by investigating the effects of a number of endocrine disrupting chemicals in combination 
with one another and in combination with natural human hormones. This should provide a 
more realistic view of how a combination of pollutants that typically end up in the 
environment due to pollution can adversely affect organisms, and by extension, the 
ecosystem. It should also contribute to our understanding of how common pollutants that 
gets applied on the skin as personal care products (PCPs) can possibly influence human 
health and be linked to diseases such as breast cancer. 
The first aim resulted in a method that can be used to isolate, identify and quantify 
11 endocrine disrupting chemicals (3 hormones, 1 synthetic hormone analog, 4 PCPs, 2 
plasticizers and 1 anticonvulsant) and one human indicator. The method uses solid phase 
extraction to isolate compounds, dansyl chloride derivatization of compounds to enhance 
mass spectrometry detection and a novel super-critical fluid chromatography system, 
called an ultra-performance convergence chromatography (UPC2) system, coupled to 
tandem mass spectrometry for detection and quantification of each compound. This 
method can be used to evaluate the removal efficiency of waste water treatment systems. 
However, method validation revealed additional optimization and simplification should be 
considered. The second aim yielded data that showed the combined effect four common 
PCP pollutants as either being additive, antagonistic or synergistic. The data highlights 
how these PCPs can possibly interfere with the endocrine system of humans and animals 
if used as PCPs or are found in environment as pollutants. Finally, the data also suggest 
how common PCPs can influence diseases such as breast cancer. 
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Opsomming 
 
Water skaarste is ‗n wereld-wye probleem en die besoedeling van hierdie belangrike 
hulpbron is ‗n toenemeende bekommernis. Suid-Afrika is geen uitsondering. As deel van ‗n 
voortgaande studie met die doel om gedesentraliseerde water sisteme wat gebaseer is op 
biomimieke beginsels te ontwikkel, het hierdie projek beoog om die analitiese metodes wat 
gebruik kan word om hierdie sisteme se bekwaamheid in die verwydering van endokrien 
ontwrigtende produkte te ondersoek te evalueer en te optimiseer. Daarmee saam het 
hierdie projek ook beoog om die moontlike nadelige effekte van besoedeling te ondersoek 
deur ondersoek in te stel op ‗n kombinasie van endokriene ontwrigters met mekaar, asook 
in kombinasie met natuurlike menslike hormone. Hierdie behoort ‗n realistiese oorsig te 
gee oor hoe algemene produkte wat water bronne besoedel in kombinasie organismes 
ongunstig kan affekteer en so ook die ekosisteem. Dit sal ook bydra tot huidige kennis oor 
hoe algemeen besoedelende produkte wat op die vel aangesmeer word as persoonlike 
hieniese produkte (PHPs) die mens se gesondheid kan affekteer en verbind kan word tot 
siektes soos bors kanker. 
Die eerste doelwit het ‗n metode opgelewer wat 11 endokriene ontwrigters (3 
hormone, 1 sintetiese hormoon anoloog, 4 PHPs, 2 plastiseerders en 1 antistuipgif) en een 
menslike indikator kan isoleer, identifiseer en kwantifiseer. Die method maak gebruik van 
soliede fase ekstraksie vir die isolering van produkte, dansiel chloried derivatisering van 
produkte vir verbeterde massa spektrometrie deteksie en ‗n nuwe super-kritiese vloeistof 
kromatografie, bekend as ‗ultra-performance convergence chromatrogarphy (UPC2)‘, 
gekoppel aan aaneengekoppelde massa spektrometrie vir die deteksie en kwantifisering 
van elke produk. Hierdie metode kan gebruik work om die verwyderings bekwaamheid van 
afval-water behandeling sisteme te evalueer. Metode bevestiging wys wel dat aandag 
gegee sal moet word aan verdere optimisering en vereenvoudiging van die metode. Die 
tweede doelwit het bewys dat die effek van kombinasies van PHP besoedelende produkte 
sommerend, antagonisties of sinergisties kan optree. Die data wys verder die moontlike 
effekte wat PHPs kan hê op die endokriene sisteem van mense en diere as hierdie 
produkte gebruik word as PHPs of as besoedelende produkte in die natuur voorkom. 
Laastens, wys die data ook hoe algemeen gebruikte PHPs siektes soos bors kanker kan 
beïnvloed. 
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CHAPTER 1 
 
 
Thesis overview 
 
1.1 General background 
 
1.1.1 This project forms part of a bigger study that aims to solve a current water 
pollution problem 
In South Africa, most of the freshwater is supplied by the Orange, Mzimvubu, Mvoti, 
Thukela, Usutu, Inkomati and Vaal Rivers, while the Olifants, Luvuvhu/Letaba, Fish, 
Gouritz, Breede and Berg rivers contribute to a lesser extent (1). Of these thirteen rivers 
the Gouritz, Olifants, Breede and Berg rivers supply the Western Cape (WC) with 
freshwater. In early 2011, it came under the WC‘s department of environmental affairs and 
development plannings (DEA & DP) attention that untreated effluent water (greywater) 
from two informal settlements (Langrug outside Franschoek, and MBekweni near Paarl) 
were running directly into the Berg River. A study by Royden-Turner (2) found that the 
effluent greywater from these settlements had high microbial counts and were highly 
concentrated in pharmaceutical and personal care products (PPCPs). 
Agriculturally important for irrigation, contamination of the Berg River could lead to 
a decrease in exported crops due to presence of microbes and pollutants such as PPCPs 
in irrigation supplies. This in retrospect will then negatively influence the economy. 
Residents of both Langrug and Mbekweni heavily depend on the economy of the Cape 
Winelands district, of which Franschoek and Paarl form part of, as most of these residents 
are seasonal farmworkers. Therefore, the health status of the Berg River is of the utmost 
importance to residents depending on its water supply. In addition, the river is also 
important for wildlife living in its vicinity. 
In 2013 John Todd Ecological Design (JTED) partnered with Biomimicry SA, 
Informal SouthTM, GreenhouseTM and Maluti WatersTM to develop an onsite, eco-friendly, 
natural treatment system that will firstly, treat the effluent greywater from Langrug informal 
settlement, and secondly, create jobs to uplift the community. A pilot scale model of the 
developed biomimicry based treatment system, called the JTED Eco-machine, suggested 
effective treatment of greywater. However, the treatment of PPCPs was not investigated 
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and the efficiency of such a system will only be known through testing of the actual system 
(3, 4). 
Evaluating/Monitoring the efficiency of a system such as the JTED Eco-machine 
requires a trans-disciplinary approach involving amongst others microbiologists, 
biochemists, ecologists and engineers, considering the complexity of such a system, as 
the hydraulics, the effect of microbial communities (e.g. biofilms) and the health of the 
fauna and flora are equally important. Hence, the bigger picture of a study such as the one 
this project forms part of provides unique challenges. 
 
 
1.1.2 Evaluating the JTED Eco-machine: from a biochemistry perspective 
 
From the study by Royden-Turner followed an inquiry into the ability of the JTED Eco- 
machine to remove PPCPs. Considered as emerging contaminants (5, 6), PPCPs can 
elicit certain biological responses in humans and animals coming in contact with water 
polluted with these compounds and therefore they pose a health risk. Some PPCPs have 
been linked to causing and contributing to endocrine disruption (ED) – a phenomenon of 
great importance to biochemists and physiologists that will be discussed in more detail in 
chapter 2 section 2.5.5. Together with personal and family history of cancer, the use of 
alcohol, smoking and a number of other consequences, ED is thought to be the root of 
diseases such as obesity, diabetes and cancer. Therefore, the JTED Eco-machine needs 
to be evaluated for its ability to remove PPCPs. To achieve this, methods would need to 
be in place that will enable the pre-concentration, detection and quantification of PPCPs. 
 
 
1.1.3 Methods that can be employed to measure the presence of PPCPs 
 
Over the past century numerous methods have been developed to detect compounds 
such as PPCPs in different matrices such as the environment, blood, urine and breast 
milk. Gas chromatography (GC), liquid chromatography (LC) and supercritical fluid 
chromatography (SFC) all coupled to mass spectrometry are the most noteworthy and will 
be discussed in chapter 2 section 2.4. Alternatively, methods have also been developed to 
show the presence of a group of compounds, e.g. endocrine disrupting chemicals (EDCs), 
in a sample. However, here a biological response is tested indicative of the members in 
that specific group rather than the individual compounds. Noteworthy of these methods are 
the yeast estrogen screen (YES) and E-SCREEN, which will be discussed in chapter 2 
section 2.3. In addition to their ability to show the presence of a group of compounds in a 
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sample, these biological assays can also be used to investigate the modes of action 
(MOA) of EDCs. This added benefit will be highlighted in chapter 2 section 2.3 and their 
use become apparent in chapters 4 and 5 when the aforementioned assays are used 
investigate the risks associated with the presence of certain antimicrobials present in 
personal care products (PCPs) that find their way into the environment. 
 
1.2 Objectives of this study 
 
The overall goal of this study was to find the most suitable chromatography method that 
could be used to evaluate the JTED Eco-machine‘s ability to remove pollutants such as 
PPCPs. In addition, the study aims to substantiate the possible consequences to humans 
and animals if exposed to pollutants with ED abilities from contaminated water resources. 
The specific objectives were to: 
 
a) Develop analytical techniques for the pre-concentration, identification and 
quantification of 11 commonly occurring pollutants with ED capabilities from 
environmental matrices (CHAPTER 3). 
b) Elucidate the pharmacological property – drug potency, of four antimicrobials and 
three human estrogens on the YES and E-SCREEN (CHAPTER 4). 
c) Investigate the combinatory effects of PCPs and their possible contribution to breast 
cancer (CHAPTER 5). 
Chapters 4 and 5 use breast cancer (BC) as an example of the possible consequence of 
EDC exposure to humans. 
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CHAPTER 2 
 
 
Literature review 
 
2.1 Introduction 
 
Chapter 1 provided a short history on how this project came into play, touched on some of 
the most important topics that will be discussed and dealt with throughout the rest of this 
thesis and supplied the overall goal and specific objectives set out for this study. This 
chapter aims to provide additional or a deeper knowledge into some of the subjects that 
were touched on. Chapter 2 is divided into three additional sections. The second section 
will deal with the global problem of water pollution and the issue at hand in the Berg River, 
as well as the methods that can be used for monitoring pollution. Together, these topics 
aim to provide information relevant to why the current study is needed and a background 
into the methods used in chapter 3 that can be used to evaluate the JTED Eco-machine. 
The third section will focus on two screens, which like the chromatographic techniques 
discussed in topic 2c, can be used to monitor pollution. However, here the two screens will 
be discussed as bioassays that can be used to investigate endocrine modulation. The aim 
of this section is to provide background information into the bioassays as they are used in 
chapter 4 and 5 to emphasize the affect that certain pollutants can have on the endocrine 
system of humans and animals. However, special regard will be given to humans as the 
pollutants in question are thought to also contribute to ED mediated breast cancer. From 
this, parallel conclusions can be drawn on their possible effects on wildlife in the vicinity of 
the Berg River, their possible effect on crop export and evidently the residents of the two 
informal settlements if present in the Berg River. Finally, section four will provide 
background information into the human endocrine system and its role in the regulation of 
homeostasis, how pollutants such as PPCPs with ED capabilities find their way into the 
human body, their modes of ED and current data on the most prominent EDCs of concern. 
The aim of this final section is to highlight how important the clean-up of a river such as the 
Berg River is and the diverse consequences that can follow if not. In addition, the section 
will summarise the current state of EDC research and serves as supporting information 
that the compounds investigated in chapter 4 and 5 are reason for concern. 
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2.2 Water pollution 
 
In 2000 the United Nations set out eight Millennium developmental goals (MDG‘s) – one of 
which was to ensure environmental sustainability – with water availability being a primary 
concern. According to the 2015 MDG report, ‗water scarcity affects more than 40% of the 
global population and is projected to rise‘, with Northern Africa and parts of Western Asia 
already exceeding sustainable limits. Nonetheless, places such as Eastern Asia, South- 
Eastern Asia, Latin America and the Caribbean, Oceania and Sub-Saharan Africa have 
adequate water resources, but in some of these regions, such as Africa face a different 
problem: inadequate sanitation services – a problem that may threaten water resources. 
With up to 62% of the urban population living in slums, having insufficient waste removal 
system, waste water is discarded outside homes creating unsanitary living conditions. In 
most cases this waste water runs off into smaller streams that eventually end up in rivers, 
lakes, ponds or dams, contaminating the remaining freshwater supply (7). 
South Africa‘s water vulnerability is no exception and the pollution of the Berg 
River is a typical example. Alongside the Berg River two informal settlements are 
threatening the health of the river as household waste water from these settlements is 
draining into the river. As the Berg River is one of the primary rivers used for irrigation in 
the Cape Winelands, pollution of the river could have dire consequences. These include 
possible reduced crop export due to high microbial and PPCP loads from crops irrigated 
with water from the Berg River and the health of the ecosystems surrounding the river. As 
the agricultural industry in the areas surrounding and supplied by the Berg River heavily 
depend on exports and tourism, reduced export of crops or tourism could in retrospect 
affect the livelihood of those making a living from these sectors. As a large portion of the 
population is seasonal farmworkers, living in these informal settlements, these residents 
stand to lose the most. 
In an effort to save the river, the agricultural and tourism industry and the 
livelihood of those that could be affected from a declining economy, a number of 
organisations worked together with the WC‘s DEA & DP to solve this growing concern. 
The proposed solution, called the JTED Eco-machine (Figure 2.1), operates on biomimetic 
principles. In short, these biomimetic principles are in fact the genius of nature itself, where 
humans learned how nature solves problems and then imitated them. These principles are 
encapsulated in the field of biomimicry. Good examples where biomimicry has been used 
are bioSTREAM, bioWAVE and Sharklet antimicrobial surfaces. The first two technologies 
are reverse-engineered technologies imitating the efficiency of the tail of a tuna fish to 
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create energy. Sharklet technologies in contrast imitated the antimicrobial surface of 
sharkskin to create antimicrobial surface coverings that can be used in hospitals. 
 
 
 
Figure 2.1 The JTED Eco-machine. A) Top-view of one of three 26-cell cascades showing the influent 
and effluent points. After the third cascade water flows onto an algal turf scrubber (not shown). B) 
Side view of three cells of a 26-cell cascade, showing how water will be treated and the natural flow 
of the water downwards. 
 
 
 
The JTED Eco-machine aims to treat greywater from the informal settlements 
using the biomimetic principles in two stages. First, recipient greywater is cascaded 
through multiple aquatic cells, wherein the water is slowed down and sped up sequentially, 
allowing sufficient retention time for biological degradation of solid waste and the uptake 
and metabolism of dissolved or suspended substances by a diverse set of microbial, plant 
and animal species. The cascading aquatic cells work on the dendritic principle, whereby 
each cell feeds two or more cells downstream, distributing load and effectively filtering the 
water from one cell to the next, before converging to one filtered mass of water. During the 
final stage of treatment the filtered water is scrubbed from remaining nitrates, nitrites, 
ammonia, ammonium and phosphates by an algae turf scrubber before being released 
into the environment (2). 
As mentioned in section 1.1.1, a pilot scale study found that greywater was treated 
efficiently but the study did not include ability of the Eco-machine to remove PPCPs and 
that its robustness (section 1.1.2) will only be evident from the actual system under real 
conditions. Henceforth, the appropriate PPCP monitoring methods would need to be in 
place if the PPCP removal efficiency is to be determined. 
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2.3 Biological methods employed to monitor pollution 
 
2.3.1 Biological methods overview 
 
To date several biological methods have been validated to investigate pollution (Table 
2.1). Most of these methods relate to water pollution. 
 
 
Table 2.1 Validated methods used to investigate pollution. Adapted from P Kumar (8). 
 
 
General bio-assays Cell bioassays Molecular bioassays Biosensors 
 
 
Algal Cytogenicity Immuno assays Microbial gas 
 
 
Mosses Micronucleus test Yeast estrogen 
screen (YES) 
 
 
Pollution-induced peptides Chromosomal damage 
 
 
Protozoa 
 
 
 
 
In the past 2 decades the focus of pollution has shifted from general pollution to 
specific pollution, with the use of assays such as the YES/YAS and E-SCREEN describing 
rather the type of pollution than just pollution in general. Specifically, the focus has shifted 
to pollution that can disrupt the homeostasis of organisms such as the type of pollution that 
can disrupt the endocrine system of mammals, termed endocrine disruption, leading to 
adverse side effects (e.g. feminization of male fish). For the purpose of this thesis the YES 
and E-SCREEN assays will be used as examples of how pollution can be monitored with 
Plant Membrane damage DNA probes Biological/chemical 
oxygen deman. 
(BOD/COD) 
Vascular macrophytes Sister chromatid exchange Bioluminescence Lux- Immuno assays 
reporter genes 
Lichens Ames test Yeast androgen 
screen (YAS) 
Fish E-SCREEN (MCF7 proliferation) 
Helminthic 
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biological methods. Both methods are used to test for pollution that can cause ED in 
mammals and are used in chapters 4 and 5. 
 
 
2.3.2 The yeast estrogen screen (YES) 
 
The YES was originally developed by Routledge and Sumpter (9) to detect compounds in 
water with estrogen-like properties. Positive results from a sample subjected to the assay 
indicate that under cellular conditions the sample has the ability to stimulate the estrogen 
receptor (ER). As these receptors play an intricate role in regulating cellular processes 
(discussed in section 2.5.4), unwanted stimulation of these receptors could disrupt 
homeostasis. This is then indicative of a sample that contains pollutants able to cause ED. 
In the assay (Figure 2.2), yeast stably expresses the human ERα. In the presence 
of an ERα agonist, the ERα-ligand complex binds to the ERE of an ERE-containing 
plasmid where-after TF‘s and other transcriptional components are recruited for 
transcription. Following this, the transcriptional complex transcribes the gene Lac-Z, 
coding for β-galactosidase. The latter is secreted into the medium where it metabolizes 
chlorophenol red-β-D-galactopyranoside (CPRG) – a chromogenetic substrate, causing a 
colour change from yellow to red. The change in colour is then measured 
spectrophotometrically. 
 
 
 
 
 
Figure 2.2 Yeast estrogen screen (YES) assay used for observing modulatory effects mediated 
through ERα. 
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In addition to its ability to serve as an ED pollution indicator, this screen has also 
proven useful in determining dose-response parameters (e.g. potency and efficacy) of 
certain estrogen-like compounds. These include environmental estrogens (10), surfactants 
(9), natural and synthetic estrogens, pharmaceuticals, antimicrobials and alkylphenols 
(11), flavonoids (12), food contact materials and dichlorobenzenes (13), among other 
chemicals. The benefit of using this assay is that modulation of ERs can be viewed in 
isolation, without the interference of other cellular signal transduction pathways (see 
section 2.3.2), such as the case with cellular assays (e.g. the E-SCREEN). 
2.3.3 The E-SCREEN 
 
Round about the same time as Routledge and Sumpter developed the YES, Soto et al. 
(14) developed the E-SCREEN to evaluate the estrogenicity of environmental compounds 
as an alternative method to the then used rodent assay. The screen makes use of 
Michigan cancer foundation 7 (MCF-7) breast cancer cells [ERα positive cells, (15)] and 
tests the ability of a compound to cause the cellular proliferation of these cells. However, in 
recent years a modified form of the MCF-7 cells, MCF-7 BUS cells, has been used in the 
E-SCREEN. These cells provide a higher proliferative response than normal MCF-7 BC 
cells (16) and therefore increases the sensitivity of the assay. 
In the original assay MCF-7 cells are cultured before being plated in wells. Plated 
cells are allowed to attach overnight before the seeding medium is removed and replaced 
with experimental medium. Test compounds are then added to the experimental medium 
at a range of different concentrations and incubated for a number of days. After 
terminating the assay by removing the medium, cells are lysed and the nuclei counted. 
The range of concentrations and their nuclei  counts then provide information on the 
proliferative effects of the compound. However, modifications to the screen such as the 
method used to quantify proliferation (12, 17), seeding density and preconditioning of cells 
with experimental medium (18) have previously been done. To date the E-SCREEN has 
been used among other things to detect estrogenic pollution in water resources (19), 
bottled water (17), characterizing estrogenic potential of flavonoids (12) and 
pharmaceuticals (20). In contrast to the YES, the E-SCREEN provides information on 
cellular effects, i.e. how will a compound in isolation or a subjected sample affect cells with 
an intricate number of signal transduction pathways. 
In conclusion, several biological methods exist to monitor pollution. However there 
is a global trend to move away from general pollution to determining what type of pollution 
is  present.  Two  bioassays  used  for  detecting  pollution  were  discussed  and  their 
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differences highlighted. However, these bioassays require more time to prepare, can be 
expensive (e.g. the E-SCREEN) and their pollution information are still not exact. 
However, analytical chemistry methods exist that can determine exactly what type of 
polluting chemicals are present and from these conclusions can be drawn on how they 
might affect things like the endocrine system of mammals when present in for e.g. water 
resources. These methods will be discussed in the next section. 
 
2.4 Analytical chemistry methods employed to monitor pollution 
 
2.4.1 Analytical chemistry methods overview 
 
Globally there is effort to develop methods that will enable exact determination of the type 
of pollutant present in water. However, due to the large number of possible pollutants, 
method development proves a daunting task. Moreover, detecting some pollutants at low 
levels further stonewalls method development. Nevertheless, existing chromatographic 
techniques, such as ultra-performance liquid chromatography (UPLC), gas 
chromatography (GC) and super-critical fluid chromatography (SFC) coupled to mass 
spectrometry instrumentation, such as Time-of-Flight (TOF), quadrupoles (Q) and ion- 
traps, prove to be the future for identifying pollution. These methods are sensitive and can 
identify many pollutants simultaneously with high precision. Figure 2.3 illustrates how 
these systems are able to determine the exact chemical pollutants in a sample 
simultaneously. 
 
 
 
 
 
Figure 2.3 Graphic illustration of how a pollutant can be identified from a sample using analytical 
chemistry techniques. Here the chromatographic system is connected to a mass spectrometer. The 
cleaned up sample refers to a sample  that underwent pre-clean up to remove debris and any 
unwanted matrix constituents such as salts and metals. The output generated on the computer 
screen is usually generated with a software package such as Masslynx 
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Sections 2.4.2, 2.4.3 and 2.4.4 will deal with the above mentioned 
chromatographic systems and the different detector systems that have been coupled to 
them. However, special regard will be given to mass spectrometry (section 2.4.5) as a 
detector system, as its use is becoming ever more important and the chromatographic 
systems used in chapter 3 all use this technology. The second last section (section 2.4.6) 
will deal with the chemical process of derivatization as a method to enhance GC-, LC- and 
SFC-MS analysis, while the last section (section 2.4.7) will take everything together and 
put things in perspective. Together these sections aim to provide background information 
and a deeper understanding and knowledge into the systems used in chapter 3. 
2.4.2 Gas chromatography 
 
Although chromatography dates back to 1903, modern gas chromatography as it is known 
today was only first developed and published by A.T James and A.J.P Martin in 1952 (21). 
In their publication (22) the authors described the modifications necessary to allow the 
compression of the mobile phase to the theory of gas-liquid partition chromatography 
(GLPC), or GC, originally proposed by Martin and R.L.M Synge in 1941. Martin and 
Synge‘s theory stated the following: ‗a very refined separation of volatile substances 
should be possible in a column in which permanent gas is made to flow over a gel 
impregnated with a non-volatile solvent‘ (23). From these two publications followed the 
concept of separating volatile substances on a column with a gaseous mobile phase. 
Today these theories and their improvements are practically invisible with state-of- 
the-art equipment implementing almost a century worth of knowledge in mere minutes. 
Currently, the most noteworthy improvement to conventional GC is the use of a pair of 
columns, normally one polar and the other non-polar, in what is known as two dimensional 
GC, or GCxGC chromatography. In this technique separated compounds from the first 
column is transferred to a second column for further separation. Finally, specialized 
software renders the chromatograms of both columns in two dimensions (24). The 
advantage of using this technique is that compounds with similar boiling points co-eluting 
on one column can be separated on the second before traveling to the detector, yielding 
improved results. 
To detect the volatile compounds separated by GC and GCxGC various detection 
methods have been employed over the years such as thermal conductivity- (TCDs), flame 
ionization- (FIDs), catalytic combustion- (CCDs), discharge ionization- (DIDs), electron 
capture- (ECDs), helium ionization- (HIDs), nitrogen-phosphorus- (NPDs), infrared- (IRDs), 
photo-ionization-  (PIDs),  pulsed  discharged  ionization-  (PDDs)  and  vacuum  ultraviolet 
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detectors (VUV) as well as mass spectrometers (MS). Of these, TCDs and FIDs are the 
most commonly used detectors for GC (21, 25, 26). However, the use of MS is becoming 
ever more increasing as smaller quantities of sample are needed and these detectors yield 
improved sensitivity. The use of MS as a detector will be discussed in section 2.4.5. 
2.4.3 Liquid chromatography 
 
Although the ground breaking work  on liquid chromatography (LC) by Mikhael Tsvet 
should not be forgotten, Martin and Synge‘s work also set the stage for modern liquid 
chromatography with the development of high performance liquid chromatography (HPLC) 
in the early 1960s and 1970s. Seeing that GC relies on the volatility of compounds, 
scientists in the field of biology found it difficult to separate biological molecules with GC as 
these normally had too high a molecular weight or were far to polar to be volatile enough 
for use in GC instrumentation. With this came the development of HPLC as a 
consequence of both the unsuitability of GC and the long separation times of existing LC 
techniques. 
Unlike conventional LC, HPLC entails the separation of compounds in a sample on 
a column under highly pressurized liquids. Samples injected on these instruments do not 
require volatilization of compounds for analysis and have the added benefit of shorter 
separation times (27). With the break of the 21st century advances in column technology 
and instrumentation  ‗upgraded‘ HPLC to UPLC and  with that again came  significant 
increases in speed, sensitivity, resolution and shorter separation times (28). 
Like GC, a number of LC detectors have also been used over the years. These 
detectors include the likes of electrochemical-, refractive index-, UV-, fluorescence-, light 
scattering-, conductivity, infrared, chemiluminescent-, chiral, corona discharge-, radio- 
active- and MS detectors (29). Here, the most widely used detector is probably the UV/VIS 
detectors coupled to HPLC, while modern UPLCs are mostly coupled to photo diode 
arrays (PDA, UV), fluorescent or MS detectors, or a combination thereof, but are not 
limited to only these. 
2.4.4 Super-critical fluid chromatography 
 
Much effort was put into the development of GC and LC over the past century to the point 
of modern day instruments, with improvements initially focussed on GC and later HPLC. 
However, it was probably only in the past three decades that improvements to SFC let to 
the recognition of the technique as a useful separations method. This is particularly 
concerning as the first report of SFC was in 1962 by Klesper and colleagues, round about 
Stellenbosch University  https://scholar.sun.ac.za
13 
 
 
 
the same time HPLC was the technology of interest. In SFC, a gas at its super-critical 
point is used as the mobile phase to separate compounds in a sample injected on a 
column similar to that of HPLC/UPLC. Like HPLC, a major limitation of SFC was due to 
instrumentation that was unable to handle the pressures required. However, the 
improvement of HPLC equipment lead to the improvement of SFC and consequently 
improved performance. While GC had a high resolution and sensitivity, HPLC and later 
UPLC had shorter sample run times. Importantly, GC often required compounds to be 
derivatized (e.g. estradiol) – a labour intensive and expensive task, to increase the 
compound‘s volatility, while, HPLC had a lower resolving power than GC (30). 
SFC, on the other hand, has properties of both GC and HPLC/UPLC. Gas 
compressed to a super-critical fluid has a density similar to that of a liquid in HPLC/UPLC, 
gas-like viscosity similar to that of GC, while at the same time having a diffusivity 
somewhere between that of GC and HPLC/UPLC. This makes SFC ideal in that the 
technique could have high resolution, sensitivity and shorter sample run times (30). 
Indeed, in 2012 the Waters Corporation released the first of its kind SFC instrument, called 
the UPC2, able to fulfil the requirements of high resolution, sensitivity and shorter run 
times. In addition, the UPC2 also provides high selectivity for compounds where it is able 
to separate structural analogues, enantiomers, diastereomers and isomers. According to 
Waters, the UPC2 is further both economically and environmentally friendly, making it an 
attractive alternative to GC and HPLC/UPLC (31). The efficiency of this system was 
recently shown in two articles focussing on the separation of endogenous hormones 
normally not possible or economically viable on GC or HPLC/UPLC (32, 33). 
Since its first appearance in 1962, SFC instrumentation has been coupled to both 
detectors normally associated with GC and LC. These include FIDs, UV photometers, 
PDAs, and MS detectors, with the most frequently used being FIDs from the ‗60s to the 
‗90s and MS detectors from the 21st century (30). 
 
2.4.5 Mass spectrometry as an ultra-senstive detector system for GC, LC and 
SFC 
The ion source 
 
After chromatographic separation, compounds travel to the MS unit where they are first 
ionized by the ion source to form precursor ions. For vapours and gasses, such as those 
used for the mobile phase of GC instruments, electron- or chemical ionization (EI or CI) 
are  used,  while  electrospray-  and  matrix  assisted  laser  desorption  ionization  (ESI  or 
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MALDI) are used for liquid mobile phases such as those from UPLC instrumentation. Of 
the aforementioned ionization processes CI, ESI and MALDI are soft ionization 
techniques, while EI is a hard ionization technique – referring to the ability of an ionizing 
source to cause maximal fragmentation compared to minimal fragmentation in soft 
ionization. GC is most often associated with hard ionization as the high degree of 
fragmentation provides unique insight into the structural integrity of a molecule that allows 
the identification of unknown compounds from libraries. In contrast, LC is more commonly 
associated with soft ionization with minimal fragmentation, allowing the determination of 
e.g. molecular weights of biological molecules (34). 
 
The mass analyser 
 
Following ionization, the ions are transported by electric or magnetic fields to the second 
component of a MS unit – the mass analyser. Here, they are separated according to their 
mass-to-charge ratio. This step is then normally followed by a collision step, with a specific 
collision energy (CE), in the collision chamber to generate a wide variety of product ions. 
The three most commonly used mass analysers are time-of-flight (TOF), quadrupole and 
ion trap analysers. TOF analysers operate on the time it takes an ion to travel to the 
detector when accelerated by an electric field. In contrast, quadrupoles selectively filter 
ions from an electric field, using radio frequencies and direct current voltages, according to 
their m/z ratio before reaching the detector (35–37). Both analysers offer great advantages 
to the user. Quadrupoles offer selectivity, especially when used in tandem (MS/MS), for 
targeted method approaches such as looking for a specific drug in a water matrix. The 
downfall of the targeted approach is that the same drug modified, e.g. by chlorination 
through waste water treatment, in the same water matrix might be missed. TOFs, on the 
other hand, offer the screening of a sample for ions with masses over a specific range and 
therefore can detect e.g. both the ion in question and modified forms. However, TOF lacks 
sensitivity and linearity when compared to quadrupoles and therefore are rarely used for 
quantitation. In contrast to TOFs and quadrupoles, ion traps store selected ions in a trap 
where they can be manipulated before reaching the detector (38). This makes ion traps 
highly sensitive and provides high resolution MS. However, the trapping of ions comes at a 
price : the quality of the mass spectrum can be influenced by other ions generated in the 
experiment that is also trapped by the ion trap analyser (39). 
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The detector 
 
Finally, the MS  detector measures the current produced when a product ion passes 
through an electromagnetic field or the charge induced when it hits a metal plate. It is then 
also this transition detected from the precursor ion (the ion produced by the ion source and 
monitored with the mass analyser) to a product ion (the ion generated from collision) that 
is used in single or multiple reactions monitoring (SRM or MRM). The resulting transition is 
specific to each compound and therefore is the identity of the compound of interest. The 
type of detector used in a MS depends on the analytical application and instrument design. 
A number of detectors have been used over the years. These include photographic plate-, 
Faraday cup-, electron multiplier (EM)-, electro-optical ion-, orbitrap- and Fourier transform 
ion cyclotron resonance (FTICR) detectors, with the most frequent detector used today 
being the EM (40). 
2.4.6 Derivatization as a tool for enhancing GC-, LC and SFC-MS analysis 
 
Improvements to chromatographic techniques or their detectors can significantly improve 
obtainable results. However, results can also be improved through alternative methods. 
One such a method is derivatization. Plainly, derivitization is a chemical process in which a 
compound is modified by the addition of a derivitizing agent to a functional group of the 
compound, forming a product similar to the original with altered physiochemical properties. 
The altered properties can then be used as an advantage in analytical techniques. One of 
the best known groups of chemicals often derivatized for analysis is the estrogens and 
their synthetic analogues. Analysis with GC-MS proves difficult as these compounds have 
too low a volatility, while difficulty in their ionization is the primary concern when using LC- 
MS. However, the problem with low volatility and insufficient ionization can easily be 
solved by derivatizing these compounds with agents such as Dansyl Chloride (DNCl, LC- 
MS), or N,O-Bis(trimethylsilyl)trifluoroacetamide (BSTFA, GC-MS). For a  detailed 
summary of currently available derivatization techniques aimed at targeting the ketone and 
aldehyde, alcohol and phenol, carboxylic acid, amine and thiol functional groups, the 
reader is kindly referred to the review by Bao-Ling Qi et al. (41) (LC-MS) and a chapter by 
Francis Orata (42) (GC-MS). 
2.4.7 Connecting the dots of the chromatographic systems with those of the 
mass spectrometry systems and derivatization 
From sections 2.4.2, 2.4.3, 2.4.4 and 2.4.5 it is evident that a number of analytical systems 
are available to determine exactly what type of pollutants are present in a sample and that 
mass spectrometry provide a high sensitivity for the different chromatographic systems. 
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Furthermore, together with derivatization even difficult-to-analyse pollutants can be 
detected in samples. Therefore, the use of chromatography coupled to mass spectrometry 
is highly recommended for pollutant detection. However, unlike the biological methods, 
methods developed on the analytical instrumentation for detection of pollutants in samples 
require each method to be validated. This process can be an expensive and tedious 
process. Nevertheless, after method validation, analyses of samples become more 
affordable. For a detailed overview on chromatography mass spectrometry method 
validation the reader is referred to two articles by Kruve et al. (43, 44). 
 
2.5 The risk of EDC pollutants on humans and animals using 
breast cancer as an example of a possible consequence 
2.5.1 Overview 
 
In section 2.2 the global state of water scarcity and the risk of polluting the remaining water 
resources were discussed, while sections 2.3 and 2.4 focussed on how to monitor pollution 
with biological and analytical chemistry methods. This section, in contrast, aims to 
emphasize the risk to humans and animals if some of the discussed pollutants  are 
detected in water resources. The discussed pollutants all belong to the group known as 
EDCs. The focus will fall on these compounds as they have a tendency to lead to bio- 
magnification with health consequences throughout the different trophic levels. As humans 
are on top of  the food chain, the discussions to follow will mostly deal with human 
physiology and the consequences related to us. To conceptualize the incredible risk that 
these compounds pose in our water resources, BC is used as one of the many possible 
consequences. The three sections (Sections 2.5.2, 2.5.3 and 2.5.4) to follow will deal with 
the human endocrine system and its function in the regulation of homeostasis. The 
remaining sections will focus on ED with specific regard to the routes of EDC exposure, 
EDC modes of action, BC and the most common EDC and their role in BC. 
2.5.2 Maintaining homeostasis 
 
Levels of organisation in the human body 
 
The human body can be organised into five levels – chemical, cellular, tissue, organ and 
whole-body system level. The chemical level our bodies are made up of is a combination 
of trillions of atoms. These atoms essentially form the molecules of life, such as 
carbohydrates, fats, proteins and nucleic acids. Organising these molecules into the most 
basic units of life we find cells. Cells carry out the processes of life, such as obtaining 
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nutrients and oxygen from its environment, eliminating by-products and waste formed 
during chemical reactions and synthesizing the components needed for continued growth 
and survival. Grouping cells of similar specialization we find tissue. Each of the four 
primary tissue types – muscle, nervous, epithelial and connective, contain an intricate 
number of subtypes that each fulfil a particular objective. An example of this is muscle 
tissue. Muscle tissues can move the skeleton – termed skeletal muscles, pump blood from 
the heart to the rest of the body – termed cardiac muscles, and move contents through 
hollow tubes and organs – termed smooth muscles. Together, the different types of tissues 
make up an organ. Organs each perform a particular function (e.g. O2 and CO2 exchange 
by the lungs) or functions (e.g. food storage and digestion by the stomach) that enable the 
body system to accomplish a common activity (e.g. respiration by the respiratory system) 
that is essential for survival of an organism. 
As can be seen each level of organisation contributes to both the levels above and 
beneath them, and that no level can exist without the levels beneath it. Together these 
organisational levels work together to maintain the phenomena known as homeostasis. 
Defined as a dynamic steady state, homeostasis is essential for the survival of each cell, 
so that each cell, through its specialized activities, contributes as part of a body system, to 
the maintenance of the internal environment shared by all cells (45) (Figure 2.4). 
 
 
 
 
 
Figure 2.4 Interdependent relationship of cells, body systems, and homeostasis (45). The one system 
cannot function without the other. Together cells maintain body systems and vice versa. 
Stellenbosch University  https://scholar.sun.ac.za
18 
 
 
 
Homeostasis is maintained by 11 body systems working together 
 
Whether it be relaying information (nervous system) to muscle tissue in order to prevent 
the burning of your hand or the physical activity of moving the hand (muscular system) 
attached to the rest of the body (skeletal system); be it the lungs (respiratory system) 
supplying oxygen, via the blood (circulatory system), and therefore electron acceptors 
used during the metabolism of food (digestive system) for fighting off or protecting against 
pathogens (immune and integumentary system); or the removal of unwanted waste/by- 
products (urinary and digestive system) from food and cells; or even the supply of 
hormones driving reproduction (endocrine and reproductive system); all contribute to 
homeostasis. 
2.5.3 The human endocrine system 
 
Background 
 
Of these 11 body systems, the nervous system and endocrine system (all hormone- 
secreting glands) regulate the majority of bodily actions. However, whereas the nervous 
system‘s main function is to regulate activities at great speed e.g. reflex reactions, the 
endocrine system regulates activities that necessitate duration such as fight or flight. Some 
of the endocrines major functions are the regulation of nutrients, maintenance of 
electrolyte concentration in the extra cellular fluid, to help the body cope with stress by 
inducing adaptive changes, monitoring red blood cell production and regulating 
reproduction. Unlike the nervous system that transmit electrical signals to the brain for 
interpretation and back to the relevant organ for effect, the endocrine system secretes 
hormones into the blood for transport to its target cell or organ, where they coordinate their 
effect. 
There are some 50 odd hormones, not including their chemical intermediates, 
secreted and circulating in the human body, each with its own function and target cell or 
organ. These hormones are biochemically classified as peptide, amine, steroid or thyroid 
hormones. Peptide and amine hormones are hydrophilic in nature, whereas steroid and 
thyroid hormones are lipophilic. Of these four biochemical classes, peptide and steroid 
hormones are the most prevalent hormones. However, the discussions to follow will mainly 
deal with steroid and thyroid hormones as their deregulation can affect an organism 
adversely. 
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Regulation of the endocrine system by the HPG, HPA and HPT axes 
 
The secretion of effector hormones, such as androgens, estrogens, progestogens, 
thyroxine (T4), aldosterone and cortisol, are mainly controlled by three pathways – the 
Hypothalmic-Pituitary-gonadal axis (HPG), Hypothalmic-Pituitary-Adrenal axis (HPA) and 
Hypothalmic-Pituitary-Thyroid axis (HPT) axis (Figure 2.5). 
 
 
 
 
 
Figure 2.5 The three hypothalamus controlled axis involved in maintaining endocrine homeostasis. 
TRH, Thyroid-releasing hormone; TSH, Thyroid-stimulating hormone; CRH, Corticosteroid-releasing 
hormone; ACTH, Adrenocorticotropic hormone; GnRH, Gonadotropin-releasing hormone. 
 
 
 
The HPT axis is responsible for the regulation of metabolism and growth and the 
HPA for stress, digestion, immunity, mood etc., while the HPG axis mainly play a role in 
reproduction and life cycles. In the HPT axis, the hypothalamus regulates the levels of T4 
and tri-iodothyronine (T3) by responding to low or high levels of T3 and T4 in the blood. 
When either T3 or T4 is low, the hypothalamus releases thyroid-releasing hormone (TRH) 
which stimulates the release of thyroid-stimulating hormone (TSH). TSH in turn, acts on 
the thyroid to produce T3 or T4, returning the levels in the blood to normal. Similarly, the 
HPA and HPG axis respond to low levels of glucocorticoids, mineralocorticoids and sex 
hormones by releasing corticosteroid-releasing hormone (CRH) or gonadotropin-releasing 
hormone (GnRH) followed by the production of adenocorticotropic hormone (ACTH), 
luiteinizing hormone (LH) or follicle-stimulating hormone (FSH), before the adrenal (HPA) 
or gonadal (HPG) hormone levels in the blood return to normal. However, in the case of 
excess  sex  steroids,  glucocorticoids,  mineralocorticoids  or  thyroid  hormones,  these 
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hormones suppress the release of their stimulating or releasing hormones through 
negative feedback loops. Finally, the three axes are linked in that they can coordinate 
each other‘s outcome through product inhibition. Figure 2.5 only illustrates the basic 
regulation of the endocrine system by the three axes but is in fact a complex integrated 
system regulated by many mediators. Disruption of the endocrine system can therefore 
have serious consequences to an organism. 
2.5.4 Signal transduction 
 
Signal transduction is a complex process (Figure 2.6) wherein extracellular signals, in the 
form of chemical messengers bring about an intracellular response such as the activation 
of genes responsible for cell proliferation. These chemical messengers include hormones, 
pheromones, neurotransmitters and growth factors, cytokines and cell adhesion 
molecules. Typically these messengers are synthesized by specialized cells such as those 
from the endocrine organs – the testes, ovaries and adrenal cortex. After release into e.g. 
the blood stream, these molecules are transported to the relevant tissues before they are 
detected by intracellular receptors or on the surface of a cell in tissues. Consequently, a 
response is initiated and where-after the molecules are removed again. The extracellular 
receptors detecting these molecules include G-protein coupled receptors (GPCRs), 
enzyme-linked receptors [receptor tyrosine kinases (RTKs), receptor tyrosine 
phosphatases, serine/threonine kinases, receptor guanylyl cyclases and histidine kinases], 
integrins, toll-like receptors (TLRs) and ligand-gated ion channels. Alternatively, the 
intracellular receptors include nuclear and cytoplasmic receptors. For the purpose of this 
thesis and content to follow only signal transduction through GPCRs, RTKs and nuclear 
receptors will be of value. 
 
Nuclear receptor mediated signal transduction 
 
Nuclear receptors (NRs) are a group of steroid hormone sensing receptors. However, 
these receptors are not limited to only steroid hormones and are known for their ability to 
also bind xenobiotics – chemicals not native to an organism. Forty-nine, 48 and 47 NRs 
have been identified in mice, humans and rodent respectively (47). These receptors can 
be categorized according to their sequence homology into the subfamilies thyroid hormone 
receptor-like, retinoid X receptor-like, estrogen receptor-like, nerve growth factor IB-like, 
steroidogenic factor-like, germ cell nuclear factor-like and miscellaneous (48, 49). For the 
purpose of the section on endocrine disruptor modes of action, only the subfamilies thyroid 
hormone   receptor-like,   retinoid   X   receptor-like   and   estrogen   receptor-like   are   of 
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importance and will be discussed throughout this thesis. However, the main focus will be 
on nuclear receptors. 
 
 
 
 
 
Figure 2.6 Complexity of signal transduction in mammals. Adapted from Hanahan and Weinberg (46). 
 
 
 
Nuclear receptors can be subdivided into four mechanistic classes namely Type I, 
II, II and IV (50, 51). This thesis will focus only Type I and II mechanism (Figure 2.7 and 
Figure 2.8). Type I receptors (Figure 2.7) are activated by steroid hormones/xenobiotics 
after crossing the cell membrane and binding to the nuclear receptor/heat shock proteins 
(HSPs) complex (52). This causes the HSPs to dissociate and homodimerize, followed by 
translocation to the nucleus where the dimerized complex binds the hormone response 
element (HRE), recruits co-activators and target gene transcription is initiated (52). This is 
known as transactivation. In contrast, transrepression involves the binding of a single 
liganded-receptor and NFκB/AP-1 to NFκB/AP-1 gene element (not shown in Figure 2.7), 
followed by repression of the target site genes. Type 1 receptors include the androgen 
receptor (AR), estrogen receptors (ERs), glucocorticoid receptors (GRs) and progesterone 
receptors (PRs) (53). 
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Type II receptors (Figure 2.8) reside within the nucleus of a cell regardless of 
ligand binding status (52). Unlike type I receptors, type II receptors heterodimerized with 
another NRs. The most prominent of these being the retinoid X receptor (RXR) (52). Upon 
ligand binding to NR, corepressors dissociate and co-activators proteins recruited, where- 
after additional proteins such as RNA polymerase is finally recruited for transcription of the 
target genes (52). Type II receptors include RXR, PXR, TR and CAR (52, 54). 
 
 
 
 
 
Figure 2.7 Signal transduction mediated through class I nuclear receptors. NR, Nuclear receptor; 
HSP, Heat shock protein; HRE, Hormone receptor element. 
 
 
 
 
 
Figure 2.8 Signal transduction mediated through class II nuclear receptors. LBD, Ligand binding 
domain; DBD, DNA binding domain; HRE, Hormone response element; RXR, Retinoid X receptor; TR, 
Thyroid receptor. 
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GPCR and RTK mediated signal transduction 
 
GPCRs and RTKs are part of a superfamily of transmembrane receptors, the other being 
ligand-gated ion channels, that bind ligands on the surface of the cell (Figure 2.9) (55). 
GPCRs are solely expressed on the membranes of eukaryotes and are activated by 
pheromones, neurotransmitters, hormones, odours and photosensitive compounds (55– 
57). The two principal GPCR activated pathways include the cyclic AMP (cAMP) and 
phosphatidylinositol (PI) pathway (58). In contrast, RTKs bind majorly growth factors, 
cytokines and hormones such as epidermal growth factor, hepatocyte growth  factor, 
insulin and nerve growth factor (55, 57). These receptors play an integral role in normal 
cellular processes but have been linked to the development and progression of cancer 
(59). 
 
 
 
Figure 2.9 Simplified signal transduction pathways through cell surface receptors. 
 
 
 
Upon activation of a GPCR, the receptor undergoes a conformational change that 
activates a G-protein, transducing the signal to effector enzymes such as adenylyl cyclase 
and phospholipase C. These effector enzymes then produce second messengers such as 
cAMP,  inositol-1,4,5-triphosphate  (IP3)  or  diacylglycerol  (DAG)  that  can  stimulate  the 
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release of Ca2+ from the endoplasmic reticulum or the activation of protein kinase C (PKC) 
to initiate a phosphorylation cascade leading to a cellular response. Alternatively, Ca2+ 
released from endoplasmic reticulum can also stimulate PKC to cause the phosphorylation 
of proteins as the case was with DAG (55, 57). 
In contrast to GPCRs, RTKs dimerize upon ligand activation. This enables the 
cytoplasmic structures of each monomer to trans-phosphorylate the other. Phosphorylation 
of specific tyrosine residues on the activated receptor complex causes the binding of Src 
homology 2 domains – conserved protein domains important in signal transduction, and 
phosphotyrosine binding domains. Consequently, the RTK transmit a hormone signal to a 
GTPase switch protein, Ras, which initiates a kinase signalling cascade through the 
serine/threonine-specific kinases, Raf and MEK, to mitogen-activated protein kinase 
(MAPK) cascade, evidently leading to a cellular response such as cell proliferation (55, 
57). 
EDCs initiate signal transduction leading to uncontrolled cellular processes 
 
Cells in the human body constantly respond to stimuli from either the nervous system or 
endocrine system, which enables them to perform their normal physiological functions. 
The HPA, HPT and HPG axes ensures that cells maintain homeostasis throughout these 
routine cycles by constantly adjusting the concentration of effector hormones. These 
effector hormones mediate their effect through the signal transduction pathways discussed 
above and each effector hormone controls a specific onset of cellular circumstances – 
whether it is cell proliferation or senescence, apoptosis or necrosis, metabolism or gene 
expression. The emphasis however is on controlled regulation, but every so often cellular 
processes go awry leading to things like cancer. The circumstances leading to this onset 
can be multifold but organizations such as WCRFI attributes much of what is known about 
the initiation and progression of cancer to our lifestyles. 
It is believed that our continuous exposure to the diverse set of chemicals on a 
daily basis contributes to cancer. Indeed, EDCs such as the ones discussed in the next 
section have been researched extensively and many linked to the disruption of the 
endocrine system. These EDCs are shown to interfere with the endocrine system mediate 
responses such as cellular proliferation through signal transduction pathways disrupting 
normal controlled cellular responses and processes. To substantiate this view the next 
section will deal with the endocrine disruptor, the endocrine  disruption  phenomenon, 
routes of exposure, modes of action and their link to breast cancer initiation, progression 
and recurrence. 
Stellenbosch University  https://scholar.sun.ac.za
25 
 
 
 
2.5.5 Breast cancer is one of many possible consequences of ED 
 
EDCs 
 
According to the National Institute of Health (NIH), endocrine disruptors are ‗chemicals that 
may interfere with the body‘s endocrine system and produce adverse developmental, 
reproductive, neurological and immune effects in both humans and wildlife‘. Although 
correct, this definition only describes interference with the body‘s endocrine system and 
the adverse side-effects and makes no effort to point out the possible modes of action 
through which these chemicals interfere with the endocrine system to bring about the said 
side-effects. A more comprehensive definition is probably that of Crisp and associates on 
behalf of the United States Environmental Protection Agency (USEPA). In their 1998 
report USEPA defines an endocrine disrupting chemical (EDC) as an ‗exogenous agent 
that interferes with the synthesis, secretion, transport, binding, action, or elimination of 
natural hormones in the body which are responsible for the maintenance of homeostasis, 
reproduction, development and behaviour‘. This is evident from numerous studies showing 
that EDCs can alter the signalling and function of endogenous hormones (60–62), alter the 
biosynthesis of steroid hormones (63), cause teratogenesis (64), disrupt ovarian function 
(65, 66), reduce fecundity (61, 67), influence the timing and onset of menarche (61, 68), 
lead to early menopause (61), cause irregular lactation (69) and cancer (70–72). In 
addition, EDCs influencing steroid-sensitive tissue was found to disrupt the function of the 
CNS (73–75), lipid homeostasis (76–78), immune system (79, 80), glucose levels (81, 82), 
thyroid function as well as act as epigenetic modulators (83, 84). 
In 1989, Barker and colleagues postulated that environmental influences early in 
life lay the foundation for adult disease (85). This became evident in a study by Guillette et 
al. (86) showing the feminization of juvenile American alligators in Lake Apopka exposed 
to contaminated water. Sumpter and Johnson (87) noted that environmental endocrine 
disruption is caused by co-exposure of EDC at low concentrations, leading to additive and 
synergistic effects. With an estimated 10 000 EDCs among common daily exposures (68), 
disease programmed at an early age is therefore inevitable. In addition, most EDCs 
perform their modulatory effect at concentrations well below the no-observed-effect-level 
(NOEL) (88), thereby limiting our ability to link certain EDCs to specific diseases and 
therefore attempts at prevention. With this in mind, it is no wonder that the United States 
Federal Interagency Breast Cancer and Environmental Research Coordinating Committee 
(IBCERCC) in 2013 stressed the necessity to study the effect of chemical exposure, 
predominantly EDC exposure, on a disease such as breast cancer (89). 
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Routes of EDC exposure to humans and animals 
 
The routes of EDC exposure to humans are practically limitless in our fast living, large 
production scale, processed, high performance, wealthy lives that we live, or try to live. As 
a consequence both humans and animals will suffer a similar fate – diseased-state lives. 
Unlike humans, animals don‘t have a choice of healthy living and therefore the onus lies 
with us humans to take care of the living that keeps us alive. With an estimated 1.3 billion 
tonnes of solid waste generated annually by cities around the world, leaching of EDC from 
plastics, industrial waste and medical waste etc. into our environment, especially into our 
water resources, are unavoidable (90). Moreover, every year an estimated 330 km3  of 
municipal waste water is generated (91). This generated waste water is high in soaps, 
emulsifiers, cleaning products, pharmaceuticals and personal care products (PPCPs), 
many of which has been linked to some sort of ED in both humans and animals. 
Although waste water treatment is generally considered complete, a number of 
studies show the opposite, with certain chemicals, such as Estrone (E1), 17β-Estradiol 
(E2), 17α-Ethinyl estradiol (EE2) – synthetic estrogen used in contraception, 
Carbamazepine – an antiepileptic, Venlafaxine – an antidepressant, Tramadol and 
Methadone – analgesics, Ketamine – an anaesthetic, Tamoxifen (TAM) – an anticancer 
drug, partially or incompletely removed by treatment plants (92, 93). These chemicals then 
end up in the environment where they can elicit an effect such as ED. The effect of 
chemicals such as Carbamazepine (CBZ), triclosan (TCS) and Diclofenac on aquatic life 
has been documented by Nassef et al. (94) and Jarvis et al. (95), the effect of PPCPs on 
aquatic life in a review by Brausch and Rand (96) and a case study by Zenobio et al. (97), 
while Jobling et al.(98, 99), Knacker et al. (100), Morthorst et al. (101)  and Skolness et al. 
(102) showed ED in fish, Carey and Bryant (103), van Wyk et al. (104), Hecker et al. (105) 
and Boone et al. (106) ED in amphibians, Kelce et al. (107), De Angelis et al. (108) and 
Rider et al. (109) ED in rodents and Prahalada et al. (110) ED in primates, associated with 
contaminated water sources. 
There is also a growing concern that effluent water or biosolids originating from 
waste water treatment plants that is used for irrigation and fertilization may further 
contribute to EDC build-up in the food chain by accumulating in the ground and evidently 
plants. This concern was probably initiated first by a review published by Xia et al. (111), in 
which the authors discussed the possibility of certain PPCPs to leach from biosolids into 
biosolid-applied soils. Subsequent work by the likes of Wu et al. (112), Karjanapiboonwong 
et al. (113), Wu et al. (114), Wu et al. (115), Dodgen et al. (116) and Dodgen et al. (117), 
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described the uptake of chemicals such as CBZ, diphenhydramine, triclocarban (TCC) and 
TCS, diazepam, naproxen, diclofenac, bisphenol A (BPA), 4-Nonylphenol and EE2, to 
name only a few, in roots and shoots of plants such as pepper (Capsicum annuum), 
tomato (Lycopersicon esculentum), collard (Brassica oleracea), lettuce (Lactuca sativa), 
radish (Raphanus sativus), spinach (Spinacia oleracea), Pickling cucumber (Cucumis 
sativus), Soybean (Glycine max) and Pinto bean (P. vulgaris), validating the concern that 
PPCPs – many of which are known EDCs, are possible to accumulate in agricultural 
plants. 
However few, EDC exposure through air has been reviewed by Rudel and 
Perovich (118). In their 2009 review, the authors highlights how six semi-volatile chemical 
classes – polychlorinated biphenyls (PCBs), brominated flame retardants (PBDEs), 
pesticides, phthalates, alkylphenols and parabens persist in indoor and outdoor air, can 
have potential health effects. 
In summary (Figure 2.10), anthropogenic EDC originate from a number of point 
sources such as solid waste at landfills that leach into the environment, waste water 
treatment plant (WWTP) effluent that end up in fresh water resources and agriculture as 
well as the air. These transmission sources then provide the routes for entry into humans 
and animals. Consequently, as humans are at the top of the food chain and depend on 
those things in which EDC accumulate and also cause ED, we will be the organisms 
affected most by biomagnification. It is then also this self-inflicted concern that is believed 
would one day drive the sixth mass extinction – the extinction of humanity. Whatever it 
might be first, resource limitation followed by the death of a species, diseased-state(s) 
followed by the death of a species or a combination thereof, the solution starts with us. 
EDC modes of action (MOA) 
 
The mechanism by which EDCs bring about ED is called the EDC‘s mode of action, or 
MOA. Currently the WHO leaves EDC MOA open-ended as results are still unclear (119). 
In an attempt to clarify some of the MOAs, two review articles by Tabb and Blumberg (120) 
and Swedenborg et al. (121) will be used to summarize current affairs. 
Modulation of NRs through agonistic/antagonistic binding. By far the most 
widely studied EDC MOAs are the mechanisms through nuclear receptors (NRs) (120, 
121) – specifically the estrogen receptors (ERs), androgen receptors (ARs) and thyroid 
receptors (TRs) (122). In these mechanisms, hormone-like EDCs bind the NR either as an 
agonist  or  antagonist,  full  or  only  partially,   producing  estrogenic,  anti-estrogenic, 
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androgenic, anti-androgenic, thyroidogenic or antithyroidogenic responses, consequently 
disturbing homeostatic regulation of endogenous hormones and ultimately causing a 
disease-state. An example of a NR modulator is diethylstilbestrol (DES) – a synthetic 
estrogen, renowned for its ability to mimic E2 and activating the ERs. However, some 
EDCs, exhibiting NR modulation by mimicking the natural hormone, have been shown to 
also bring about dose-responses by ulterior means. An example is the plasticizer BPA. 
Although it mimics the dose-response of the natural hormone, E2 in activating the ERs, 
closer examination of its effects on gene expression indicate that BPA does not stimulate 
the same set of genes as E2 and therefore BPA is not a true estrogen, as it was designed 
to be (122). 
 
 
 
Figure 2.10 Routes of EDC exposure to humans. The various routes that EDCs can follow that 
ultimately affect animals and humans adversely. 
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Modulation of steroid hormone metabolism. Steroid hormone metabolism is a 
complex process involving multiple steroidogenic pathways, such as the classical, 
alternative, hydroxy-androstenedione and backdoor pathways (123–125). All steroids are 
derived from cholesterol, from which progestagens, mineralocorticoids, glucocorticoids, 
androgens and estrogens are synthesized by cytochrome P450 enzymes (CYPs), 
hydroxysteroid dehydrogenases (HSDs), aldoketoreductases (AKRs) and 5α-reductases 
(SRD5As), shown in Figure 2.11 (123). 
 
 
 
Figure 2.11 Steroidogenesis of the progestagens, mineralocorticoids, glucocorticoids, androgens 
and estrogens from cholestrol. 
 
 
 
Availability of these steroid hormones depend on hormone biosynthesis, transport 
to the relevant target tissue, the amount of steroid hormone binding proteins and hormone 
catabolism. It is well known from literature that EDCs can alter all of the above mentioned 
processes (126–128). Two nuclear receptors, the human steroid and xenobiotic receptor 
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(SXR)/rodent pregnone X receptor (PXR) (129, 130) and constitutive androstone receptor 
(CAR) (131, 132), and a ligand-activated transcription factor (TF), aryl hydrocarbon 
receptor (AhR), have been implicated in modulating steroid hormone metabolism upon 
xenobiotic stimulation. SXR/PXR and CAR both regulate steroid hormone and xenobiotic 
metabolism (129–132). These receptors also mediate the induction of P450 enzymes such 
as CYP3A, CYP2B and CYP2C (133), as well as conjugation enzymes such as UGT1A1 
(134) and the transporters P-glycoprotein, organic anion transporter peptide 2 and 
multidrug resistance-associated proteins (135). In contrast, AhR act on the genes of 
CYP1A2, CYP3A4, CYP1A1 and CYP1B1 responsible for the hydroxylation of E2 (136). In 
addition, AhR also act on CYP19B (aromatase) responsible for converting testosterone (T) 
to E2 (121). 
A number of EDC have been shown to activate SXR/PXR, CAR and AhR. Schuets 
et al. (137) and Masuyama et al. (138) reported that certain phthalates, nonylphenol and 
organochlorides can activate mouse PXR and induce CYP3A. Similarly, Takeshita et al. 
(139) showed that BPA stimulate human SXR. Mikamo and colleagues (140) investigated 
the induction of CYPs by EDCs and found 54 EDC that is able to activate rat PXR and 
consequently induce the expression of CYP3A. Furthermore, classic EDCs such as Trans- 
nanochlor – a component of the currently band pesticide chlorodane, 1,1-dicloro-2,2-bis(ρ- 
chlorophenyl)ethylene – the metabolite of another band pesticide DDT and Methoxychlor – 
a substitute for DDT and structural analogue was reported to repress the basal activity of 
CAR in mice, increase both PXR and CAR transcriptional activity and activate SXR/PXR 
and CAR, respectively (141–143). It is hypothesised that the stimulation of CAR and 
SXR/PXR and the upregulation of their target genes increase the amount of EDC 
metabolites and consequently affect the bioavailability of endogenous hormones (120). 
Similarly, the activation of CYPs through the AhR by organic compounds such as 
dibenzofurans (PCDEs), polycyclic aromatic hydrocarbons (PAHs),  dioxins, 
polychlorinated biphenyls (PCBs), benzofavone and benzo[a]pyrene (BaP), is believed to 
disturb endogenous hormone homeostasis (121, 144). 
Modulation of NR co-activators. In the section on signal transduction through NR it was 
mentioned that co-activators are recruited after the NR binds to the HRE before 
transcription is initiated. These co-activators include members of the p160 family such as 
the steroid receptor coactivator-1 (SRC-1), glucocorticoid receptor interacting protein-1 
(GRIP-1),  amplified  in  breast  cancer  (AIB-1)  and  thyroid  hormone  receptor  activator 
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protein 220/peroxisomal proliferator-activated receptor gamma (THRAP220/PPAR-γ) 
(145–147). 
In their 2002 article, Min and colleagues (148) showed that CAR can inhibit the 
transcriptional activity mediated through the ERs without ever binding to the estrogen 
response element (ERE). In their study overexpression of CAR caused a decrease in ER 
activity in a dose-dependent manner. Furthermore, treatment with a CAR agonist 
enhanced transcriptional repression mediated through CAR. When the authors then 
treated with androstenol – an antagonist of CAR, CAR-mediated transcriptional repression 
was relieved. From this it can be gathered that there exist competition between steroid 
receptors (SR) and xenobiotic receptors, and that the presence of xenobiotics mediating 
their effects through xenobiotic receptors could influence transcriptional regulation leading 
to ED. This corroborates finding from Reen and colleagues (149) where overexpression of 
both the AhR and ER co-activator-binding domain in mammalian cells caused AhR and ER 
impairments. This is not surprizing as competition for ARNT by AhR and ER has been 
shown to be partially responsible for the dioxin, 2,3,7,8-Tetrachlorodibenzo-p-dioxin‘s 
(TCDD‘s), anti-estrogenic properties (150, 151). 
Furthermore, it has been suggested that disturbing the homeostasis of receptor 
and/or co-regulator mRNA and proteins would alter receptor activity (120). Inoshita et al. 
(152) showed that the EDC BPA increases THRAP220 and ERβ in mouse uterus. These 
results are similar to the findings of Lonard and co-workers (153), showing that selective 
ER modulators, hydroxy-tamoxifen (OH-TAM) and raloxifene, can increase steady-state 
NR coactivator levels, consequently boosting transcriptional activation of ERα. The results 
highlight the possibility that EDC can disturb receptor/co-regulator mRNA and protein 
homeostasis and thereby cause ED. 
Proteasome-mediated degradation of NRs to interfere with hormone receptor 
activity. Proteasomes are protein complexes found throughout most domains of life. They 
play a major role in regulating intracellular proteins and peptides by proteolytic 
degradation, to e.g. remove old or damaged constituents, ensure controlled cell cycles by 
removing cyclins mediating cell cycle progression as well as removing peptide antigens 
displayed by the major histocompatibility complex (MHC) on antigen-presenting cells. 
These old or damaged proteins, cyclins or peptide proteins are recognized by the 
proteasome after being polyubiquitinated. Other cell constituents targeted by the ubiquitin- 
proteasome include several members of the NR family. This prevents endogenous 
hormones   or   other  activating   signals   over   stimulating   cells.   Therefore,   inhibiting 
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proteasomal degradation of these NRs could increase their concentration within a cell. 
This was shown by Sheflin et al. (154). 
The receptors SXR/PXR are amongst the NRs regulated by proteasomal 
degradation. In a 2002 study Masuyama and colleagues (155) showed that the EDC 
phthalic acid can block the removal of PXR through proteasomal degradation compared to 
progesterone. This suggests that EDC can upregulate PXR protein levels by affecting 
PXR-mediated transcription. Recently Ohtake et al. (156) found that AhR and its 
heterodimerization partner, ARNT, are part of a ligand-dependent multiple-protein 
complex, 4B ubiquitin ligase, which plays a role in targeting proteins to the proteasome. 
This raises  concern as AhR ligands could then interfere with hormonal signalling by 
proteasome-mediated degradation of SRs. In 1993 Wang and co-workers (157) found that 
an anti-estrogenic AhR ligand could decrease ERα levels through proteasomal 
degradation, supporting the claim that AhR ligands can interfere with hormonal signalling. 
EDCs as hormone sensitizers. Chromosomes are packaged in chromatin that is 
folded around histones when not being transcribed. For histones to bind these chromatin 
structures histone deacytalases remove deacytal residues on histones to inhibit gene 
transcription. Work by Jansen et al. (158) showed that short chain fatty acids with no 
hormonal ability, valproic acid – an anticonvulsant and mood stabilizer, and methoxyacetic 
acid – a metabolite of methoxyethanol, increased ERα, ERβ, AR, PR and TRβ activity by 
inhibiting histone deacytalases. Their work suggests that a xenobiotic could sensitize NRs. 
This is particularly concerning as any hormone therapies, such as contraception or 
hormone replacement therapy (HRT), or the presence of other hormone-like xenobiotics, 
could amplify effects by this mechanism. 
Interfering on DNA. It is thought that EDCs can bind to the AhR, which in turn 
binds inhibitory xenobiotic response elements (iXREs) situated close to the ER binding 
site, and thereby interfere with gene transcription (159). Hockings and colleagues (160) 
showed that the activated AhR could also bind XRE sites, normally occupied by unliganted 
AhR necessary for transcription, thereby abrogating gene induction by ER. However these 
findings need further investigation. 
DNA methylation as a method for reprograming germ cells. Like histone 
deacytalation plays a role in gene transcription, so does the methylation of DNA. DNA 
methylation has been associated with key genetic processes such as X-chromosome 
inactivation, aging, carcinogenesis, genomic imprinting, and the repression of repetitive 
elements  and  is  important  in  normal  development.  In  primordial  germ  cells,  DNA  is 
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demethylated and remethylated during gonadal sex determination. As correct 
remethylation is vital during this step any ED mediated through NRs by EDCs could 
reprogram the germ line. 
Anway and co-workers (161) showed this MOA for methoxychlor and vinclozolin – 
a fungicide, when both these compounds altered, through DNA methylation, male germ 
cell spermatogenic capacity as well as the viability of sperm in rats. Rats further showed 
reduced fertility and lowered sperm development that was carried throughout the male 
germ line to the fourth generation. These results highlight the possible outcome of early 
exposure to EDCs. 
Species specific effect. A particular interesting phenomenon was recently 
documented. Tabb and colleagues (162) found that highly chlorinated PCBs stimulated 
rodent PXR but antagonized the SXR of humans, consequently inhibiting gene expression 
involved in three phases of xenobiotic and hormone metabolism. The ability of these PCBs 
to have agonistic properties in one species and antagonist in another could point to a new 
MOA. The results, although interesting, could demerit EDC studies in toxicological model 
organisms. 
EDCs as obesogens. Both Tabb et al. (120) and Swedenborg et al. (121) in their 
reviews acknowledge the role that EDCs play in acting as obesogens. It is known that 
certain NR play a crucial role in glucose uptake and fat metabolism and their dysregulation 
by EDC could contribute to obesity. In addition, AhR and its role in glucose homeostasis 
and lipogenesis have been shown by Thackaberry et al. (163) and Sato et al. (164),while 
the role of ARNT in diabetes-2 was established by Gunton et al. (165). It is hypothesized 
that loss ARNT expression coincides with impaired insulin release, leading to diabetes 
(165). Furthermore, the key regulator of adipose tissue, PPAR-γ, and its 
heterodimerization with RXR are known for their ability to regulate the genes involved in 
glucose and fatty acid metabolism as well as insulin signalling. Both PXR and RXR have 
been shown to be activated by organotins such as trybutyltin (TBT) and thereby induce 
adipocyte differentiation (166–168). Finally, EDCs such as PCB-77 has also been shown 
mediate adipocyte differentiation through the AhR, the surfactant, octylphenol, to increase 
the adipocyte specific hormone, resistin, which plays a role in insulin-resistance and BPA 
to increase pancreatic β-cell insulin as well as inhibiting adipocytes to release adiponectin 
(169–171). 
Stellenbosch University  https://scholar.sun.ac.za
34 
 
 
 
Breast cancer 
 
BC is the most common cancer in women worldwide and leading cause of cancer deaths 
in the US for women aged 20-59. In the US alone, new breast cancer incidences for the 
year 2016 were expected to reach 29% while the death toll was estimated to reach 14%. 
Globally, 15% of cancer-related deaths in women are attributed to breast cancer (172, 
173). However, according to US cancer statistics only 5-10% of BCs can be linked to gene 
mutations, such as BRCA1 and BRCA2, (174). Moreover, 85% of women with breast 
cancer have no family history (174). These statistics thus raises the question: If not genetic 
and there exists no family history, what then causes BC? 
Anatomy and physiology of the human breast. Anatomically, the breast area 
can be divided into four quadrants (Figure 2.12), namely, the upper inner and outer 
quadrants (UIQ and UOQ), and lower inner and outer quadrants (LIQ and LOQ). Studies 
have shown that 66% of breast tumours occur in the outer quadrant of the breast (175– 
177). Female breast is mostly made up of adipose tissue that covers the breast lobes, 
containing lobules, and milk ducts. The ductal system is covered by  epithelial  cells, 
thought to be the site where most breast cancers originate from (178). Each  lobule 
contains milk secreting alveoli consisting of a lumen, surrounded by alveolar epithelial cells 
and myo-epithelial cells. Within the adipose tissue there are also ligaments, fibrous 
connective tissue, nerves, lymph vessels, lymph nodes and blood vessels. Together these 
systems maintain a healthy breast necessary for possible parturition. 
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Figure  2.12  Frontal  view  of  the  human  breast  divided  into  four  quadrants.  UOQ,  Upper  outer 
quadrant; UIQ, Upper inner quadrant; LIQ, Lower inner quadrant; and LOQ, Lower outer quadrant. 
 
 
 
Throughout developmental the breast undergoes dramatic changes in shape, size 
and function. However, it is only during puberty that lobule formation starts and at the end 
of the first full term of pregnancy that the breast is fully matured. During all stages of 
development estrogens – estrone (E1), estradiol (E2), estriol (E3) and estetrol, and 
progesterone play a central role in the proliferation and differentiation of normal breast 
epithelium. Of these estrogens estradiol is the most common estrogen and most abundant 
estrogen form in nonpregnant women. In contrast, estriol is most commonly found in 
pregnant women. Estrone, on the other hand, is primarily detected in post-menopausal 
woman (179). It is also believed that during the stages of gestation, puberty and 
pregnancy women are particularly susceptibility to breast cancer where exposure to 
xenobiotics such as EDCs can cause irreversible and cross-generational effects (180). 
These hormones thus represent the different stages of a female‘s life and are key 
regulators during development. Deregulation of the estrogens and progesterone are 
therefore thought to be responsible for BC development (178, 180, 181). 
Breast cancer types. Histologically, BC can be grouped into four molecular 
subtypes, namely, luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) 
type and triple negative, corresponding to their ER, HER2 and PR status. Here ER-, PR- 
or HER2-positive refers to a BC cell expressing the ER, PR or HER2 receptor and 
therefore is responsive to estrogens, progestens or the human epidermal growth factor. 
One other factor, Ki67 – an antigen serving as a cellular marker for proliferation, is also 
used to distinguish the different types. Luminal A is by far the most common BC (30-70%) 
and has a HER-, ER+ and PR- or ER- and PR+ receptor status. These BC cells are 
normally responsive to hormone therapy. In contrast, luminal B only presents itself 10-20% 
of the time, with a HER2+ or HER2- receptor status with high levels of Ki67. In addition, 
luminal B also have an ER+ and/or PR+ receptor status. The HER2 type presents itself 5- 
15% of times and have ER-, PR-, and HER2+ receptor status. These BC are treated with 
drugs such as Herceptin. Lastly, triple negative/basal-like BC presents itself 15-20% of 
times and is unresponsive to hormone therapy as all receptor statuses are negative. 
Treatment normally involves surgery, radiation and chemotherapy (182–186). 
Factors influencing the initiation, progression and reoccurrence of breast 
cancer. The Centres for Disease Control (CDC) attributes breast cancer to several factors 
(Table 2.2). Some of these factors, such as HRT, contraception, early menstrual period 
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and the use of DES is the direct result of ED, and therefore these causes should be 
attributed to ED. BC are mainly attributed however to loss of function of BRCA1/BRCA2 
genes, diet, smoking, alcohol, radiation and a lifetime exposure to estrogens (Lipworth 
(187), Key et al. (188) and Yoshida and Miki (189)). In 1995 Lipworth‘s epidemiological 
study showed that 90% of BC cases are environmental in origin (187). This started an era 
of research dedicated to linking xenobiotics to health effects. 
 
 
 
 
Table 2.2 Factors attributed to breast cancer. Adapted from the CDCs website (190) 
 
Age Genetic mutations Early menarche 
Late/no pregnancy Not being active HRT 
Contraception Personal history of BC Family history of BC 
Radiation therapy History with DES Alcohol 
 
 
Most reports until 2003 investigated the link between BC and environmental 
estrogens that enter the body through food, water and air (191–194). However valuable 
these studies have been, some of the results cannot be extended to the high amount of 
xeno-estrogens present in the breast or the ability of these xeno-estrogens to migrate to 
the breast through food, water or air, where they can have their adverse effects. In 2001 
Darbre started investigating underarm cosmetics as the cause of breast cancer (195), 
showing that long-term exposure, to a variety of chemicals, at regular application intervals, 
of underarm cosmetics to the underarm breast area significantly increase BC susceptibility 
(178, 196, 197). This is in agreement with the earlier statement that 66% of breast tumours 
occur in the outer quadrant of the breast. Darbre and colleagues have since extended the 
list to personal care products (PCPs) (198). Some of these PCPs and their relevance to 
BC will be discussed in the section on common EDCs and their involvement in breast 
cancer. 
The hallmarks of cancer: setting the stage for the role of EDCs in breast 
cancer. Cancer is an extremely complex disease. To better understand its complexity it is 
often reduced to a number of ‗hallmarks‘ first suggested by Hanahan and Weinberg (46, 
199).  In  the  two  publications  on  ‗The  hallmarks  of  cancer‘  the  authors  reduce  the 
complexity of cancer development down to four basic underlying principles in addition to 
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two cancer enabling hallmarks. One, cancer cells cause sustained proliferation. Two, 
cancer cells can evade growth suppression and induce angiogenesis. Three, cancer cells 
can resist cell death. Four, cancer cells have the ability to activate invasion and 
metastasis. In addition, cancer cells have increased genomic instability and are able to 
reprogram energy metabolism. 
Since being first described in 2000 these hallmarks have been regarded as the 
gold standard for deciding the potential threat of chemicals, i.e. whether or not a chemical 
could cause cancer. In 2013, Sonnenschein and Soto (200) criticized the hallmarks for 
inconsistencies in data, ignored data, viewing cancer as a cell-based genetic disease, and 
the fact that their explanation of cancer phenotypes is based on the somatic mutation 
theory (SMT), namely, the theory that cancer is the consequence of mutations in body 
cells rather than germ cells, and its cell-centred variants. Instead the authors argue that 
cancer should be viewed as a tissue-based disease where the default states of all cells are 
proliferation and motility. Furthermore, carcinogenesis should be viewed as a 
miscommunication of reciprocal interactions between cells and their extracellular matrix. 
Nevertheless, the hallmarks of cancer proposed by Hanahan and Weinberg (46, 
199) serve as good characteristics of cancer when describing the ability of anthropogenic 
chemicals to modulate endogenous hormones necessary for normal cellular development. 
Therefore, the next section will deal with common EDCs and their involvement in breast 
cancer as if they can contribute to these hallmarks. 
Common EDCs and their involvement in breast cancer 
 
Pesticides. Pesticides are diverse group of chemicals which include herbicides, avicides, 
nematicides, repellents, insecticides, molluscicides, rodenticides, antimicrobials, 
disinfectants, fungicides, miticides, defoliants and desiccants (201). Generally defined as 
any substance or mixture applied to soil, water, plants, crops, animals, structures, clothing 
and furnishing, these substances attract or repel, kill, interrupt or regulate their targets 
(201). However, many of these substances have been shown to leach into ground or river 
water where they affect non-targeted organisms in the environment (202). Evidently, these 
compounds then also pose a risk to third parties, such as humans, that live in and depend 
on the affected environment for food. A case study by London and colleagues (203) linked 
organophosphate exposure under farm workers to an increased risk of suicide, 
emphasizing the effect on non-targeted organisms. 
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Probably one of the best described pesticides having ED properties is 
dichlorodiphenyltrichloroethane (DDT). First synthesized in the 1870s, this organochloride 
was used as an insecticide to control malaria and typhus during World War II. However, 
during the 1950s animal studies suggested that DDT influence reproductive success (204, 
205). These results were also discussed in the very controversial book, Silent Springs, by 
Rachel Carson (206). By the 1970s DDT was shown to accumulate in predatory animals 
higher up in the food chain (207). Later it was shown that DDT and its metabolites have 
estrogenic potential (208) and act as an androgen antagonist (209). In 1992 Wolff and 
Toniolo linked DDT to breast cancer (210). However, work by Lopez-Carillo et al. (211) did 
not support the findings of Wolff and Toniolo. In 2015, a case-control study by Cohn and 
colleagues (212) again showed that DDT exposure increased the risk of developing BC. 
Since the use of DDT a number of studies have linked other pesticides to 
diseased-states.  These  include  leukaemia  (213,  214),  lymphopoietic  cancers  (215), 
prostate  cancer  (216,  217),  non-Hodgkin‘s  lymphoma  (218),  brain  cancer  (219),  liver 
cancer (220), pancreatic cancer (221), multiple myeloma(222), diabetes (223, 224) and 
developmental effects (225). As pesticides are widely used today and so many of their 
active metabolites linked to some kind of ED, it is recommended that ED studies be 
performed before being released on the market. 
Industrial EDCs. The range of industrial EDCs is large and diverse. Therefore, 
this part will only focus on the members of most concern that includes plasticizers, plastic 
intermediates, alkylphenol ethoxylate precursors and industrial coolants. 
Plasticizers are the collective term used to describe additives added to a variety of 
materials for enhanced plasticity or fluidity. They can be added to plastics, concrete, 
gypsum wallboard and energetic materials such as rocket propellants and smokeless 
powders to enhance the elasticity and structure of commercial products. The most 
common plasticizers include trimellitates – used in the automotive industry or where 
resistance to high temperatures are needed, adipates and sebacates as well as maleates 
– used where resistance to low temperatures and UV are needed, biodegradable citrate 
plasticizers and phthalates. Many of these, particularly the latter group, phthalates, have 
been shown to be EDCs. 
Phthalates are lipophilic compounds used primarily in the production of polyvinyl 
chloride (PVC), nitrocellulose and polyvinyl acetate (PVA), medical products, toys, plastic 
coatings, cosmetic formulations and food wraps etc. (226). These compounds have been 
shown to be ubiquitously present in the environment and able to be absorbed through the 
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skin, to cross the placenta (227–229) as well as accumulate in breast milk (230–232). 
Moreover, these compounds have shown numerously to be potent endocrine disrupters 
exhibiting anti-androgenic activity in animal models (233), reduce reproductive organ 
weight and sperm count in male rodents, prolong estrous cycles and lowering circulating 
E2 in female rodents (234–237) as well as cause the late onset of menarche (238). Their 
role in breast cancer is also clear as these compounds mimic the natural hormones and 
bind ERs (19, 239, 240) and induce the expression of c-Myc – a regulatory gene important 
in cell cycle progression, cellular transformation and apoptosis, in ER- BC cell lines (241). 
In addition these compounds have also been shown to increase MCF-7 BC cell 
proliferation (226, 240) and mediate the activations of PPAR-α (242). In addition 
phthalates can also inhibit Tamoxifen-induced apoptosis in MCF-7 BC cells (226), 
reducing the effectiveness of endocrine therapy. It is therefore no shock to find that 
phthalate use in consumer products is restricted in both Europe and the United States. 
Another well-known is plasticizer with ED properties is the compound BPA. It is 
primarily used in the production of polycarbonate plastics and resins used for the 
packaging of beverage bottles and canned foods. A number of studies found that BPA can 
leach from the linings of food and soda cans, polycarbonate bottles and dental sealants, 
respectively (243–245). This is particularly concerning as BPA has been shown to 
increase the susceptibility of rats to develop prostate cancer and at low doses also reduce 
their sperm count. Additionally, BPA could increase prostate gland weight in male rats, 
while in also disturbing the development and tissue organization of the mammary gland. 
Moreover, BPA was found to cause deleterious effects in the vagina, accelerated growth 
and puberty as well as disrupt sexual differentiation in female rats (246–251). Hunt and 
colleagues (252) showed that BPA can also disrupt meiosis in mouse. Furthermore, BPA 
exposure has also been associated with obesity (77, 253, 254) and diabetes (255). Like 
phthalates BPA can also mimic endogenous hormones and bind the ERs (256). Lastly, 
BPA have been shown to target the mammary gland (256) where it can alter architecture 
of a mature breast in utero (68). 
Like BPA, nonylphenols are alkylphenols, with the most widely being used being 
4-nonylphenol (257, 258). 4-Nonylphenol is primarily used in the production of alkylphenol 
ethoxylates (APEs) that are used as wetting, dispersing, emulsifying and stabilizing agents 
in agricultural, domestic, industrial and consumer products (259, 260). Also able to leach 
from their final products, 4-nonylphenol is a persistent organic pollutants often detected in 
the environment (261–263). As with BPA, these compounds have also been linked to both 
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obesity and diabetes (77, 253, 254). Furthermore, 4-nonylphenol has been found to cause 
ED by mimicking the natural hormone E2. In doing so, 4-nonylphenol has been shown to 
interfere with the estrous cycle of rats as well as altering pubertal onset (264, 265). In 
addition, it can also cause proliferation of both estrogen-dependent and estrogen- 
independent breast cancer cells (266), indicating that this compound can modulate several 
physiological pathways. In pregnant women, even al low doses, 4-nonylphenol has been 
found to increase apoptosis and cell death in the cells of the placental. Moreover, 
treatment with 4-nonylphenol resulted in an increase in the secretion of interleukin (IL)-4 
and IL-10, reduced tumour necrosis factor alpha (TNFα) and increased interferon gamma 
(INFγ), in vitro of first trimester placental cells. This marked unbalanced cytokine profile is 
linked to implantation failure and pregnancy loss (267). 
Another group of EDCs commonly associated with cancer is polychlorinated 
biphenyls (PCBs). PCB‘s are lipid soluble persistent environmental pollutants used as 
dielectric fluids in capacitors and transformers, plasticizers, adhesives, organic diluents 
and flame retardants (268, 269). The group consist of 209 PCB congeners of which most 
have been linked to ED (268). These organochlorides are widely studied for their ability to 
act as a carcinogen, estrogen mimic, immune disruptor, modulator of cellular 
communication and inducer of human cytochrome P-450 (CYP) genes (270–273). In rats 
PCBs have been shown to cause liver cancer and in humans suggested to lead to the 
progression of BC (192, 274, 275). A study done by Liu et al. (276) showed that PCBs can 
increase the motility of both non-metastatic MCF-7 BC cells as wells as metastatic MDB- 
MB-231 BC cells. As metastasis in a fundamental characteristic of cancer cells, these 
properties link them to BC progression. However, PCBs doesn‘t only act as carcinogens, 
Brouwer and colleagues (277) showed that PCBs could also influence thyroid homeostasis 
by reducing their concentration of thyroid hormones in experimental animals. 
In conclusion, industrial by-products are shown to exert several mechanisms of ED 
by altering several physiological pathways within vertebrate endocrine systems. 
Pharmaceuticals. Many people consider pharmaceutical usage as safe when 
prescribed by a health practitioner. However, it is quite evident from most drug leaflets that 
medication can have severe side effects. In most cases, the longer a drug is on the 
market, the more adverse side effects are noted. However, as these side effects only get 
noticed over time, by the time a person has used the medicine multiple times, the adverse 
side effects have already run its course. A good example of a well-intended medicine, now 
an EDC, gone awry is the drug diethylstilbestrol (DES). Prescribed to women over the 
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period 1938-1971, this synthetic non-steroidal estrogen was meant to prevent 
miscarriages and contribute to a healthy pregnancy as well as to treat gonorrhoeal and 
atrophic vaginitis, postpartum lactation and menopausal symptoms (278). However, in 
woman taking DES prescriptions vaginal adenocarcinomas and an increased risk of BC 
was found (279–281). In addition DES daughters displayed an increased risk of cervical 
intraepithelial neoplasms, leukoplakia, mosaicism, clear cell adenocarcinomas, infertility 
and complication during pregnancy (279). Moreover, epididymal cysts, variococele and 
hypoplastic and undescended testes were observed in DES sons (282). From this it is 
clear what the possible outcome could be if a drug is not properly researched. 
An emerging environmental pollutant, detected regularly in aquatic systems 
around the world (283–285), and EDC is the anticonvulsant carbamazepine (CBZ). 
Primarily used to treat neuropathic pain, schizophrenia, bipolar disorder and epilepsy, this 
drug is the most widely used first-line anti-epileptic drug (AED). Studies done on patients 
treated with CBZ found that both men and women are prone to sexual dysfunction and 
reproductive endocrine disorders when taking this drug. In men, reduced potency of sperm 
as well as sperm abnormalities was noted (286–288), while women displayed menstrual 
disorders, polycystic ovaries and infertility (288–293). It is thought that CBZ causes AED- 
induced androgen deficiency by either inducing the synthesis of sex hormone binding 
globulin (SHBG) – the glycoprotein that binds androgens and estrogens, and thereby 
reduce the amount of loosely bound or unbound hormones, or, CBZ increases serum E2 
levels, which in turn suppress the synthesis of testosterone through a negative feedback 
loop (287, 288, 294–296). This is supported by findings from a number of studies that 
found CBZ-therapy was associated with lowered levels of dehydroepiandrosterone sulfate 
(DHEAS) (297–299). However, Perucca and coworkers (300) argued that the decrease is 
the result of induced CYPs. CBZ was also shown to alter the behaviour and growth of 
certain algae, fish and cladocerans (301–305), developmental abnormalities (306), 
modifications to fecundity (303, 305, 307) and histological changes in gonads and 
decrease levels of testosterone (308). Conversely, similar results obtained for CBZ was 
found for three other anti-epileptic drugs – Levetiracetam, Lamotrigine and Valproate. 
Personal care products. The term personal care products (PCPs) refer to any/all 
products used by consumers to enhance their personal well-being, including but not limited 
to, sun screens, toothpaste, antiperspirants, deodorants, roll-ons, soaps, detergents, body 
wash, lotions and cosmetics. Like pharmaceuticals, consumers often consider the use of 
these products as safe. Recently it has come to light that some active ingredients in PCPs 
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have endocrine disrupting properties, many of which are shown to cause proliferation of 
breast cancer cells in vitro. Particularly, research has shown the potential of three PCP 
preservatives to modulate endocrine system pathways, namely triclosan (TCS), 
triclocarban (TCC) and parabens. Of note, in September 2016 both TCS and TCC was 
classified as NOT generally recognized as safe and effective (GRAS/GRAE) by the FDA 
and therefore their use in consumer antiseptic washes banned in the USA (309). 
TCS is a chlorinated aromatic additive with bactericidal properties, present at 0.1- 
0.3% (w/w) of PCPs (310, 311). Its frequent use in PCPs is evident from WWTP 
concentrations reaching the parts per billion (ppb) to parts per million (ppm) range (312, 
313). A recent study by Calafat and colleagues (314) found that TCS is present in 75% of 
urine samples taken from US citizens. Moreover, TCS has further been shown to 
accumulate in breast milk (315), therefore creating the potential to bio-accumulate in 
lactating offspring. However, TCS has also been detected in women with no prior 
exposure to PCPs containing TCS (310, 316), suggesting there might be background 
exposure such as contaminated water. Due to the structurally similar conformation of TCS 
to thyroid hormones (317), its presence in vertebrates could have detrimental effects. TCS 
has been shown to accelerate metamorphosis in North American bullfrogs (Rana 
catesbaenia), as well as to decrease TRβ mRNA expression (318), reduce plasma 
testosterone and vitelloginin levels in the African clawed frog (Xenopus laevis) (319), 
inhibit the activity of rat and human microsome iodothyronine (T2) sulfotransferase (320) 
and decrease circulating T4 levels in rats (317). With regards to its ability to contribute to 
BC, TCS was found possess both intrinsic estrogenic and androgenic properties (321), 
able to bind the ER and thereby induce cell proliferation (321), and increase the 
expression of cyclin D1 and decrease the expression of p21 in MCF-7 BC cells (322). 
However contrasting results have also been noted as TCS have been found to inhibit fatty 
acid synthase (FAS) – overexpressed in certain cancers (323–326), as well as inhibits 
tumour development in rats fed with a diet supplement of a 1000 ppm TCS (327). From 
these studies it is evident that TCS might seriously contribute to ED and pose risk to BC, 
but more data is needed to support its link to the development of BC as contrasting 
findings suggest it might act as an anticancer drug or at least a cancer sensitizer. 
TCC is a TCS analogue with an identical biocidal activity as TCS. In contrast to 
TCS, TCC is used at higher concentration – typically 2% (w/w). However like TCS, TCC is 
also a commonly used in PCPs (328). Work by Ahn et al. (329), Chen et al. (330) and 
Sood et al. (331) showed that TCC on its own lacks the ability to induce ER-responsive 
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gene expression but in combination with E2 stimulates the expression of ER-responsive 
genes. Sood and colleagues also found that a single TCC exposure could activate the Erk- 
Nox pathway, increase cell proliferation, cause the elevation of reactive oxygen species 
(ROX) and DNA damage in MCF10A cells. In contrast, repeated exposure induced 
transient cancer-like characteristics in MCF10A cells such as reduced dependence on 
growth factors (RDGF) and anchorage-independent growth (AIG). Additional repeatedly 
exposed to TCC showed constitutive endpoints, including RDGF, AIG, cell proliferation, 
elevated ROS levels and Mek-Erk-Nox pathway activation. TCC is therefore considered to 
be an EDC with carcinogenic properties. Finally, TCC has been shown to be also able to 
disrupt thyroid hormone-responsive gene transcript levels in GH3 cells (332). 
Another group commonly used as preservatives are the parabens. These 
chemicals are esters of parahydroxybenzoate and are added to PCPs to a final 
concentration of no more than 0.8% (w/w). Of all the parabens the most commonly used in 
PCPs are methylparaben (MeP), ethylparaben (EtP), propylparaben (PrP) and 
butylparaben (BuP), of which MeP and PrP are the most likely to be found in PCPs, either 
alone or in combination with one another. Like TCS and TCC their frequent use is evident 
from their widespread detection in WWTPs and other aquatic systems. However these 
compounds have also been detected in urine (333–336), blood (337), semen (335, 338), 
breast milk (339, 340), breast tissue (341) and breast tumours (342). Their widespread 
distribution throughout the human body has raised concern even before Darbre and 
colleagues started investigating their link to ED and BC in 2002 (343–349). Since then 
parabens have attracted much attention for being present in tissue at concentrations 
equivalent to the amount needed for ER-responsive proliferation (350, 351) and their 
ability to stimulate not only MCF-7 BC cells but also MCF10A cells at low concentrations 
(351). In addition, parabens have not only been shown to induce both ESR1 and ESR2 
gene expression (349, 352, 353) but also increase CYP19A1 gene and protein expression 
in MCF-7 BC cells (351). 
Individually, PrP and BuP increase PR mRNA while MeP and PrP increase PR 
protein expression in MCF-7 BC cells and MCF10A cells (354). PrP have been found to 
increase plasma vitellogenin levels in Japanese medaka fish (355), while BuP and PrP at 
low doses could alter sperm production in rats and mice as well as cause DNA 
fragmentation, chromosome alterations and increase sister-chromatid exchanges in 
treated Chinese hamster ovary (CHO-K1) cells (356). Lastly, MeP was found to not only 
upregulate the mTOR pathway in human breast epithelial but also prevented OH-TAM 
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from suppressing breast cancer cell proliferation (357). Together, these properties show 
that parabens can act as EDC, carcinogens, BC progressors and act as BC treatment 
effectors, enough evidence to suggest their use in consumer PCPs are NOT GRAS/GRAE 
and therefore should also be banned, like the case is with TCS and TCC. 
2.5.6 Summary 
 
The sections above emphasized the importance of maintaining homeostasis and that 
disruption of the endocrine system could have adverse effects. Section 2.5.3 and 2.5.4 
discussed the role that the HPA, HPG and HPT axes play in maintaining homeostasis and 
how the hormones controlled by these axes play a central role in signal transduction to 
bring about effects such as the proliferation of cells. The last section (section 2.5.5) 
stressed how certain compounds can partake in uncontrolled signal transduction or 
interfere with signal transduction and that this disruption can be the causative effect behind 
diseases such as breast cancer. Finally, the sections also discussed the various routes 
that humans can be exposed to EDCs, with the environment that we find ourselves in 
playing a major role. 
Stellenbosch University  https://scholar.sun.ac.za
45 
 
 
 
CHAPTER 3 
 
 
DEVELOPING ANALYTICAL TECHNIQUES FOR THE 
PRE-CONCENTRATION, IDENTIFICATION AND 
QUANTIFICATION OF 9 COMMONLY OCCURRING 
POLLUTANTS WITH ED CAPABILITIES FROM 
ENVIRONMENTAL MATRICES 
3.1 Introduction and chapter objectives 
 
In chapter 2 section 2.3 and 2.4 the methods for monitoring pollution were discussed. It 
was concluded that the biological assays can indicate the presence of pollution but that 
these do not reveal the specific pollutant(s) present. However, the analytical chemistry 
methods discussed can both indicate pollution and identify the type of pollutant. Although 
these methods UPLC-, UPC2- and GC-MS/MS, have the advantage of specificity, their 
initial setup on the machines used is expensive, time-consuming and require a great deal 
of knowledge and experience. However, once machine setup has been validated their use 
become significantly less expensive, have a high sample throughput and does not require 
in-depth knowledge. This chapter reports on the aim to develop methods on the above 
mentioned systems that can be used to evaluate the JTED Eco-machine. The chapter 
aims and objectives are as follow: 
a) Develop and optimize methods on the identified instruments for common EDCs 
b) Determine  the  analytical  capabilities  of  each  instrument  and  thereby  the  best 
suitable analytical instrument 
c) Develop an EDC method capable of pre-concentrating the majority of identified 
EDCs from water or synthetic waste water (SWW) matrix 
d) Validate the pre-concentration, identification and quantification method 
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3.2 Results 
 
3.2.1 Eleven commonly occurring EDCs were selected for monitoring the 
efficiency of the Ecomachine and the state of water pollution by GC-, 
UPLC- and UPC2-MS/MS analysis. 
To monitor the efficiency of the Ecomachine and the state of EDC pollution in the Berg 
River, 11 commonly occurring EDCs and one human indicator were selected. Selection 
was based on already available EDC standards in the lab, most studied EDCs, the severe 
consequences (see section 2.5.5) if found in nature and possible contribution to breast 
cancer or the recurrence thereof. These EDCs include the three human estrogens – E1, E2 
and E3, the synthetic E2 analogue used as contraceptive – EE2, the four common PCP 
preservatives relevant to chapters 4 and 5 – MeP, PrP, TCS and TCC, the alkyl phenols 
BPA and 4NP, and the anticonvulsant CBZ. Additionally, paracetamol (PCM) was used as 
human indicator. To account for variation in sample preparation during the determination 
of each instruments analytical capability, development of the EDC pre-concentration 
method from water and SWW matrices and final validation, three radio-labelled internal 
standards  (IS)  –  4NP-d4,  E2-d5   and  CBZ-d10   were  chosen.  Finally,  three  analytical 
instruments readily available for analysis were selected. These include a Thermo Fischer 
GC coupled to an EI-MS/MS and a Waters UPLC and UPC2 coupled to the same ESI- 
MS/MS. All three instruments are considered state-of-the-art. The mass spectrometer 
coupled to both the UPLC and UPC2 is newly developed by Waters with tandem 
quadrupole S-wave (TQ-S) technology that is able to remove non-ionized compounds 
before proceeding to the detector, effectively decreasing background noise normally 
associated with non-ionized compounds. Seeing that the same mass spectrometer is used 
for UPLC and UPC2, setup was carried out once and the same precursor-to-product 
(transitions) used for both UPLC-MS/MS and UPC2-MS/MS. To improve the volatility and 
ionization of certain compounds during analysis, compounds were derivatized with DSCl 
(UPLC/UPC2) or BSTF (GC). The optimized MRM setup for UPLC/UPC2-MS/MS can be 
found in Table 3.2, while the optimized SRM setup with retention times for GC-MS/MS is 
displayed in Table 3.3. Retention times for UPLC/UPC2 are shown in Table 3.1. 
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Table 3.1 Retention times (min) of the different compounds when separated with UPLC or UPC
2 
on the respective columns described in materials and 
methods. 
 
 
 
 
CBZ 1.16 2.46 4.27 
CBZ-d10 1.15 2.45 4.26 
PCM 1.80 6.12 7.83 
E3 2.90 8.36 8.85 
TCC 2.85 6.12 9.28 
MeP 2.83 1.25 1.40 
PrP 5.14 1.19 1.37 
E2 5.37 5.82 7.20 
E2-d5 5.33 5.81 7.17 
EE2 5.60 5.73 7.44 
E1 5.70 3.11 3.80 
TCS 6.93 1.70 2.27 
BPA 7.54 5.36 5.99 
4NP 8.61 1.31 1.55 
4NP-d4 8.59 1.30 1.54 
Compound UPLC-MS/MS  UPC
2
-MS/MS 
 BEH BEH 2-EP Torus 2-PIC 
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Table 3.2 MRM transitions of each compound used in both UPLC- and UPC
2
-MS/MS analysis. Product ions printed in bold were used as quantifiers while 
their respective partners were used as qualifiers. Internal standards: 4NP-d4, E2-d5 and CBZ-d10. DND, did not derivatize; CV, cone voltage; CE, collision 
energy. 
 
 
Compound 
ESI 
Precursor CV (V) Product ion 1 Product ion 1 CE (eV) Product ion 2 Product ion 2 CE (eV) 
 mode  
CBZ + 237 (DND) 25 179 25 194 15 
CBZ-d10 + 247 (DND) 30 202 15 204 15 
PCM + 385 35 156 35 171 20 
E3 + 522 35 156 55 171 35 
TCC - 313 (DND) 20 126 20 160 25 
MeP + 386 35 156 40 171 20 
PrP + 414 35 156 40 171 35 
E2 + 506 35 156 40 171 35 
E2-d5 + 511 35 156 50 171 30 
EE2 + 530 40 156 40 171 35 
E1 + 504 20 156 45 171 35 
TCS + 522 20 156 55 171 35 
BPA + 695 50 170 35 171 35 
4NP + 454 20 156 40 171 20 
4NP-d4 + 458 30 156 50 171 30 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
49 
 
 
 
 
 
 
 
 
Table 3.3 SRM transitions and retention times of each compound used in GC-MS/MS analysis. Quantifier transitions are printed in bold. N/A. not 
applicable; DND, does not derivatize. Rt, retention time; m/z, mass to charge; CE, collision energy. 
 
Compound Underivatized 
mass 
Derivatized 
mass 
Precursor 
1 
Product ion 
1 
Product ion 
1 CE 
Precursor 
2 
Product ion 
2 
Product ion 
2 CE 
Rt 
(min) 
   (m/z) (m/z) (eV) (m/z) (m/z) (eV)  
CBZ 236.1 DND 193 165 10 193 193 12 20.88 
CBZ-d10 246.1 DND 203 175 10 203 203 12 20.80 
PCM 151.1 295 280.3 206.1 10 295 206.1 10 11.56 
E3 288.4 360 386.2 296.2 10 504.2 414.2 8 22.63 
TCC 314.0 DND 296 226 10 298 228 10 14.25 
MeP 152.0 224 209.1 177.1 8 224.1 209.1 8 10.51 
PrP 180.1 252 210.1 195.1 8 252.1 195.1 14 12.51 
E2 272.4 416 416.2 282.2 12 416.2 326.1 8 21.60 
E2-d5 277.4 421 421.3 287.4 15 421.3 331.3 8 21.56 
EE2 296.2 440 425.2 425.3 8 440.3 425.3 10 22.60 
E1 270.4 342 342.2 218 12 342.2 257.2 12 22.92 
TCS 288.0 360 345 200 12 347 202 8 17.83 
BPA 228.1 372 357.2 191.1 16 372.2 257.2 12 17.77 
4NP 220.2 292 292 292 8 292.2 179.1 10 14.44 
4NP-d4 224.2 296 296 296 8 296 183 8 14.35 
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3.2.2 Instrument method optimization 
 
After initial setup on each instrument, a number of variables were investigated that can 
affect the overall performance of each instrument to detect and quantify compounds. For 
UPLC- and UPC2-MS/MS, derivatizing solvent composition, mobile phase flow rate, 
column temperature (excl. UPC2-MS/MS), and desolvation gas temperature and flow rate 
were considered. In contrast, derivatizing solvent composition, EI emission current and Q1 
resolution, and split/splitless mode were considered for GC-MS/MS. To assess the 
influence of each variable on the overall performance of the instrument the parameters 
peak area, peak shape (b/a) and signal-to-noise (S/N) were monitored. Variable influences 
on the different instruments are shown in Error! Reference source not found. - Error! 
ference source not found.. The optimized method for UPLC-MS/MS, UPC2-MS/MS and 
GC-MS/MS are shown in Table 3.4, Table 3.5 and Table 3.6, respectively. Unfortunately 
during the optimization process it was found that the compounds 4NP and CBZ gave 
unreliable results and were excluded from the rest of the study. 
Table 3.4 UPLC-MS/MS method optimization. A, Acetone; B, 0.1 M NaHCO3 buffer (pH 10.5); C, 
Acetonitrile. 
 
 
Variable Tested Before optimization After optimization 
 
 
Mobile phase flow rate 0.35 mL/min 0.4 mL/min 
 
 
Desolvation gas Temperature 500 °C 550 °C 
 
 
 
Table 3.5 UPC
2
-MS/MS method optimization. A, Acetone; B, 0.1 M NaHCO 
Acetonitrile. 
buffer (pH 10.5); C, 
 
Variable Tested Before optimization After optimization 
Derivatizing solvent composition 50% A, 50% B 75%C, 25%B 
Mobile phase flow rate 1.8 mL/min 1.7 mL/min 
Desolvation gas Temperature 500 °C 500 °C 
Desolvation gas flow rate 800 L/Hr 800 L/Hr 
 
Table 3.6 GC-MS/MS method optimization. SPLESS. splitless; PSPLESS, pulsed splitless; P, pyridine 
 
Variable Tested Before optimization After optimization 
Derivatizing solvent composition 67% P, 33% BSTFA 67% P, 33% BSTFA 
EI emission current 50 µA 50 µA 
Q1 Resolution Wide (1.5 at 50%) Wide (1.5 at 50%) 
Injection (PSPLESS/SPLESS) PSPLESS PSPLESS 
 
50 
Desolvation gas flow rate 900 L/Hr 1000 L/Hr 
Column Temperature 50 °C 60 °C 
Derivatizing solvent composition 50% A, 50% B 75%C, 25%B 
3 
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Figure 3.1 The effect of derivatizing solvent on a compounds signal-to-noise (S/N) ratio, peak shape (b/a) and area during UPLC-MS/MS analysis. 
Derivatizing solvent consisted part organic solvent (see figure titles) and part buffer (0.1 M NaHCO3). The influence of the organic solvent part on a 
compounds’ S/N, b/a or area are represented as a significant effect caused. Effects are arbitrarily quantified as 0, 1, 2 and 3, corresponding to the 
significant (ns, non-significant; *, p<0.05; **, p<0.01;***, p<0.001) change observed from the initial S/N, b/a and area of pre-optimization conditions. 
Positive values represent favourable changes whereas negative values unfavourable. Significance was calculated using one-way ANOVA (n=3) with 
Dunnett multiple comparison post-test. 
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Figure 3.2 The effect of mobile phase flow rate (A) and column temperature (B) on a compounds signal-to-noise (S/N) ratio, peak shape (b/a) and area 
during UPLC-MS/MS analysis. The influence of mobile phase flow rate and column temperature on a compounds’ S/N, b/a or area are represented as a 
significant effect caused. Effects are arbitrarily quantified as 0, 1, 2 and 3, corresponding to the significant (ns, non-significant; *, p<0.05; **, p<0.01;***, 
p<0.001) change observed from the initial S/N, b/a and area of pre-optimization conditions. Positive values represent favourable changes whereas 
negative values unfavourable. Significance was calculated using one-way ANOVA (n=3) with Dunnett multiple comparison post-test. 
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Figure 3.3 The effect of desolvation gas flow rate (A) and temperature (B) on a compounds signal-to-noise (S/N) ratio and area during UPLC-MS/MS 
analysis. The influence of desolvation gas flow rate and temperature on a compounds’ S/N or area are represented as a significant effect caused. Effects 
are arbitrarily quantified as 0, 1, 2 and 3, corresponding to the significant (ns, non-significant; *, p<0.05; **, p<0.01;***, p<0.001) change observed from the 
initial S/N and area of pre-optimization conditions. Positive values represent favourable changes whereas negative values unfavourable. Significance 
was calculated using one-way ANOVA (n=3) with Dunnett multiple comparison post-test. 
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Figure 3.4 The effect of derivatizing solvent on a compounds signal-to-noise (S/N) ratio, peak shape (b/a) and area during UPC
2
-MS/MS analysis. 
Derivatizing solvent consisted part organic solvent (see figure titles) and part buffer (0.1 M NaHCO3). The influence of the organic solvent part on a 
compounds’ S/N, b/a or area are represented as a significant effect caused. Effects are arbitrarily quantified as 0, 1, 2 and 3, corresponding to the 
significant (ns, non-significant; *, p<0.05; **, p<0.01;***, p<0.001) change observed from the initial S/N, b/a and area of pre-optimization conditions. 
Positive values represent favourable changes whereas negative values unfavourable. Significance was calculated using one-way ANOVA (n=3) with 
Dunnett multiple comparison post-test. 
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Figure 3.5 The effect of mobile phase flow rate on a compounds signal-to-noise (S/N) ratio, peak shape (b/a) and area during UPC
2
-MS/MS analysis. The 
influence of mobile phase flow rate and column temperature on a compounds’ S/N, b/a or area are represented as a significant effect caused. Effects are 
arbitrarily quantified as 0, 1, 2 and 3, corresponding to the significant (ns, non-significant; *, p<0.05; **, p<0.01;***, p<0.001) change observed from the 
initial S/N, b/a and area of pre-optimization conditions. Positive values represent favourable changes whereas negative values unfavourable. 
Significance was calculated using one-way ANOVA (n=3) with Dunnett multiple comparison post-test. 
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Figure 3.6 The effect of desolvation gas flow rate (A) and temperature (B) on a compounds signal-to-noise (S/N) ratio and area during UPC
2
-MS/MS 
analysis. The influence of desolvation gas flow rate and temperature on a compounds’ S/N or area are represented as a significant effect caused. Effects 
are arbitrarily quantified as 0, 1, 2 and 3, corresponding to the significant (ns, non-significant; *, p<0.05; **, p<0.01;***, p<0.001) change observed from the 
initial S/N and area of pre-optimization conditions. Positive values represent favourable changes whereas negative values unfavourable. Significance 
was calculated using one-way ANOVA (n=3) with Dunnett multiple comparison post-test. 
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Figure 3.7 The effect of derivatizing solvent and injection mode on a compounds signal-to-noise (S/N) ratio, peak shape (b/a) and area during GC-MS/MS 
analysis. Derivatizing solvent consisted part organic solvent (see figure titles) and part BSTFA. The influence of the organic solvent part and injection 
mode (PSPLESS, pulsed splitless; SPLESS, splitless) on a compounds’ S/N, b/a or area are represented as a significant effect caused. Effects are 
arbitrarily quantified as 0, 1, 2 and 3, corresponding to the significant (ns, non-significant; *, p<0.05; **, p<0.01;***, p<0.001) change observed from the 
initial S/N, b/a and area of pre-optimization conditions. Positive values represent favourable changes whereas negative values unfavourable. 
Significance was calculated using one-way ANOVA (n=3) with Dunnett multiple comparison post-test. 
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Figure 3.8 The effect of derivatizing solvent and injection mode on a compounds signal-to-noise (S/N) ratio, peak shape (b/a) and area during GC-MS/MS 
analysis. Derivatizing solvent consisted part organic solvent (see figure titles) and part BSTFA. The influence of the organic solvent part and injection 
mode (PSPLESS, pulsed splitless; SPLESS, splitless) on a compounds’ S/N, b/a or area are represented as a significant effect caused. Effects are 
arbitrarily quantified as 0, 1, 2 and 3, corresponding to the significant (ns, non-significant; *, p<0.05; **, p<0.01;***, p<0.001) change observed from the 
initial S/N, b/a and area of pre-optimization conditions. Positive values represent favourable changes whereas negative values unfavourable. 
Significance was calculated using one-way ANOVA (n=3) with Dunnett multiple comparison post-test. 
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Figure 3.9 The effect of Q1 resolution and emission current on a compounds signal-to-noise (S/N) ratio, peak shape (b/a) and area during GC-MS/MS 
analysis. The influence of the Q1 resolution and emission current on a compounds’ S/N, b/a or area are represented as a significant effect caused. 
Effects are arbitrarily quantified as 0, 1, 2 and 3, corresponding to the significant (ns, non-significant; *, p<0.05; **, p<0.01;***, p<0.001) change observed 
from the initial S/N, b/a and area of pre-optimization conditions. Positive values represent favourable changes whereas negative values unfavourable. 
Significance was calculated using one-way ANOVA (n=3) with Dunnett multiple comparison post-test. 
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3.2.3 Analytical Capabilities of each instrument 
 
To assess the performance of each optimized method on the three different instruments, a 
mixture of 250 ppb was prepared and a dilution series created to find the limit of detection 
(LOD), limit of quantification (LOQ) and upper limit of quantification (ULOQ). Together 
LOQ and ULOQ are regarded as the linear region of quantification for which the R2 value 
is an indication of linearity. The limits for the UPLC- and UPC2-MS/MS instruments were 
tested on the UPLC-MS/MS instrument and extrapolated to the UPC2-MS/MS instrument. 
Although this extrapolation is not entirely correct seeing that ionization efficiency is 
influenced by the composition of the mobile phase, which differs between these systems, 
the results obtained from the UPLC-MS/MS data provided insight into the possible 
detection and quantification limits obtainable with the mass spectrometer in question. The 
analytical capabilities of UPLC/UPC2-MS/MS are given in Table 3.7 and that of GC in 
Table 3.8. 
From the tabulated results it is evident that both UPLC/UPC2-MS/MS and GC- 
MS/MS will be sufficiently sensitive in determining sub ppb concentrations with exceptional 
linear signal strength over the specified linear range. However, the UPLC/UPC2-MS/MS 
instrument was more sensitive than GC-MS/MS with an extended quantification range for 
all compounds, offering ultra-low level detection and quantification. 
 
 
Table 3.7 UPLC and UPC
2
-MS/MS analytical capabilities. LOD, limit of detection; LOQ, limit of 
quantification; ULOQ, upper limit of quantification; ND, not detected. 
 
Compound LOD (ppb) LOQ (ppb) ULOQ (ppb) R2 
PrP 0.005 0.05 250 0.998 
MeP <0.001 0.001 5 0.991 
TCS <0.001 0.05 100 0.997 
E1 0.05 0.1 100 1 
BPA <0.001 0.25 100 0.998 
EE2 0.05 0.25 100 1 
E2 0.05 0.1 100 1 
PCM 0.05 0.05 100 0.999 
E3 0.05 0.05 250 0.999 
TCC ND ND ND ND 
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Table 3.8 GC-MS/MS analytical capabilities. LOD, limit of detection; LOQ, limit of quantification; 
ULOQ, upper limit of quantification; ND, not detected. 
 
Compound LOD (ppb) LOQ (ppb) ULOQ (ppb) R2 
PrP 0.1 0.25 100 1 
MeP 0.25 0.5 100 1 
TCS 0.5 0.5 100 0.999 
E1 0.1 5 100 0.998 
BPA 1 5 100 0.999 
EE2 0.5 1 100 0.998 
E2 0.25 1 100 0.999 
PCM ND ND ND ND 
E3 0.5 5 100 0.995 
TCC ND ND ND ND 
 
 
3.2.4 SPE cartridge selection for the pre-concentration of EDCs 
 
By far the most commonly used sample preparation methods used for pre-concentrating 
compounds from liquid matrices are liquid-liquid- and solid-phase extraction (SPE). 
However of these, SPE is probably the most straight-forward and preferred sample 
preparation method available if the cost of SPE cartridges is negligible. In SPE, 
compounds are removed from the matrix by passing the liquid matrix through a SPE 
cartridge containing a stationary phase that selects for the desired compounds. The 
concentrated compounds are then eluted from the column by applying a solvent with a 
higher affinity for the stationary phase. Various SPE cartridges are currently available on 
the market that is able to select for a wide variety of compounds with different chemical 
properties. 
To pre-concentrate the 9 EDCs from water and waste water matrices, two SPE 
cartridges were under consideration: a strong lipophilic C18 SPE cartridge (Supelclean 
ENVI-18) and a ‗dual function‘ SPE cartridge (Supel-select HLB) that selects for 
compounds with both hydrophilic and lipophilic properties. A screen was performed on 
each to determine which would yield the best result – i.e. retaining the highest possible 
number of selected EDC at the highest possible eluent strength. This provides both 
selectivity and ensures that eluents with a weaker strength can be used to remove 
unwanted compounds found in complex matrices. In the screen compounds were loaded 
onto SPE cartridges and varying concentration of methanol (MeOH), at three different 
pH‘s, used to elute the compounds from the cartridges. 
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The varying concentration range provides insight into the SPE elution profile while 
at the same time suggesting the optimum pH for each compound. Results are shown in 
Error! Reference source not found. and indicate that the Supel-select HLB cartridges 
ind the selected compounds stronger to the stationary phase, allowing the use of a 
stronger wash step to purge the cartridge from unwanted weakly bound matrix 
constituents. Furthermore, 60% MeOH seems to be a good wash solvent as 9/10 
compounds are still bound to the stationary phase after use, the only exception being 
PCM. From this data preliminary studies were performed that investigated the possible 
recoveries obtainable under different acidification conditions. Results are shown in Error! 
eference source not found.. 
 
 
Figure 3.10Preliminary recoveries obtained for each of the 9 compounds extracted from different 
acidified water matrices using Supel-select HLB cartridges conditioned with and aqueous phase 
similar to that of the sample. Formic acid (1%), 10 mM ammonium formate and 10 mM ammonium 
acetate were used to acidify equilibration solutions, samples and wash steps. Two-way ANOVA 
followed by a Bonferroni post-test were used to test for significant differences. No significance was 
observed 
 
 
 
Statistical analysis of the possible recoveries obtainable under different 
acidification conditions indicated neither that 1% formic acid nor 10 mM ammonium 
formate or 10 mM ammonium acetate yield recoveries more desirable than the other. From 
this data estimated recoveries were determined under 1% formic acidified equilibration 
solutions, samples and wash solvents. Both water and SWW were investigated as to 
determine expected recoveries from these matrices. The filtering of samples was also 
investigated to simulate removal of excess debris that might clog SPE cartridges. 
Estimated recoveries are given in Table 3.9. 
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Figure 3.11 Heatmap showing the elution profile of each compound on the two different SPE cartridges under different pH conditions. The map only 
indicate the presence of a compound at the a specific elution step and by no means infer quantity. 
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TCS 87.2 ± 18.1
a
 
a 
145 ± 26.1
ab
 
ab 
376 ± 12.1
abc
 
abc 
2658 ± 831 
abc 
BPA 98.6 ± 27
a
 
a 
206 ± 4.33
ab
 
ab 
134 ± 9.34
abc
 
abc 
247 ± 24.9
abc
 
abc 
 
Table 3.9 Estimated percentage recovery for the different compound in two matrices and under two 
pre-treatment conditions. Compounds were extracted from a HLB cartridge (preconditioned to pH 2) 
preloaded with unfiltered or filtered water or synthetic waste water (SWW). Values represent the 
mean ± SE (n= 3). Statistical significance between unfiltered water, filtered water, unfiltered SWW and 
filtered SWW was determined with a two-way ANOVA followed by a Bonferroni post-test. 
 
 
Compound         Unfiltered water Filtered water Unfiltered SWW Filtered SWW 
 
 
 
 
E1 72.6 ± 1.87 75.3 ± 9.85 81.4 ± 5.84 96.3 ± 17.0 
 
 
EE2 66.9 ± 6.44 246 ± 14.3 215 ± 39.0 86.6 ± 10.7 
 
 
 
 
 
 
 
 
All compounds from unfiltered water showed good recovery, with the exception of 
PCM showing a very low recovery. Furthermore, filtering of water seemed to have little 
effect on recovery compared to that of unfiltered water. Recoveries from unfiltered and 
filtered SWW showed unusually high recoveries for PrP, MeP, TCS and E3. Finally, like the 
filtering of water, the filtering of SWW also increased the recoveries of certain compounds 
such as PrP and TCS. 
3.2.5 Method validation 
 
After extensive optimization of all the instruments being used and the EDC pre- 
concentration protocol, the best performing instrument and optimized EDC pre- 
concentration protocol needed to be validated as a whole. Seeing that small variations in 
method performance between UPLC- and UPC2-MS/MS were not investigated and that 
the UPC2 instrument is new to the market, it was decided to do the method validation 
procedure on the UPC2-MS/MS. Two recent papers by Kruve et al.(43, 44) were used as 
guidelines for the method validation. The results from the validation procedure are shown 
in Table 3.10 - Table 3.12 and Error! Reference source not found.. 
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E3 
TCC 
193 ± 19.3 
a 
39.9 ± 10.0 
ab 
785 ± 28.8 
c 
1081 ± 190 
c 
159 ± 28.8
a
 123 ± 44.6
ab
 0.926 ± 0.236
abc
 28.3 ± 26.3
abc
 
E2 
PCM 
73.9 ± 0.968 
a 
67.0 ± 4.36 
ab 
74.5 ± 3.60 
abc 
109 ± 34.0 
abc 
2.63 ± 0.275
a
 6.93 ± 5.54
ab
 20.0 ± 3.18
abc
 0.041 ± 0.003
abc
 
PrP 
MeP 
87.6 ± 1.87
a
 
176 ± 10.1
a
 
87.2 ± 2.01
ab
 
65.8 ± 11.7
ab
 
1146 ± 136
c
 
1086 ± 135
c
 
3047 ± 318 
988 ± 211
c
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Table 3.10 Comprehensive method validation data: Limit of detection (LOD, n = 3), limit of quantification (LOQ, n = 3), upper limit of quantification (ULOQ, 
n = 3), signal linearity (R
2
), instrumental accuracy (% RSD, n = 4), precision (% RSD, n = 6) and percentage stability (mean ± SE, n = 4). Statistical analysis 
on the % stability of compounds was performed with a one-way ANOVA, followed by a dunnett post-test. Significance is indicated by *, ** and *** 
representing p < 0.05, p < 0.01 and p < 0.001, respectively. TLTQ, Too low to quantify. 
 
Compound LOD LOQ ULOQ R2 Instrumental accuracy % RSD (ppb) Precision % RSD (ppb) % Stability 
 
PrP 0.05 0.1 20 0.986 6.47 (1) 2.01 (1) 1.76 (1) 0.627 (1) 103 ± 3.62 
MeP 0.005 0.01 1 0.752 18.8 (0.1) 17.3 (0.1) 6.66 (0.1) 17.8 (0.1) 112 ± 6.54 
TCS 0.05 0.05 20 0.990 11.3 (1) 4.25 (1) 4.66 (1) 5.83 (1) 99.3 ± 8.25 
E1 0.05 0.05 20 0.997 17.1 (1) 2.01 (1) 4.38 (1) 5.09 (1) 76.6 ± 0.327*** 
BPA 0.125 0.125 50 0.995 5.86 (2.5) 6.56 (2.5) 4.43 (2.5) 6.38 (2.5) 96.5 ± 0.566 
EE2 0.125 0.125 50 0.996 1.69 (2.5) 2.76 (2.5) 9.89 (2.5) 9.14 (2.5) 99.2 ± 0.669 
E2 0.05 0.05 20 0.998 1.30 (1) 2.95 (1) 2.60 (1) 2.71 (1) 101 ± 0.817 
PCM 0.125 0.125 50 0.993 1.57 (2.5) 4.33 (2.5) 3.63 (2.5) TLTQ (2.5) 102 ± 1.85 
E3 0.05 0.1 20 0.995 0.626 (1) 3.82 (1) 8.91 (1) 2.31 (1) 130 ± 0.749*** 
TCC 0.1 0.1 20 0.893 4.05 (1) 19.5 (1) 77.3 (1) 16.8 (1) 136 ± 7.35*** 
 pg on column pg on column pg on column  Solvent Water SWW  
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Figure 3.12 The matrix effect of matrix constituents on each compound. Where the water and SWW matrices regression lines appear above that of the 
solvent, ionization is enhanced, whereas below the solvent line indicates ionization suppression. Linear regression lines were drawn with the statistical 
package GraphPad Prism and departure from linearity tested for with runs test. The matrix effect observed under solvent conditions for BPA, TCC and E1 
are clearly wrong as solvent conditions would yield better conditions than both water and SWW. It is possible that these compounds did not dissolve 
properly when stocks were created. 
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Table 3.11 Comprehensive method validation data (continued): Process efficiency (%, n = 3) at a low (C1), medium (C2) and high (C3) SPE cartridge load. 
 
 
Investigator 1 Investigator 2 
 
Compound Water SWW Water SWW 
C1 C2 C3 C1 C2 C3 C1 C2 C3 C1 C2 C3 
 
MeP 3.40 37.0 16.3 552 1.50 x103 2.23 x103 11.3 138 56.1 7.33 x103 4.96 x 104 7.84 x 104 
PrP 5.32 21.2 8.94 40.5 340 68.1 10.3 50.2 25.9 500 1.70 x 10
3
 679 
TCC 109 1.47E+03 194 62.6 147 81.9 1.08 x10
3 
1.75 x10
3 
1.42 x10
3 
90.3 154 347 
E2 85.9 94.9 108 258 192 236 60.5 44.0 114 311 274 201 
EE2 76.9 117 130 5.2 6.94 7.36 47.7 65.0 91.5 2.11 25.4 16.4 
PCM 22.8 14.3 2.15 0.080 0.068 0.00 20.5 49.2 9.20 0.00 85.3 25.7 
 
 
TCS 38.3 172 109 15.7 66.5 29.8 133 72.2 54.8 192 246 183 
 
E1 2.25 x10
3 2.46 x103 1.05 x103 1.93 x103 2.07 x103 1.33 x103 517 509 333 2.11 x103 1.07 x103 1.27 x103 
 
E3 99.8 27.5 31.2 64.7 119 92.6 28.7 288 42.7 97.5 165 163 
 
BPA 1.59 x 103 1.98 x103 205 319 599 382 2.48 x103 4.17 x103 2.26 x103 170 164 45.9 
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Table 3.12 Comprehensive method validation data (continued): Recovery (%, n = 3) at low (C1), medium (C2) and high (C3) SPE cartridge load. ULOQ, 
upper limit of quantification. 
 
 Investigator 1      Investigator 2   
Compound  Water   SWW   Water   SWW 
 
C1 C2 C3 C1 C2 C3 C1 C2 C3 C1 C2 C3 
MeP 13.0 23.5 6.21 2.42 82.8 15.3 10.2 74.2 94.3 4.20 53.4 65.6 
PrP 20.8 44.3 19.0 14.1 64.1 63.8 34.9 203 119 23.0 128 69.8 
TCS 0.0 94.6 56.4 33.7 48.5 39.2 0.00 105 56.3 38.6 99.9 132 
TCC 11.1 58.6 8.37 42.7 63.3 36.2 32.5 139 40.3 67.0 70.3 153 
E1 95.0 146 94.5 0.00 105 115 34.1 68.6 16.5 0.00 4.20 15.3 
E2 0.00 95.5 114 >ULOQ 106 78.8 0.00 60.1 114 >ULOQ 107 79.6 
E3 228 43.9 89.5 55.9 106 90.4 65.8 909 93.2 74.0 170 159 
EE2 54.8 67.3 72.7 0.00 35.4 37.6 27.4 36.2 51.0 0.0 360 24.6 
BPA 17.5 50.2 36.6 42.1 52.2 48.1 27.3 53.9 35.7 13.1 10.2 4.53 
PCM 107 24.6 3.86 0.00 0.00 0.02 115 99.0 17.9 0.00 2.72 1.52 
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Table 3.10 shows similar sensitivities to those predicted for the different 
compounds in the preliminary study, with all three investigated concentration (C1, C2 and 
C3) for all compounds falling within the predicted linear region of quantification. 
Furthermore, E1, E2, EE2 and BPA showed lower LOQs than originally determined by 
UPLC-MS/MS. However, PrP, MeP and E3 showed higher LOQs with decreased signal 
linearity for MeP. Finally, TCC could be detected, its linear range and linearity of signal 
determined – not previously possible. Method accuracy experiments showed that the 
measured values for all compounds were in close relation to their true value, while 
precision experiments indicated that solvent and both water and SWW prepared sample 
concentration could be detected with high precision. Percentage stability reports suggest 
that most compounds stay stable in the final derivatization solution for at least 18 hours. 
Only TCC, E1 and E3 show deviations from stability. 
Data from Error! Reference source not found. suggest that water has an 
onization enhancement effect on MeP, TCS, TCC, BPA and E1, suppression effect on PrP, 
E3, EE2 and PCM, while having little to no effect on the ionization of E2. In contrast, SWW 
shows ionization enhancement for MeP, PrP, BPA, E1 and E2, a suppression effect on EE2 
and PCM, while having no or little effect on the ionization of TCS, TCC and E3. 
Process efficiency and recovery was highly variable for most compounds between 
investigators and between the different matrices (Table 3.11 and Table 3.12). TCS, TCC, 
E1, E2 and E3 showed some degree of agreement between investigators and between 
matrices for process efficiency. Furthermore, compounds such as MeP, PrP, TCC, E1 and 
BPA showed unachievably high process efficiencies and E2 unachievably high recoveries. 
PCM in contrast to unachievably high process efficiencies and recoveries showed a very 
low to no process efficiency and recovery. 
 
3.3         Discussion 
 
In the present study the aim was to develop analytical methods that would enable the pre- 
concentration, detection and quantification of known EDCs in the environment, as tool to 
evaluate the JTED Ecomachine. Three highly sensitive analytical instruments were 
identified to detect and quantify the pre-concentrated EDCs from the environment, namely 
a UPLC-, UPC2- and GC-MS/MS system. Methods were developed on each instrument 
and optimized by changing variables such injection solvent, column temperature, eluent 
flow rate, and desolvation gas temperature and flow rate, before selecting the optimal 
conditions. The optimized instrumental methods were then evaluated for their sensitivity. 
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Together with their feasibility, i.e. how many of the selected EDCs can be detected and 
quantified, and economic friendliness one instrument was selected for the final method 
validation. Next, a SPE protocol was developed that would enable the pre-concentration of 
the compounds of interest from environmental samples. Here, two SPE cartridges with 
different stationary phase chemistries were considered. In addition, an optimum extraction 
pH (2, 4, or 6) was examined. Second to last, a preliminary recovery study for the pre- 
concentration protocol was performed to determine its feasibility before extensive method 
validation. Finally, an extensive method validation study was carried out to evaluate the 
pre-concentration, identification and quantification protocol as whole. 
Method development was initiated by first setting up the relevant SRMs or MRMs 
on each instrument. This required the direct injection of each derivatized compound on 
each instrument separately. Table 3.2 shows the optimized MRMs for each compound set 
up on both the UPLC- and UPC2-MS/MS. For UPLC- and UPC2-MS/MS the base peak 
observed for all compounds except CBZ-d10 and TCC was that op the product ion at m/z 
171. The main secondary product ion for these compounds was found to be at m/z 156, 
with the exception of BPA whose secondary ion was selected to be at m/z 170. These 
product ions corresponds to previous studies utilizing DNCl as derivatizing agent (41, 358, 
359). The product ion for BPA has not been reported before using an ESI mass 
spectrometer. TCC and CBZ-d10 did not show these product ions as these compounds do 
not get derivatized with DNCl under the conditions prescribed. The product ions m/z 160 
(base peak) and m/z 126 observed for TCC have been report by Hancock et al. (360) and 
Jongmun et al. (361). The product ions found for CBZ-d10 corresponded to an m/z at 202 
and 204 (base peak), which is 10[2H] heavier than the reported m/z 192 and m/z 194 
reported for CBZ (362, 363). Finally, each compound was injected on the relevant columns 
and the retention time on each column noted in Table 3.1. From the results in Table 3.1 it 
is evident that sufficient separation was achieved for all compounds on all UPC2 columns. 
However, TCC eluted at nearly the same retention time as that of E3 and MeP on the 
UPLC column. Both E3 and MeP MRM scans were performed in positive mode and 
therefore greatly influenced the sensitivity of the method for TCC. This is evident from 
Table 3.7 showing that TCC could not be detected when a preliminary sensitivity study 
was performed. For GC-MS/MS analysis Table 3.3 shows the relevant precursor and 
product ions as well as each compound‘s retention time on the column. The different 
precursors or product ion were matched to that found in literature (364–371). Like the 
UPC2-MS/MS, sufficient separation of compounds could also be achieved on the GC- 
MS/MS. 
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After method development, certain variables were investigated to improve the 
peak area, peak shape and S/N. The optimized conditions are laid out in Table 3.4, Table 
3.5 and Table 3.6. According to Kruve et al.(43), of the parameters being investigated on 
the UPLC, injection solvent composition/derivatizing solvent have the highest likelihood to 
have an effect on parameters such as peak shape, area and S/N. However, the current 
study showed that column temperature played a bigger role (Error! Reference source 
ot found., Error! Reference source not found. and Error! Reference source not 
found.). Nevertheless, injection solvent composition significantly affected the peak area of 
all compounds investigated. This was also the case for desolvation gas temperature. Next 
to column temperature, desolvation flow rate had the greatest effect on peak shape, while 
all variables contributed similarly to the effect on S/N. A possible explanation for the larger 
role column temperature played in results could be explained by the temperature at which 
derivatization is normally carried out. The optimal heat conditions resembling that of the 
derivatization conditions could help influent compounds to be at the correct temperature 
for all to be at their derivatized masses before injection into the mass spectrometer. On the 
UPC2-MS/MS, injection solvent composition affected the parameters the least, while all 
other variables played an equally important role on parameter improvements/impairments 
(Error! Reference source not found., Error! Reference source not found. and Error! 
erence source not found.). The smaller effect injection solvent composition played 
suggests that the UPC2 instrument may be more compatible with a diverse range of 
injection solvents. Lastly, flow rate showed to be the most effective in improving the overall 
performance of the method. In contrast to both UPLC- and UPC2-MS/MS analysis, 
injections solvent composition and split mode on GC-MS/MS displayed the greatest effect 
on parameters (Error! Reference source not found., Error! Reference source not 
und. and Error! Reference source not found.). Although it is impossible to pinpoint the 
main contributor to parameter improvements between solvent composition and split mode 
without testing the conditions separately, pulsed splitless injections have been shown to 
improve sample transfer and enable trace level analysis (372–375). 
Before samples could be analysed using either developed instrumental method, a 
preliminary sensitivity study needed to be done to determine which system – UPLC/UPC2 
would yield the best results in future. This include being able to optimize the EDC pre- 
concentration protocol. Therefore, a dilution series was prepared consisting of a mixture of 
all the compounds under investigations. The dilution series was injected on the UPLC- and 
GC-MS/MS and preliminary LODs, LOQs, ULOQs and linearity‘s for the different 
compounds calculated. Results are shown in Table 3.7 and Table 3.8. The obtained 
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results suggested that the UPLC/UPC2-MS/MS instruments have higher sensitivities than 
the GC-MS/MS instrument and therefore latter was excluded from further investigations 
and the final extensive validation. While in the process of deciding which of the two 
instruments – UPLC or UPC2 to use for the optimization of EDC extraction protocol from 
environmental matrices, the then used UPC2  2-EP column failed and no other columns 
were available for use. This forced the use of the UPLC-MS/MS as instrument of choice for 
the use of optimizing the EDC pre-concentration protocol. 
During the first trials of constructing an EDC pre-concentration protocol, the 
Supelclean ENVI-18 – a C18 cartridge, and a Supel-select HLB – a hydrophilic and 
lipophilic cartridge, were under investigation. Extractions were carried out on each and 
results showed that the HLB cartridge could retain compounds at a higher percentage 
MeOH wash step than the ENVI-18 (Error! Reference source not found.). Most EDC 
nvestigated in this study are hydrophobic in nature. However, many of the EDCs contain 
hydroxyl groups and therefore will interact better with a stationary phase also containing 
polar groups. In the final step of constructing the EDC pre-concentration protocol the pH at 
which compounds would be optimally retained on the HLB cartridge was investigated. 
Here different organic acids were used to acidify both the equilibration solvent as well as 
the sample. Error! Reference source not found. shows the preliminary recoveries under 
ifferent sample and equilibration solvent conditions. Statistical analysis revealed no 
noteworthy differences between the different acidification steps. However, extensive work 
by Baker and Kasprzyk-Hordern suggest acidifying samples to a pH of two for 
pharmaceuticals and illicit drugs in surface and waste water (376). From this suggestion 
the studies that followed used a pH of two. Finally, a more comprehensive recovery study 
was performed to assess the EDC pre-concentration protocol performance. Here an 
additional matrix was added that represented environmental samples more closely. Table 
3.9 shows the estimated recoveries to be expected during method validation. For both 
filtered and unfiltered water acceptable recoveries were obtained for 8 of the 12 
compounds. However,  under both filtration and no filtration the SWW matrix showed 
recoveries never achievable. This suggests that the complex matrix might have ionization 
enhancing effects and therefore would first need to be quantified before accurate 
recoveries can be determined. The acceptable recoveries obtained from water allowed the 
proceeding to extensive method validation. 
Finally, the pre-concentration protocol needed to be validated together with either 
the UPLC- or UPC2-MS/MS instrument. While evaluating the data from the preliminary 
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recovery study a new column for the UPC2 arrived. Although the column  chemistry 
differed, it was decided to do the final extensive method validation on the UPC2-MS/MS for 
the following reasons: First and foremost, this is ‗n newly available instrument that will 
need to be reviewed. Therefore, completing the validation on this instrument will serve as 
publicity. Second, between the UPLC and the UPC2, only the UPC2 system was able 
successfully separate all compounds. Second to last, the UPC2 has a reduced solvent 
consumption and therefore are a cheaper alternative to the UPLC. Finally, as this thesis is 
linked to environmental studies and the UPC2 provides greener chemistry, this instrument 
will fit well into being environmentally friendly. 
Extensive validation of the EDC pre-concentration, identification and 
quantifications was performed by investigating the conditions of sensitivity, accuracy, 
precision and trueness as set out in guidelines by Kruve et al. (43, 44). Using  the 
sensitivity data from the preliminary studies as a guideline, calibration curves were 
generated to determine the LODs, LOQs, ULOQs and linearity‘s of each compound. Table 
3.10 shows the relevant information. From the table it can be gathered that the sensitivity 
data obtained from the method validation correlate with that of preliminary findings, with 
only MeP showing deviations from earlier findings. Furthermore, accuracy data confers the 
ability of the instrument to measure all compounds qualitatively within acceptable limits 
(Table 3.10). In addition, each measurement was precise for all matrices tested and the 
deviations measured neglectable (Table 3.10). Finally the stability data in Table 3.10 show 
that overall all compounds, with the acception E1, E3 and and TCC, are stable for at least 
17 hours. The latter confer minimal change to compounds and therefore infer reliability. To 
quantify the possible influence that environmental samples could exert on sample 
preparation and the final result, the matrix effects was investigated. Results are shown in 
Error! Reference source not found.. From these data we find the matrix effect for most 
ompounds are high and that results obtained from e.g. a WWTP could vary greatly. This 
data is supported by earlier finding on recovery that showed recoveries for some 
compounds that are never achievable. Finally, the method was evaluated for sample 
preparation effectiveness and the robustness of the EDC pre-concentration method. 
Process efficiency data in Table 3.11 show high variability between the different cartridge 
loads and investigators. This marks the process – from extraction to injection, as complex 
with room improvement and simplification. This view is strengthened by the results of 
Table 3.12 that show good to excellent recoveries obtainable for a number of compounds, 
in both water and SWW matrices. These results therefore highlight the care that should be 
Stellenbosch University  https://scholar.sun.ac.za
74 
 
 
 
taken in processing samples from complex matrices. Additionally, it also emphasizes that 
each step in the processing of samples needs to be done quantitatively. 
To conclude, methods were set up on three analytical instruments and through a 
process of elimination the UPC2-MS/MS was selected for the final method validation. 
Additionally, an EDC protocol developed, optimized and establish. Finally, the method was 
validated and found to be highly sensitive, accurate, precise and relatively robust, but that 
it lacked simplicity. From this information it is evident that the developed method can be 
used for environmental analysis such as the testing of samples from the JTED 
Ecomachine. However, it is recommended that the EDC pre-concentration protocol be 
simplified by doing away with steps such as the transfer between vials, as well being 
further optimized. 
 
3.4 Materials and methods 
 
3.4.1 Materials 
 
The compounds Methyl 4-hydroxybenzoate (methylparaben, ≥99.0%), propylparaben 
(USP reference standard), 3,4,4‘-Trichlorocarbanalide (triclocarban, 99%), Acetaminophen 
(paracetamol,   98.0-101.0%),   Bisphenol   A   (analytical   standard),   Irgasan   (triclosan, 
≥97.0%), Carbamazepine (≥99.0%), 4-Nonylphenol (≥99.9%), Estrone (≥99%),  17α- 
Ethynyl estradiol (≥98%), β-Estradiol (≥98%) and Estriol (≥99.3%) were purchased from 
Sigma-Aldrich (St Louis, Missouri, USA). The compounds 4-Nonylphenol-d4, β-Estradiol-d5 
and Carbamazepine-d10 used as internal standards were bought from EQ Laboratories 
GmbH (Augsburg, Bevaria, DE). The solvents methanol, acetonitrile, acetone and formic 
acid, all of analytical grade, used for SPE and chromatography were purchased from 
Sigma-Aldrich (St Louis, Missouri, USA), while pyridine (analytical grade) was purchased 
from Merck KGaA (Darmstadt, Hesse, DE). Dansyl chloride (≥99%) and N,O- 
Bistrifluoroacetamide (BSTFA, 1% Trimethylchlorosilane (TMCS), ≥99%) were purchased 
from Sigma-Aldrich (St Louis, Missouri, USA). Supelco Supelclean ENVI-18 (6 mL, 1 g 
bedweight) and Supel-select HLB (6 mL, 200 mg bedweight) cartridges for SPE were 
bought from Sigma-Aldrich (St Louis, Missouri, USA). Meat extract (microbiological grade) 
and di-potassium hydrogen orthophosphate anhydrous were bought from Merck KGaA 
(Darmstadt, Hesse, DE), while vegetable extract no 1 (microbiological grade), D-(+)- 
Glucose monohydrate (≥99.0%), Magnesium sulphate heptahydrate (ACS reagent, ≥98%), 
Iron (II) sulphate heptahydrate (ACS reagent,  ≥99.0%) and sodium chloride (BioXtra, 
≥99.5% AT) were bought from Sigma-Aldrich (St Louis, Missouri, USA). Glass wool was 
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kindly supplied by Stefan Hayward (Department of Biochemistry, University of 
Stellenbosch), while Whatman 41 ashless filter papers (90 mm in diameter) were bought 
from Sigma-Aldrich (St Louis, Missouri, USA). 
3.4.2 Stock solutions 
 
Stock solution of each compound was made by analytically weighing the appropriate 
amount into a 4 mL amber vial before dissolving it to a final concentration of 1000 ppm 
using methanol. The internal standards 4-Nonylphenol-d4, β-Estradiol-d5 and 
Carbamazepine-d10 were prepared in a similar manner but dissolved in acetonitrile. These 
solutions were further diluted with methanol or acetonitrile to 10 ppm and stored at -20 °C. 
3.4.3 Instrument method development 
 
UPLC- and UPC2-MS/MS 
 
Multiple reaction monitoring (MRM) were set up by directly injecting 1 µL of the pure 
derivatized compound at a concentration of 1 ppm into a Waters Acquity UPC2 instrument 
coupled to a Waters Xevo TQ-S tandem mass spectrometer (MS/MS). Masslynx version 
4.1 software was used for instrumental analysis. Derivatization was carried out according 
to Anari et al. (377). In short, the appropriate amount of each stock solution were dried 
with N2 and reconstituted 1:1 with 2 mg/mL DNCl in acetone and 0.1 M NaHCO3 (pH 10.5) 
in deionized water. The resulting solution was incubated for 10 min at 60 °C and cooled to 
room temperature before injection. Precursor scans were carried out between 15 and 55 V 
and the optimum cone voltage (CV) selected based on highest signal intensity. Using this 
CV, a product scan was performed between 15 and 55 V, selecting the two most 
prominent ions yielding the highest signal intensity at their respective collision energy 
(CE). The precursor CV and two product ions at their respective CE were used  to 
construct a MRM table to monitor the different compounds. This MRM table was used for 
both UPC2-MS/MS analysis and UPLC-MS/MS analysis as both are connected to the 
same MS. Transitions for each compound yielding the strongest signal intensity was used 
as quantifiers, while the rest were regarded as qualifiers. 
Chromatographic  separation  of  compounds  –  from  a  1µL  injection,  using  the 
UPC2-MS/MS instrument was achieved on a Waters UPC2 BEH C18 2-EP 2.1 x 100 mm, 
1.7 μm pore size column – maintained at 60°C. The mobile phase consisted of solvent A 
(A; super critical CO2) and solvent B (B; 1% formic acid in methanol) – supplied by a 
makeup pump at a rate of 0.2 ml/min. The column was equilibrated with 2% B before a 
linear gradient from 2 to 4.5% B, spanning 4.3 min, were applied. This gradient was 
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followed by a 2.5 min linear gradient to 7%B and a 1 min linear gradient to 10% B, where it 
was kept constant for another minute. Finally, a 30% B wash step was applied for 1 min, 
before the column was again equilibrated for 2 min with 2% B. In contrast, separation on 
the Waters Acquity UPLC instrument was achieved on a Waters UPLC BEH C18 2.1 x 100 
mm, 1.7 μm pore size column – maintained at 50°C. The mobile phase consisted of A (1% 
formic acid in ultrapure water) and B (0.1% formic acid in acetonitrile) at a flow rate of 0.35 
ml/min. Prior to a 1 µL injection, the column was equilibrated with 15% B. Following 
injection, a 0.1 min linear gradient, from 15% to 60% B, was applied. This was followed by 
a 6.8 min linear gradient from 60% to 95% B, before being kept constant for 1 min. Finally, 
the column was equilibrated for 2 min at 15% B. 
GC-MS/MS 
 
Like UPLC- and UPC2-MS/MS analysis, compounds and internal standards were 
derivatized. In short, the appropriate amount of a 10 ppm solution of each compound was 
dried in separate vials with N2. Compounds and internal standards were then reconstituted 
in a solution consisting of two thirds pyridine and one third BSTFA, before being incubated 
for 60 min at 60 °C. Samples were allowed to cool to room temperature before being 
injected on the GC-MS/MS instrument. 
Method development on GC-MS/MS was carried out on a Thermo-Fisher Scientific 
Trace 1300 GC, fitted with a Varian FactorFour Capilliary VF-17ms (30 m x 0.25 mm ID, 
DF = 0.25) column, coupled to a Thermo-Fisher Scientific TQS 8000. The retention time 
for each compound were determined by injecting 1 μL of each compound or internal 
standard in a pulsed splitless w/Surge manner under the following inlet conditions: Helium 
was used as carrier gas at a flow rate of 1 mL/min. The inlet temperature was set to 250 
°C with a split flow of 50 mL/min after 2 min. Following injection the column was kept 
constant at 100 °C for 3 min, ramped to 300 °C at 10 °C/min and kept constant at 300 °C 
for 5 min. The MS transfer line and ion source temperature were set to 280 °C and 250 °C, 
respectively, with MS in full-scan mode between the m/z values of 40 and 550. AutoSRM 
(XCalibur, version 2.2) software was used to find the two most prominent transitions of 
each compound at their optimal collision energy. An SRM table was constructed from this 
information and used for method optimization and sensitivity determination. Finally, the 
transitions of each compound yielding the strongest signal intensity was used as 
quantifiers while the rest were used as qualifiers. 
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3.4.4 Instrument method optimization 
 
UPLC- and UPC2-MS/MS 
 
A 100 ppb mixture consisting of all 12 compounds and the three internal standards were 
made from each compound‘s 10 ppm stock solution. Aliquots of the mixture was dried and 
reconstituted in the same volume as the aliquot in either 1:1 (acetone:0.1 M NaHCO3), 1:1 
(acetonitrile:0.1 M NaHCO3), 3:1 (acetonitrile:0.1 M NaHCO3), 2:1:1 
(acetone:acetonitrile:0.1 M NaHCO3) or 1:2:1 (acetone:acetonitrile:0.1 M NaHCO3), with 
the final concentration of DNCl equal to 1 mg/ml. These solutions were incubated at 60°C 
for 10 min, allowed to cool to room temperature and 1 µL injected on either the UPLC- or 
UPC2-MS/MS instruments. The best solvent composition were selected for further 
optimization steps based on improved peak areas, signal to noise (S/N) ratios and peak 
shape (b/a). 
One microliter of the aforementioned was injected on the UPLC-MS/MS in 
triplicate, the eluent flow rate changed to either 0.3 or 0.4 ml/min and triplicate injections 
performed again. Peak area, peak shape and S/N were re-evaluated and the best 
condition selected for further optimization. Similarly, column temperature (40 or 60 °C), 
desolvation gas flow rate (800 or 100 L/h) and desolvation gas temperature (450 or 50 °C) 
were evaluated. Alike, eluent flow rate (1.7 or 1.9 mL/min), desolvation gas flow rate (700 
or 900 L/h) and desolvation gas temperature (450 or 550 °C) was investigated on the 
UPC2-MS/MS after solvent optimization. 
 
Results obtained from changing the different parameters were analysed with a 
one-way ANOVA followed by a Dunnet multiple comparisons test from the statistical 
package GraphPad Prism 5.00. 
After the optimization of the UPC2-MS/MS method, column failure forced an 
investigation into an alternative column available: a Waters Acquity UPC2 Torus 2-PIC (3.0 
x 100 mm, 1.7 µm pore size). Consequently, retention times for each compound and 
internal standard were determined as described in section 3.4.3 and incorporated into 
UPC2-MS/MS method. No changes were made to the gradient used in section 3.4.3 or the 
optimal settings found in this section. 
 
GC-MS/MS 
 
Similar to UPLC- and UPC2-MS/MS analysis, a 100 ppb solution of the 12 compounds and 
three internal standards were made and aliquots reconstituted in the same volume of 
either 2:1 (pyridine:BSTFA), 2:1 (Acetonitrile:BSTFA), 1:1:1 (pyridine:acetonitrile:BSTFA) 
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or 1:4:2.5 (Pyridine:acetonitrile:BSTFA). These samples were then incubated at 60 °C for 
60 min and allowed to reach room temperature before injection. In contrast to UPLC- and 
UPC2-MS/MS method optimization however, two variables were investigated at the same 
time. First, solvent composition together with injection mode (Pulsed splitless and 
splitless). Second, Q1 resolution (Wide or Normal) together with emission current (50 or 75 
A). Peak area, shape and S/N were evaluated in both cases and the optimal conditions 
selected for method sensitivity determination. 
3.4.5 Preliminary sensitivity of methods developed on UPLC-, UPC2- and GC- 
MS/MS 
From the 10 ppm stock solutions a 250 ppb mixture was created, containing all 12 
compounds and three internal standards. Consequently a dilution series was created from 
the 250 ppb mixture down to 1 ppt. Aliquots of the dilution series were reconstituted in the 
same volume of the appropriate optimized derivatizing solvent solution and incubated at 
and for the required temperature and time as found in the results of the previous methods 
section (section 3.4.4). After reaching room temperature, 1 µL of the derivatized dilution 
series was injected on the UPLC- and GC-MS/MS instruments. As the UPLC and UPC2 
are connected to the same instrument, sensitivity results from the UPLC were regarded as 
the same for the UPC2. 
A linear calibration curve was constructed by Masslynx version 4.1 (UPLC- 
MS/MS) or Xcalibur version 2.2 (GC-MS/MS) from the data obtained from the dilution 
series, with the lowest (S/Nquantifier > 10 and S/Nqualifier > 3) and highest data points yielding 
a straight line regarded as the limit of quantification (LOQ) and upper limit of quantification 
(ULOQ), respectively. The lowest data point yielding a S/Nquantifier > 3, were regarded as 
the limit of detection. The linearity of the signal is represented as the root-mean-square 
value (R2-value). 
3.4.6 EDC pre-concentration from environmental matrices: method 
development 
SPE cartridge selection 
 
Twelve Supelclean Envi-18 and twelve Supel-select HLB cartridges were loaded with 100 
mL spiked dH2O samples according to a modified manufacturer‘s protocol. In short, 
cartridges were activated with 6 mL MeOH, equilibrated with a 6 mL aqueous solution 
similar to that of the sample and the sample loaded onto the cartridge. Finally compounds 
were eluted from the resin bed in 6 mL wash steps using different concentrations of 
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MeOH. Of these 24 cartridges, four Supelclean Envi-18 and four Supel-select HLB 
cartridges were pre-treated with MeOH and equilibrated with dH2O acidified with 1% formic 
acid to a pH of 2. Consequently, 4 ng of each compound (MeP = 0.2 ng) and 5 ng of each 
internal standard were loaded onto the cartridge resin bed through the addition of a 100 
mL sample acidified with 1% formic acid to a pH of 2. Finally, compounds were eluted from 
the resin bed sequentially with 5 (1% Formic acid), 10 (1% Formic acid), 20 (1% Formic 
acid), 50 (1% Formic acid), 60 (1% Formic acid), 80 (1% Formic acid) and 100% MeOH. 
The 6 mL fractions were dried with N2 and reconstituted in 1.5 mL acetonitrile, before 
being transferred to separate 1.5 mL amber MS vials. Reconstituted fractions were dried 
with N2, derivatized in 200 µL 3:1 (acetonitrile:0.1 M NaHCO3) and 1 µL of the solution 
injected on the UPLC-MS/MS instrument using the optimized instrumentation method 
(section 3.4.4). The remaining 8 Supelclean ENVI-18 and 8 Supel-select HLB cartridges 
were similarly treated. However, where 1% formic acid was used for acidification either 10 
mM ammonium formate (pH 4) or 10 mM ammonium acetate (pH 6) was used. 
Preliminary estimation of recoveries from Supel-select HLB cartridges under 
different acidification conditions 
Twelve Supel-select HLB cartridges were loaded with 100 mL spiked distelled water 
(dH2O) samples according to the manufacturers‘ protocol. Of these 12 cartridges, four 
were pre-treated with MeOH and equilibrated with dH2O acidified with 1% formic acid to a 
pH of 2. This was followed by loading the sample containing 4 ng of each compound (MeP 
= 0.2 ng) and 5 ng of each internal standard onto the cartridge. The cartridge was washed 
with 60% MeOH (1% formic acid) and the compounds eluted from the resin bed with 6 mL 
100% MeOH. The 6 mL fraction were dried with N2, reconstituted in 1.5 mL acetonitrile, 
transferred to a 1.5 mL amber MS vial, dried with N2 and derivatized with 200 µL 3:1 
(acetonitrile:0.1 M NaHCO3), before 1 µL was injected on the UPLC-MS/MS instrument 
using the optimized instrumentation method (section 3.4.4). The remaining 8 cartridges 
were treated similarly. However, where 1% formic acid was used for acidification either 10 
mM ammonium formate (pH 4) or 10 mM ammonium acetate (pH 6) was used. The 1 µL 
injection from the differentially treated cartridges were compared to a 1 µL injection of a 
solvent-prepared and derivatized standard mixture, containing 20 ppb (4 ng/200 µL) of 
each compound and 25 ppb (5 ng/200 µL) of each internal standard. 
Recoveries for each compound were calculated according to section 3.4.7 and 
statistical significance evaluated with a two-way no matching ANOVA followed by the 
Bonferroni post-test from the statistical package GraphPad Prism version 5.00. 
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Estimated recoveries for compounds from a water and synthetic waste water 
matrix 
Compounds and internal standards were diluted in water and synthetic waste  water 
(SWW) so that each 100 mL contain 4 ng of each compound (MeP = 0.2 ng) and 5 ng 
internal standard. The synthetic waste water matrix were adapted from van den Berg et al. 
(378) and consisted of 2182 mg/L meat extract, 218 mg/L vegetable extract, 72.7 mg/L 
NaCl, 182 mg/L glucose, 373 mg/L MgSO4•7H2O, 145 mg/L K2HPO4 and 65.9 mg/L 
FeSO4•7H2O. 
Four 100 mL water samples (1% formic acidified to pH 2) and four SWW (1% 
formic acidified to pH 2) samples were pre-filtered through glass wool and Whatman 41 
ashless filter paper to simulate waste water pre-treatment. Filtered samples were then 
loaded onto Supel-select HLB cartridges, compounds eluted from the resin bed and 
analysed with the optimized instrumentation method (section 3.4.4). The aqueous solution 
used to equilibrate the cartridge after MeOH pre-treatment were acidified with 1% formic 
acid to pH 2. In contrast, four more 100 mL water (1% formic acidified to pH 2) and SWW 
(1% formic acidified to pH 2) samples were loaded onto Supel-select HLB cartridges, 
compounds eluted from the resin bed and analysed with the optimized instrumentation 
method (section 3.4.4), without pre-filtration. 
Statistical significance between filtered water, unfiltered water, filtered SWW and 
unfiltered SWW were determined with two-way ANOVA followed by Bonferroni post-test, 
using the statistical package GraphPad Prism version 5.00. 
3.4.7 Comprehensive method validation 
 
Instrumentation settings and extraction protocol 
 
SPE column: Supel-select HLB 
 
Pre-conditioning: 6 mL MeOH and 6 mL 1% formic acidified dH2O 
Sample volume: 100 mL 
Wash solution: 60% MeOH (1% formic acid) 
 
Eluent: 100% MeOH 
 
Reconstitution: 1.5  mL  acetonitrile  (transferred  to  MS  vial  and  dried  for 
derivatization) 
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Derivatization solvent:       75% acetonitrile and 25% 0.1 M NaHCO3  (1 mg/ml DNCl, pH 
10.5) 
 
Derivatization volume: 200 µL 
Instrument: UPC2-MS/MS 
Column: Waters UPC2 Torus 2-PIC 
 
Instrument setup: As set up in section 3.4.3 and optimized in section 3.4.4 
Injection volume: 1 µL 
Procedure 
 
Twenty-four mixture extractions were performed by two method investigators per day per, 
over a three day period. Twelve of these extractions (three concentrations, 4 replicates) 
were from a spiked water matrix and the remaining 12 (three concentrations, 4 replicates) 
from a spiked pre-filtered (see section 3.4.6) SWW matrix. Compounds (from a 100 ppm 
stock) were diluted to the three different concentrations in the water and SWW matrices, 
so that each 100 mL mixture sample would theoretically contain the following amount 
(Table 3.13) of each compound in the derivatized sample upon injection. Each 100 mL 
sample also contained 5 ng of each internal standard. 
 
 
Table 3.13 Low (C1), medium (C2) and high (C3) 
Supel-select HLB cartridge load. Final 200  µL 
sample concentration for injection is indicated in 
brackets. 
 
Compound Low (C1) Medium (C2) High (C3) 
 ng (ppb) ng (ppb) ng (ppb) 
PrP 0.02 (0.1) 0.2 (1) 2 (10) 
MeP 0.002 (0.01) 0.02 (0.1) 0.2 (1) 
TCS 0.02 (0.1) 0.2 (1) 2 (10) 
E1 0.02 (0.1) 0.2 (1) 2 (10) 
BPA 0.05 (0.25) 0.5 (2.5) 5 (25) 
EE2 0.05 (0.25) 0.5 (2.5) 5 (25) 
E2 0.02 (0.1) 0.2 (1) 2 (10) 
PCM 0.05 (0.25) 0.5 (2.5) 5 (25) 
E3 0.02 (0.1) 0.2 (1) 2 (10) 
TCC 0.02 (0.1) 0.2 (1) 2 (10) 
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A solvent calibration series were prepared from 100 ppm stocks. First, compounds 
were diluted in acetonitrile, so that final concentration of each compound in the mixture 
would equal the highest concentration standard in the calibration range. From this solution 
a seven point calibration series were prepared by dilution with acetonitrile (Table 3.14). 
Three of the calibration points matched the theoretical concentration of the extracted 
samples prepared above in Table 3.13. To each of the calibration point solutions internal 
standards (100 ppm stocks) were added to a final concentration of 25 ppb. Two-hundred 
microliters of each calibration point solution was dried, reconstituted and derivatized. 
 
 
Table 3.14 Solvent calibration series prepared in acetonitrile. Low (C1), medium (C2) and high (C3) 
Supel-select HLB cartridge load corresponds to that of Table 3.13. 
 
Compound Cmin Low (C1) Ca Medium (C2) Cb High (C3) Cmax 
 ppb ppb ppb ppb ppb ppb ppb 
PrP 0.05 0.1 0.5 1 5 10 20 
MeP 0.005 0.01 0.05 0.1 0.5 1 10 
TCS 0.05 0.1 0.5 1 5 10 20 
E1 0.05 0.1 0.5 1 5 10 20 
BPA 0.125 0.25 1.25 2.5 12.5 25 50 
EE2 0.125 0.25 1.25 2.5 12.5 25 50 
E2 0.05 0.1 0.5 1 5 10 20 
PCM 0.125 0.25 1.25 2.5 12.5 25 50 
E3 0.05 0.1 0.5 1 5 10 20 
TCC 0.05 0.1 0.5 1 5 10 20 
 
 
 
LOD, LOQ, ULOQ, linear range and linearity of signal 
 
The limit of detection (LOD), limit of quantification (LOQ), upper limit of quantification 
(ULOQ), linear range and linearity of signal was determined, in triplicate, by injecting each 
derivatized solvent prepared calibration point solution.  Data was analysed using Masslynx 
4.1 software from the Waters Corporation. LOD, LOQ, ULOQ, linear range and linearity of 
signal conditions are outlined in section 3.4.5. 
Precision, accuracy and trueness 
 
Instrumental precision was determined by consecutively injecting the derivatized solvent- 
prepared calibration point solution, medium (C2), six times. Data analysis was performed 
using GraphPad Prism 5.00 and data is presented as a percentage of the relative standard 
deviation (% RSD). Instrumental accuracy was determined in three matrices: solvent, 
water and SWW. 
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From the water and SWW extracted samples prepared above, the medium (C2) 
samples of Day 1 were injected. Four separately prepared medium (C2) calibration 
solutions were injected in a similar way. Data analysis was performed using GraphPad 
Prism 5.00 and data is presented as a percentage of the relative standard deviation (% 
RSD). 
Method trueness was assessed on four counts according to Kruve et al. (44): 
Compound stability in the final solvent, matrix effects (ionization 
enhancement/suppression), process efficiency and recovery. Stability was assessed by 
injecting a freshly prepared calibration solution, medium (C2), three times consecutively 
(time point zero), followed by triplicate injection of the same solution 18 hours later. 
Equation 1 was used to calculate each compound‘s stability. 
 
 
 
 
      (1) 
 
 
 
 
Matrix effects were analysed by injecting each of the replicates for solvent (n= 3), 
water (n = 4) and SWW (n= 4) extracted low (C1), medium (C2) and high (C3) 
concentration of each day and each method investigator. Data analysis was performed 
using Masslynx 4.1 and GraphPad Prism 5.00. Mean concentrations calculated by 
Masslynx 4.1 were plotted against sample prepared concentrations (Table 3.13) and the 
gradients generated from fitted linear regression lines used in Equation 2 to calculate the 
matrix effect. All regression lines were test for departure from linearity with runs test. 
 
 
 
 
      (2) 
 
 
 
 
Recovery was determined by injecting each of the replicates for water and SWW 
extracted low (C1), medium (C2) and high (C3) concentrations of each day and each 
method investigator. Matrix calibration graphs were constructed from the Masslynx 4.1 
calculated mean concentrations utilizing the solvent calibration curve. Linear regression 
lines were plotted on these graphs and the regression line equations used calculate the 
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original compound concentrations before extraction. Equation 3 was used to calculate 
recovery. 
 
      (3) 
 
 
 
 
Process efficiency was determined by injecting each of the replicates for water and 
SWW extracted low (C1), medium (C2) and high (C3) concentrations of each day and 
each method investigator. The calibration solutions were used to determine the 
concentration of each compound in each sample and Equation 4 used to assess process 
efficiency. 
 
      (4) 
Stellenbosch University  https://scholar.sun.ac.za
85 
 
 
 
CHAPTER 4 
 
 
ELUCIDATING THE PHARMACOLOGICAL PROPERTY – 
DRUG POTENCY, OF FOUR ANTIMICROBIALS AND 
THREE HUMAN ESTROGENS ON THE YES AND E- 
SCREEN 
4.1 Introduction and chapter objectives 
 
In chapter 2 section 2.5.5, the endocrine disruptor (ED) effects of a wide variety of 
compounds were discussed as well as their possible contribution to BC carcinogenesis 
and progression. Chapter 3 focused on developing methods for the pre-concentration, 
identification and quantification of 11 of those EDCs on a newly available technology. 
These developed methods would prove useful in evaluating the JTED Eco-machine‘s EDC 
removal efficiency. This chapter however will focus on establishing techniques and gaining 
pharmacological information necessary to complete chapter five. The latter aims to 
elucidate the possible ED consequences to humans if some of those chemicals tested for 
in chapter two co-occur in our water resources or are applied dermally to the underarm 
and/or breast region. To achieve this, the pharmacological parameter for drug potency 
needs to be determined. The two screens discussed in chapter 2 section 2.3.2 and 2.3.3 
will be used to achieve this goal. The EDCs to be tested on these screens include TCS, 
TCC, MeP and PrP, as they are commonly used in PCPs and can therefore find their way 
into the environment through the routes discussed in chapter 2 section 2.5.5. The 
compounds BPA, CBZ, EE2 and 4NP will not be tested in this chapter as their inclusion in 
the combination studies will increase the study complexity beyond the scope of this thesis, 
which is to develop methods to detect EDC and to only show some of possible effects 
these compounds might cause to humans and animals. In addition E1, E2 and E3 will also 
be tested on these screens as EDC-estrogen effects will also be investigated in chapter 4. 
Together the pharmacological information gained from these screens will be used to study 
drug interaction effects in chapter 4. The chapter aims and objectives are as follow: 
a) Determine the drug potency concentrations of E1, E2, E3, MeP, PrP, TCS, and TCC 
and at 25, 50 and 75% (EC25, EC50 EC75) of the maximal response. 
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b) Obtain repeatable results that can be used in chapter four for the mixture studies 
 
4.2 Results 
 
4.2.1 Yeast estrogen screen 
 
To determine the EC25, EC50 and EC75 values of compounds E1, E2, E3, MeP, PrP, TCS 
and TCC, dose-response curves were generated from yeast exposed to a dilution series of 
each compound. Figure 4.1 shows a typical dose-response relationship for E1, E2, E3, 
MeP, and PrP obtained using the YES, while Figure 4.2 and Figure 4.3 shows no dose- 
response properties for TCS and TCC. Results show that potency increases as follow: 
MeP < PrP < E3 < E1 < E2 (Figure 4.1). Finally, all compounds had an efficacy close to that 
of E2. Error! Reference source not found. shows potency data for each compound 
enerated from three independent YES experiments. 
 
 
 
 
 
Figure 4.1 Typical dose-response curves generated from the YES for E1, E2, E3, MeP and PrP. 
Statistical analysis and curve-fitting were carried out with the statistical package GraphPad Prism. 
Data points represent the mean ± SE (n =6). The log(agonist) vs. response functions were used to fit 
dose-responses to data. 
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Figure 4.2 Non dose-response behaviour for TCC using the YES. Statistical analysis were carried out 
with GraphPad Prism and data points represent the mean ± SE (n =6). 
 
 
 
 
 
Figure 4.3 Non dose-response behaviour for TCS using the YES. Statistical analysis were carried out 
with GraphPad Prism and data points represent the mean ± SE (n =6). Negative values represent 
cytotoxic conditions. 
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4.2.2 E-SCREEN 
 
Similar to the YES, MCF-7 BUS cells from the E-SCREEN were exposed to a range of 
compounds over a range of concentrations to determine their respective EC25, EC50 and 
EC75 values. Figure 4.4 shows similar results for E1, E2, E3, MeP, MeP and PrP to that of 
the YES, with the potency of compounds increasing from right to left. Table 4.2 shows the 
EC25, EC50 and EC75 values calculated for each compound. Comparing the YES and E- 
SCREEN potency results, we find that all estrogens showed approximately a 200 fold 
higher potency when tested on the E-SCREEN, while MeP and PrP paraben potencies 
were approximately a 30 and 40 times higher, respectively. Finally, Figure 4.5 and Figure 
4.6 indicate no dose-response behaviour for TCS and TCC, similar to results from the 
YES. 
 
 
 
Figure 4.4 Typical dose-response curves generated from the E-screen for E1, E2, E3, MeP, and PrP. 
Statistical analysis and curve-fitting were carried out with the statistical package GraphPad Prism. 
Data points represent the mean ± SE (n =6). The log(agonist) vs. response functions were used to fit 
dose-responses to data. 
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Figure 4.5 Non dose-response behaviour for TCC using the E-SCREEN. Statistical analysis were 
carried out with GraphPad Prism and data points represent the mean ± SE (n =3). 
 
 
 
 
 
Figure 4.6 Non dose-response behaviour for TCS using the E-SCREEN. Statistical analysis were 
carried out with GraphPad Prism and data points represent the mean ± SE (n =3). 
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Table 4.1 Drug potency values for E1, E2, E3, MeP, PrP, TCS and TCC with their respective curve fitting parameters. Data are the result of three 
independent YES experiments carried out. Statistical analysis were performed with GraphPad Prism and represent the mean ± SEM (n = 3). The average 
relative potency was calculated as the mean of the three relative potencies for EC25, EC50 and EC75 of each compound with respect to the E2 EC-value. 
 
 
Test Compound EC25 (nM) EC50 (nM) EC75 (nM) 
Response 
Hill Coefficient R
2
 of fit 
Average relative 
 
 
 
 
 
 
 
 
TCS Non dose-response behaviour 
 
 
 
 
Table 4.2 Drug potency values for E1, E2, E3, MeP, PrP, TCS and TCC with their respective curve fitting parameters. Data are the result of three 
independent E-SCREEN experiments carried out. Statistical analysis were performed with GraphPad Prism and represent the mean ± SEM (n = 3). The 
average relative potency was calculated as the mean of the three relative potencies for EC25, EC50 and EC75 of each compound with respect to the E2 EC- 
value. 
 
 
Test Compound EC25 (pM) EC50 (pM) EC75 (pM) 
Response 
Hill Coefficient R
2
 of fit 
Average relative 
 
 
 
 
 
 
 
 
TCS Non dose-response behaviour 
 
 
 
 
90 
TCC Non dose-response behaviour 
TCC Non dose-response behaviour 
 (% of Max E2)   potency to E2 
E1 1.39 ± 0.087 2.77 ± 0.212 5.49 ± 0.568 108 ± 6.59 1.62 ± 0.092 0.995 ± 0.001 0.3 
E2 0.535 ± 0.076 0.816 ± 0.090 1.33 ± 0.180 101 ± 2.34 2.42 ± 0.020 0.990 ± 0.006 1 
E3 7.25 ± 0.243 12.2 ± 0.465 20.4 ± 0.951 101 ± 0.879 2.13 ± 0.059 0.997 ± 0.002 0.1 
MeP (2.25 ± 0.165) x 105 (5.28 ± 0.279) x 105 (6.84 ± 0.431) x 105 80.3 ± 15.6 2.58 ± 1.07 0.972 ± 0.010 2 x 10-6 
PrP (7.92 ± 1,44) x 104 (1.34 ± 0.220) x 105 (2.27 ± 0.356) x 105 86.7 ± 5.56 2.11 ± 0.236 0.993 ± 0.003 6 x 10-6 
 
 (% of Max E2)   potency to E2 
E1 6.28 ± 0.872 14.8 ± 2.61 34.8 ± 7.50 85.6 ± 1.58 1.31 ± 0.055 0.831 ± 0.030 0.3 
E2 1.89 ± 0.138 4.06 ± 0.053 8.81 ± 0.644 87.2 ± 0.332 1.46 ± 0.137 0.944 ± 0.009 1 
E3 31,7 ± 2.07 76.9 ± 1.58 188 ± 12.0 85.8 ± 1.77 1.25 ± 0.080 0.891 ± 0.008 0.1 
MeP (3.07 ± 0.249) x 107 (5.21 ± 0.313) x 107 (8.97 ± 0.888) x 107 116 ± 3.70 2.13 ± 0.214 0.959 ± 0.004 8 x 10-8 
PrP (1.84 ± 0.002) x 106 (3.25 ± 0.002) x 106 (5.74 ± 0.007) x 106 114 ± 9.18 1.93 ± 0.029 0.961 ± 0.002 1 x 10-6 
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4.3 Discussion 
 
A vast number of mechanisms can be linked to ED; one of which is the binding to NRs. 
Modulation of certain NRs, such as ERα, have been linked to the carcinogenesis, 
progression and recurrence of BC. In this chapter modulation of ERα by E1, E2, E3, MeP, 
PrP, TCS and TCC were investigated using two in vitro models. Results (Figure 4.1 and 
Figure 4.4) indicated that only E1, E2, E3, MeP and PrP exhibit estrogenicity, with both 
models showing the potency order of compounds increasing as follow: MeP < PrP < E3 < 
E1 < E2. Potency order for MeP and PrP are in agreement with literature showing a higher 
potency for PrP than MeP (344, 349, 350, 353). However, the potency order for the 
estrogens are somewhat of controversy – with some studies (379, 380) in agreement with 
results obtained in this chapter, while others (381–383) showing the order of potency to be 
E1 < E3 < E2. 
The controversy observed could be attributed to the type of model used to investigate 
proliferative effects. However, Lippman et al. (380) and Gutendorf et al. (382) both made 
use of a competitive binding assay using [3H]-E2, with minor differences in experimental 
protocol. Gutendorf and colleagues used 250 nM [3H]-E2, while Lippman and coworkers 
only used 1.46 nM [3H]-E2. The more than 170 fold difference in [
3H]-E2 could explain why 
consensus between the assays could not be reached. Nonetheless, Gutendorf and 
colleagues also investigated proliferative effects of estrogens using two different 
luciferase-reporter-gene assays and the E-SCREEN. Both luciferase-reporter-gene assays 
and the E-SCREEN  results correlated with their competitive binding studies. Results 
obtained by Escande et al. (383), with a luciferace-reporter-gene construct different from 
that of Gutendorf et al., coincided with that of Gutendorf and colleagues. Data from this 
chapter however show results different from that attained by Gutendorf and colleagues 
with the E-SCREEN. The differences may be explained by four experimental differences 
between the protocol of Gutendorf et al. and the one used in this chapter. First, the cell line 
used by Gutendorf et al. was that of the original E-SCREEN protocol developed by Soto 
an co-workers (14), while highly responsive MCF-7 BUS cells, later developed by C. 
Sonnenschein and co-workers (16), were used in this chapter. The highly responsive 
MCF-7 BUS cells used in this chapter is highly sensitive towards estrogens or estrogen- 
like compounds and therefore increases the sensitivity of the experiment. Second, seeding 
density differed between the two protocols with only 3000 cells/mL seeded by Gutendorf et 
al. compared to 100 000 cells/ml used in this chapter from a well-established MCF-7 BUS 
protocol in our laboratory. Third, unlike Gutendorf et al., cells were treated for five days 
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compared to their three. Although both treatment times are in correlation with that of the 
original E-SCREEN assay, five days was selected instead of three to ensure proliferation 
is observed if treatments with EDCs yield weaker responses than that of estrogens. 
Finally, an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium) assay was used by 
Gutendorf and colleagues, while resazurin was used in this chapter to assess the 
metabolic activity of cells after treatment as it was readily available in the laboratory. 
Error! Reference source not found. and Table 4.2 show different potencies 
btained for each compound using the two ERα models. EC50 results from Error! 
Reference source not found. for E1 and E2 are in accordance with the findings (E1, EC50 = 
3 nM and E2, EC50 = 0.5 – 1.0 nM) of another yeast model used by Bovee and colleagues 
(381), but not for E3 (E3, EC50 = 0.6 – 1.2 nM). Furthermore, EC50 results in Table 4.2 for E2 
and E3 correlate with results from a study by Gutendorf et al. (E2, EC50 = 5 pM and E3, EC50 = 
70 pM) who also used the E-SCREEN. However, their data for E1 (E1, EC50 = 500 pM) 
differed. Other authors reporting similar results for E1 (78 - 80 pM), E2 (15 – 17 pM), E3 (60 
- 100 pM) using other in vitro cellular models, include Yang et al. (379), Legler et al. (384), 
van den Belt et al. (385) and Gutendorf et al. EC50 potencies obtained from the YES 
matched results (MePEC50 = 0.25 mM and PrPEC50 = 0.15 mM) from a competitive binding 
assay by Blair et al. (344). Potencies obtained from the E-Screen was similar for PrP, but 
dissimilar for MeP, to results (MePEC50 = 0.1 mM and PrPEC50 = 0.15 mM) from Charles 
and Darbre (350). Finally, from Error! Reference source not found. and Table 4.2 we 
ind that potencies obtained from the E-SCREEN is much higher than those of the YES. 
This observation can be attributed to MCF-7 BUS cells, in contrast to yeast, having 
multiple other nuclear pathways and targets that could lead to proliferation and therefore 
an increase potency value. 
To conclude, this study showed that TCS and TCC have no proliferative effects as 
shown in Figure 4.2, Figure 4.3, Figure 4.5 and Figure 4.6. The findings from TCS are in 
sharp contrast to results from Gee et al. (321) suggesting the binding of this compound to 
the ER for proliferation. Much of the proliferation seen in the results of Gee et al. could 
possibly be attributed to medium not fully stripped of all estrogens or the natural state of all 
cells to grow and divide. Also, extended exposure of cells, normal or cancerous, to almost 
any compound could induce abnormalities such E2-independent growth. This is in line with 
a recent publication by Sonnenschein and Soto (200). Finally, TCC results are in 
agreement with results from both Ahn et al. (329) and Chen et al. (330) suggesting TCC 
lacks agonist activity. 
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4.4 Materials and methods 
 
4.4.1 Yeast estrogen screen 
 
Materials 
 
KH2PO4, (NH4)2SO4, KOH pellets, MgSO4 anhydrous, Fe2(SO4)3·7H2O, CuSO4 anhydrous, 
L-Leucine, L-Histidine, L-Arginine-HCl, L-Methionine, L-Tyrosine, L-Isoleucine, L-Lysine- 
HCl, L-Phenylalanine, L-Glutamic acid, L-Valine, L-Serine, L-Aspartic acid, L-Threonine, 
Adenine, Thiamine,-HCl, Pyridoxine, D-Pantothenic acid hemicalcium salt, Inositol, D- 
Biotin, D-(+)-Glucose anhydrous, Glycerol, Chlorophenol red-β-D-Galactopyranoside 
(CPRG) and analytical grade methanol was bought from Sigma-Aldrich (St Louis, Missouri, 
USA). 
U-buttom 96-well microtitre plates used for the dilution series were bought from 
Becton Dickinson Labware (Franklin Lakes, New Jersey, USA), while the 96-well optically 
flatbottom microtitre plates and lids were bought from Thermo Fisher Scientific (Waltham, 
Massachusetts, USA). 
The test compounds, methyl 4-hydroxybenzoate (methylparaben, ≥99.0%), 
propylparaben (USP reference standard), Irgasan (triclosan, ≥97.0%), 3,4,4‘- 
trichlorocarbanalide (triclocarban, 99%), estrone (≥99%), β-estradiol (≥98%) and estriol 
(≥99.3%) were purchased from Sigma-Aldrich (St Louis, Missouri, USA). 
The yeast (Saccharomyces cerevisiae BJ1991) used in this assay was a kind gift 
from Professor. J. H. van Wyk (Department of Botany and Zoology, University of 
Stellenbosch, Stellenbosch, RSA) who obtained it from Professor J. P. Sumpter 
(Department of Life Sciences, Brunel University, London, UK). 
Methods 
 
Estrogen and EDC freezer stocks. All test compounds were analytically weighed and 
dissolved in analytical grade methanol. For ease of use, a 1000 ppm stock was prepared 
for each test compound, except MeP (4000 ppm), and from this a 100 ppm and 10 ppm 
stock created. From these stocks dilutions were made for the YES. All stocks were stored 
at -20 °C. 
Preparation of glassware. All glassware was scrupulously cleaned with detergent 
and rinsed well before being cleaned twice with methanol and once with ethanol. The 
glassware was then sterilised for 30 min at 121 °C. 
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Composition of minimal medium. Minimal medium, D-(+)-Glucose (20% w/v), L- 
Aspartic acid (4 mg/ml), vitamin solution, L-Threonine (24 mg/mL), CuSO4 (20 mM) and 
CPRG (10 mg/mL) was prepared according to the protocol set out by Routledge and 
Sumpter (9). In short: Minimal medium (pH 7.1) consisted of KH2PO4 (13.61 g/L), 
(NH4)2SO4 (1.98 g/L), KOH pellets (4.2 g/L), MgSO4 (0.2 g/L), 1 ml Fe2(SO4)3 solution (0.8 
mg/ml in deionised water), L-Leucine (50 mg/L), L-Histidine (50 mg/L), Adenine (50 mg/L), 
L-Arginine-HCL (20 mg/L), L-Methionine (20 mg/L), L-Tyrosine (30 mg/L), L-Isoleucine (30 
mg/L), L-Lysine-HCl (30 mg/L), L-Phenylalanine (25 mg/L), L-Glutamic acid (100 mg/L), L- 
Valine (150 mg/L), and L-Serine (375 mg/L), dissolved in deionised water. The vitamin 
solution comprised of thiamine (0.04 mg/mL), pyridoxine (0.04 mg/mL), pantothenic acid 
(0.04 mg/mL), inositol (0.2 mg/mL) and 20 ml biotin (0.02 mg/mL in deionised water) 
solution in deionised water. The minimal medium, D-(+)-Glucose, L-Aspartic acid and L- 
Threonine were sterilized at 121 °C for 30 min, while the vitamin, copper (II) sulfate and 
CPRG solutions were filter-sterilized with a 0.2 µm syringe filter. All solutions were stored 
at room temperature with the exception of the vitamin, L-Threonine and CPRG solutions 
that were stored at 4°C. 
Yeast freezer stocks. The yeast stock obtained from J H van Wyk was added to a 
conical flask, containing growth medium (5 ml glucose solution, 1.25 mL L-Aspartic acid 
solution, 0.5 mL vitamin solution, 0.4 mL L-Threonine and 125 µL copper (II) sulfate 
solution and 45 mL minimal medium), prior to incubation at 26 °C for 24 hours on an orbital 
shaker. After 24 hours, 1 mL of the overnight culture was added to two conical flasks, with 
fresh growth medium, and incubated for another 24 hours at 26 °C on the orbital shaker. 
On day 3, the overnight cultures were transferred to 50 mL centrifuge tubes and the 
cultures spun down at 4 °C for 10 min at 2000 x g using an Avanti JE centrifuge. The 
supernatant was decanted and each pellet resuspended in 5 mL minimal medium with 
15% glycerol. Aliquots of 500 µL (10X concentrated) were stored at -20 °C for a maximum 
of 4 months before new stocks were made from the existing ones and the old discarded. 
YES protocol. On day one, a 125 µL of the 10X concentrated yeast stock were 
incubated in growth medium for 24 hours on an orbital shaker at 26 °C. After 24 hours the 
yeast were passaged by incubating 1 mL of the overnight culture at 26 °C on an orbital 
shaker in fresh growth medium. On day three, test chemicals were serially diluted in a 96- 
well U-bottom microtitre plate with methanol as needed. Ten microliter aliquots were then 
transferred to sterile 96-well optically flat bottom microtitre plates and left to evaporate to 
dryness (Coated wells). Ten microliter aliquots of methanol were transferred to blank wells, 
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as negative control, and evaporated to dryness. β-Estradiol were used as positive control 
in all assays and are treated in a similar manner as test compounds before being 
evaporated. The assay medium (0.5 mL CPRG and 2 mL yeast per 50 mL fresh growth 
medium) was seeded according to the number of 96-well plates needed (see Table 4.3). 
To the coated wells, 200 µL of the seeded assay medium was added, prior to sealing the 
96-well plates with autoclave tape. Finally, plates were shaken for 30 min on an orbital 
shaker before being incubated at 30 °C until half the wells of the positive control changed 
colour (2-5 days). 
Table 4.3 Composition of assay medium for different plate sizes 
 
Assay constituents ½ Plate 1 Plate 3 Plates 4.5 Plates 
Minimal Medium (mL) 9 18 54 81 
Glucose (mL) 1 2 6 9 
CuSO4 (µL) 25 50 150 225 
L-Aspartic acid (mL) 0.25 0.5 1.5 2.25 
Vitamin solution (µL) 100 200 600 900 
L-Threonine (µL) 80 160 480 720 
CPRG (µL) 100 200 600 900 
Yeast (mL) 0.4 0.8 2.4 3.6 
 
 
Spectrophotometric readings. To correct for turbidity  absorbance  (abs.) 
readings were taken at 570 and 620 nm using a BioRad microtitre plate reader (BioRad 
Laboratories Ltd., Hemel Hempstead UK) and Equation 5 applied to the data. 
Consequently, the median of all blanks were subtracted from wells containing test 
compounds and the data expressed as a percentage of the maximum E2 observed in the 
experiment. 
 
 
 
                              (              )    [ 
(              ) 
] 
                      (              ) 
 
(5) 
 
Limit of detection and limit of quantification. Data used in the fitting of dose- 
response curves were considered quantifiable for all data points where the absorbance 
measurement of the sample was greater than the negative control plus three times the 
standard deviation. 
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Statistical analysis. Statistical analysis was carried out with the statistical 
package GraphPad Prism 5.00. The same statistical package was also used to fit data to 
dose-response curves. Here, the functions log(agonist) vs. response – variable slope and 
log(agonist) vs. response – find ECanything, were used to find the potencies (EC25, EC50 
and EC75) for each compound. 
4.4.2 E-SCREEN 
 
Materials 
 
Dulbecco‘s Modified Eagles Medium (DMEM, low glucose and L-glutamine, without 
sodium bicarbonate and phenol red), DMEM (high glucose, glutamine and phenol red, 
without sodium bicarbonate), Sodium pyruvate (BioReagent, suitable for cell culture, ≥ 
99%), D-(+)-Glucose (Hybri-Max, ≥ 99.5%), bovine calf serum (iron supplemented) and 
resazurin sodium salt were bought from Sigma-Aldrich (St Louis, Missouri, USA). Penicillin 
Streptomycin and TrypLETM express enzyme and Trypan blue stain (0.4%) were bought 
from Life Technologies (Grand Island, NY, USA), while sodium hydrogen carbonate was 
bought from Merck KGaA (Darmstadt, GE). 
Both the T75 flasks used for the maintenance of cells and experimental 96-well 
sterile plates (F-bottom, with lid) were bought from Sigma-Aldrich (St Louis, Missouri, 
USA). 
The test compounds, methyl 4-hydroxybenzoate (methylparaben, ≥ 99.0%), 
propylparaben (USP reference standard), Irgasan (triclosan, ≥97.0%), 3,4,4‘- 
trichlorocarbanalide (triclocarban, 99%), estrone (≥99%), β-estradiol (≥98%) and estriol 
(≥99.3%) were purchased from Sigma-Aldrich (St Louis, Missouri, USA). 
The MCF-7 BUS (Passage number 181) cell line used in the E-SCREEN was a 
kind gift from Dr D. Africander (Department of Biochemistry, University of Stellenbosch, 
Stellenbosch, RSA), who obtained it from Professor A. M. Soto (Department of Integrative 
Physiology and Pathobiology, Tufts University, Boston, USA). 
Methods 
 
Estrogen and EDC freezer stocks. All test compounds were analytically weighed 
and dissolved in analytical grade ethanol. For ease of use, a stock concentration of 1 mM 
was prepared of all test compounds, except TCC for which a 30 mM stock was made. 
From these stocks dilutions were made with ethanol that was a 100-1000 fold higher than 
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the concentration used in experiments. The 100-1000 fold higher stocks were then diluted 
in media before being plated in wells. All ethanol stocks were stored at -20°C. 
Preparation of glassware. All glassware was thoroughly cleaned with 2% 
Contrad and rinsed well before being cleaned twice with methanol and once with ethanol. 
The glassware was then sterilised for 30 min at 121°C. 
Composition of Growth and experimental medium. Growth medium (GM) 
consisted of Dulbecco‘s Modified Eagles Medium (DMEM; High glucose with phenol red) 
supplemented with 1.5 g/L NaHCO3, 0.11 g/L sodium pyruvate, 5% Heat inactivated (HI) 
Fetal Calf Serum (FCS) and 10% Penicillin-Streptomycin (PenStrep). DMEM 
supplemented with 1.5 g/L NaHCO3, 0.11 g/L sodium pyruvate was filter-sterilized with a 
0.22 µm filter and stored at 4 °C for extended periods. Before use, the remaining 
supplements were added and the medium stored at 4°C for no longer than 6 months. 
Experimental medium consisted of Dulbecco‘s Modified Eagles Medium (DMEM; Low 
glucose without phenol red) supplemented with 1.5 g/L NaHCO3, 3.5 g/L Glucose and 5% 
HI Charcoal-Dextran-Coated (DCC) stripped FCS. DMEM supplemented with 1.5 g/L 
NaHCO3 and 3.5 g/L glucose was filter-sterilized with a 0.22 µm filter and stored at 4 °C 
under dark conditions for extended periods. Before use, the remaining supplement was 
added and the medium stored at 4 °C under dark conditions for no longer than 6 months. 
MCF-7 BUS freezer stocks. MCF-7 BUS cells were maintained in GM until cell 
semi-confluent for stock solutions to be created. Following medium removal, cells were 
detached from the surface of flasks using TrypLETM express enzyme and diluted in 10 mL 
GM. Consequently cells were pelleted at 2000 rpm over 5 min and resuspended in the 10 
mL GM. Cells were counted by staining with Trypan blue before counting on a Countess 
automatic cell counter (Invitrogen). Freezer stocks were made by diluting cells to 1 x 106 
cells/mL with GM containing 7% Dimethyl sulfoxide (DMSO). Long term storage of cells 
was carried out in liquid nitrogen, while stocks for regular use were stored at -80 °C until 
use. 
E-SCREEN protocol. MCF-7 BUS cells were maintained in GM before being 
plated in 96-well plates at a seeding density of 100 000 cells/ml. Semi-confluent cells were 
detached from flasks with TrypLETM Express enzyme and resuspended in 10 mL GM, 
before being pelleted. Pelleted cells were resuspended in 10 mL fresh GM, counted as 
mentioned before and diluted with GM to a final concentration of 100 000 cells/mL. Each 
well of the 96-well plate received a 100 µL seeded GM (10 000 cells)  Plates  were 
incubated for 24 hours at 37 °C and 5% CO2 before the GM was replaced with 200 µL EM 
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and incubated under the same conditions. After 24 hours the medium was removed and 
replaced with 100 µL fresh EM, containing the compound of interest, an ethanol control 
and E2 positive control. Treated plates were incubated for 120 hours before 20 µL of sterile 
resazurin solution (0.15 mg/mL in phosphate buffered saline, pH 7.1) was added per well. 
Plates were incubated for 3-4 hours at 37 °C and 5% CO2 before spectrophotometric 
readings were taken with a Tecan Spark 10M (Tecan Trading AG, Switzerland EU). 
Spectrophotometric readings. After the final incubation step fluorescence 
readings were taken 570 and 600 nm and blanks subtracted from treated wells. Data was 
expressed as a percentage of the maximum E2 observed in the experiment. 
Limit of detection and limit of quantification. Data used in the fitting of dose- 
response curves were considered quantifiable for all data points where the fluorescence 
measurement of the sample was greater than the negative control plus three times the 
standard deviation. 
Statistical analysis. Statistical analysis was carried out with the statistical 
package GraphPad Prism 5.00. The same statistical package was also used to fit data to 
dose-response curves. Here, the functions log(agonist) vs. response – variable slope and 
log(agonist) vs. response – find ECanything, were used to find the potencies (EC25, EC50 
and EC75) for each compound. 
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CHAPTER 5 
 
 
INVESTIGATING THE COMBINATORY EFFECTS OF 
PCPs AND THEIR POSSIBLE CONTRIBUTION TO 
BREAST CANCER 
5.1 Introduction and chapter objectives 
 
In chapter 2 section 2.5.5, the ED effects of a number of EDCs, their modes of action and 
contribution to BC were discussed. Chapter 4 was dedicated to investigating the ERα 
dose-response properties of MeP, PrP, TCS and TCC – a subset of the discussed EDCs 
as well as E1, E2 and E3, using two ERα models. Results showed that MeP and PrP both 
had dose-response properties similar to that of E1, E2 and E3, but that both MeP and PrP 
had lower potencies than the estrogens. It is well documented that MeP, PrP, TCS and 
TCC have been found in both normal and cancerous breast tissue as well as breast milk 
(315, 340–342, 386–389). The presence of estrogens in the breast, or for that matter 
EDCs with estrogenic potential, can therefore play a deciding role in the progression of 
BC. It has also been shown that certain EDC such as MeP can actually inhibit the function 
of anti-estrogens prescribed to BC patients (357), emphasizing the need to do away with 
preservatives exhibiting ED effects. Furthermore, a study has also showed how low doses 
of a combination of EDC can sometimes have far more devastating effects than the 
compounds in isolation (350). An expert panel later suggested that a mixture of EDCs 
should be considered rather than compounds in isolation (68). These views and findings 
then also correlate with the way that EDCs are found in waste water such as that draining 
into the Berg River. 
This chapter aims to do just that: investigate the effects of a mixture of EDCs, with 
the compounds under investigation being MeP, PrP, TCS and TCC. The goal of this study 
was to investigate the combinatory effects mediated through ERα, by looking specifically at 
how each EDC can modulate ERα in the presence of estrogens as well as the presence of 
other EDCs. The aims and objectives of this chapter are as follow: 
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a) Using the YES: 
 Determine the ERα modulatory effects of combinations between MeP, PrP, TCS 
or TCC with the estrogens. 
 Determine the ERα modulatory effects of combinations between MeP and PrP, 
as well as TCS and TCC. 
 Determine the ERα modulatory effects of combinations between MeP or PrP 
with TCS or TCC. 
 
5.2 Results 
 
To investigate the combinatory effects between MeP, PrP, TCS, TCC, E1, E2 and E3 yeast 
expressing ERα were treated with binary mixtures of the different compounds. With the 
exception of combination with TCS and TCC, all compounds were treated so that the 
combination would theoretically yield additive effects equal to 100% E2. Concentrations 
previously investigated in literature (329) were used for combination studies with TCS and 
TCC. Figure 5.1, Figure 5.2 and Figure 5.3 show the combinatory effects between the 
parabens and estrogens, Figure 5.4, Figure 5.5 and Figure 5.6 the effects between TCS, 
TCC and the estrogens and Figure 5.7 and Figure 5.8 the effects between TCS, TCC and 
the parabens, while Figure 5.9 show the effects between the parabens or TCS and TCC. 
MeP and PrP in combination differentially affected the modulation of ERα. First, 
MeP at its EC75 potency, as well as in combination with the EC25 value of E1 showed no 
stimulatory effect and instead seemed to indicate cytotoxicity. In contrast, PrP on its own 
stimulated the modulation of ERα, while in combination with E1  showed antagonistic 
properties. All remaining combination between MeP and E1 showed ERα antagonistic 
activity, where the combined effect yielded a lower response than that of the individual 
compounds. However, when combining PrP at doses higher than its EC25 potency with 
doses for E1 lower than its EC75 potency, additivity was achieved. Similar results were 
obtained when combining MeP or PrP with E2, with only one difference: additivity was 
observed when combining MeP and E2 at their respective EC75 and EC25 potencies. 
Different results were observed for combination between MeP or PrP and E3.In isolation, 
MeP at its EC75 or E3 at its EC25 potency showed no response and neither did the 
combination. Furthermore, the stimulatory effect observed for E3 was low at all three 
concentrations. Combining MeP with E3, both at EC50, results suggest antagonism while 
synergism was observed for MeP at its EC25 potency and E3 at its EC75 potency. Finally, 
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combinations with PrP and E3 showed additivity (PrPEC50 + E3, EC50) as well as synergism 
(PrPEC25 + E3, EC75). 
The combinatory effect between TCS or TCC and the estrogens were 
subsequently investigated. Combinations with TCS showed antagonistic properties for all 
but one combination: 0.1 µM TCS in combination with E1 at its EC75 potency, which 
showed and additive response. In contrast, all combinations with TCC and E1 indicated a 
synergistic behaviour. TCS combinations with E2 resulted in responses showing either no 
response or antagonism. Like the combinations between E1 and TCC, all but one (TCC0.1 
µM + E2, EC75, additivity) combination between TCC and E2 showed synergistic effects. 
Interestingly, although the overall response was low, TCSEC75 combined with E3, EC25 
showed a synergistic response. This is in contrast to results from TCS combination with E1 
or E2, as well as the combination between TCS at its EC25 potency and E3 at its EC75 
potency. Finally, TCC combined with E3 resulted in responses similar to that obtained by 
combination between TCC and E2. 
Lastly, combinations between the different EDCs were tested. All combinations 
between MeP and TCS showed antagonistic behaviours, while combinations between 
MeP and TCC showed antagonistic (MePEC50 + TCC1.0 µM) and synergistic (MePEC25 + 
TCC10) behaviour. Similarly to combinations with MeP, combinations with PrP and TCS 
showed mostly antagonistic properties. In contrast, PrP combined with TCC showed both 
antagonistic (PrPEC75 + TCC0.1 µM and PrPEC50 + TCC1.0 µM) and synergistic (TCC10 µM + 
PrPEC75) properties. To conclude, all combinations between MeP and PrP showed 
antagonism, while most combinations between TCS and TCC showed antagonistic 
properties. The only exception was the combination between 0.1 µM TCS and 10 µM TCC 
that showed synergism. 
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Figure 5.1 ERα modulatory effects observed when combining MeP or PrP with E1 using the YES. Data shown are represented as the mean ± SE (n = 10), 
Statistical analysis was performed with one-way ANOVA followed by a Dunnett post-test. Significance are denoted by *, ** and ***, corresponding to p < 
0.05, p < 0.01 and p < 0.001, respectively. Negative values represent cytotoxic conditions. The cytotoxic effects observed for MePEC75 could possibly be 
attributed to experimental error whereby the concentration was higher than the EC75 value, resulting in cytotoxic effects. 
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Figure 5.2 ERα modulatory effects observed when combining MeP or PrP with E2 using the YES. Data shown are represented as the mean ± SE (n = 10), 
Statistical analysis was performed with one-way ANOVA followed by a Dunnett post-test. Significance are denoted by *, ** and ***, corresponding to p < 
0.05, p < 0.01 and p < 0.001, respectively. Negative values represent cytotoxic conditions. The cytotoxic effects observed for MePEC75 could possibly be 
attributed to experimental error whereby the concentration was higher than the EC75 value, resulting in cytotoxic effects. 
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Figure 5.3 ERα modulatory effects observed when combining MeP or PrP with E3 using the YES. Data shown are represented as the mean ± SE (n = 10), 
Statistical analysis was performed with one-way ANOVA followed by a Dunnett post-test. Significance are denoted by *, ** and ***, corresponding to p < 
0.05, p < 0.01 and p < 0.001, respectively. Negative values represent cytotoxic conditions. The low responses observed for E3,EC25, E3,EC50 and E3,EC75 could 
possibly be attributed to experimental error whereby the concentration was lower than the values calculated for in chapter 4. 
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Figure 5.4 ERα modulatory effects observed when combining TCS or TCC with E1 using the YES. Data shown are represented as the mean ± SE (n = 10), 
Statistical analysis was performed with one-way ANOVA followed by a Dunnett post-test. Significance are denoted by *, ** and ***, corresponding to p < 
0.05, p < 0.01 and p < 0.001, respectively. Negative values represent cytotoxic conditions. 
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Figure 5.5 ERα modulatory effects observed when combining TCS or TCC with E2 using the YES. Data shown are represented as the mean ± SE (n = 10), 
Statistical analysis was performed with one-way ANOVA followed by a Dunnett post-test. Significance are denoted by *, ** and ***, corresponding to p < 
0.05, p < 0.01 and p < 0.001, respectively. Negative values represent cytotoxic conditions. 
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Figure 5.6 ERα modulatory effects observed when combining TCS or TCC with E3 using the YES. Data shown are represented as the mean ± SE (n = 10), 
Statistical analysis was performed with one-way ANOVA followed by a Dunnett post-test. Significance are denoted by *, ** and ***, corresponding to p < 
0.05, p < 0.01 and p < 0.001, respectively. Negative values represent cytotoxic conditions. 
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Figure 5.7 ERα modulatory effects observed when combining TCS or TCC with MeP using the YES. Data shown are represented as the mean ± SE (n = 
10), Statistical analysis was performed with one-way ANOVA followed by a Dunnett post-test. Significance are denoted by *, ** and ***, corresponding to 
p < 0.05, p < 0.01 and p < 0.001, respectively. Negative values represent cytotoxic conditions. 
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Figure 5.8 ERα modulatory effects observed when combining TCS or TCC with PrP using the YES. Data shown are represented as the mean ± SE (n = 10), 
Statistical analysis was performed with one-way ANOVA followed by a Dunnett post-test. Significance are denoted by *, ** and ***, corresponding to p < 
0.05, p < 0.01 and p < 0.001, respectively. Negative values represent cytotoxic conditions. 
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Figure 5.9 ERα modulatory effects observed when combining MeP and PrP or TCS and TCC using the YES. Data shown are represented as the mean ± 
SE (n = 10), Statistical analysis was performed with one-way ANOVA followed by a Dunnett post-test. Significance are denoted by *, ** and ***, 
corresponding to p < 0.05, p < 0.01 and p < 0.001, respectively. Negative values represent cytotoxic conditions. 
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5.3 Discussion 
 
Breast cancer is life changing disease that will affect millions of woman around the world 
this year. In light of the recent evidence surrounding the presence of EDCs in normal and 
cancerous breast tissue, as well as breast milk, and their link to ED, this chapter set out to 
investigate ERα modulatory effects that could originate from their presence. The current 
chapter made use of potency values calculated in chapter three to perform binary mixture 
experiments. Combinations between estrogens and MeP, PrP, TCS or TCC were 
considered as well as combinations between TCS, PrP, TCS and TCC. Results showed 
additive, synergistic and antagonistic effects between mixtures. 
Overall MeP had a more antagonistic effect on mixtures involving estrogens, while 
additivity was the main combinatory effect observed for co-exposure to PrP. At the time of 
printing, this is the first report showing 1) the effect on ERα of combination with parabens 
and estrogens, and 2) two completely different interaction profiles for compounds 
belonging to the same chemical group. The latter can be of great concern as sharing the 
same chemical group is often regarded to also having similar physiochemical properties 
and biological effects. This means that each compound in future studies needs to be 
investigated for effects such as ED as representatives of a group would not suffice. 
Furthermore, the antagonistic and additive effects observed indicate that these mixtures 
could have severe consequences not only to estrogen-responsive BC patients but also 
woman in general. BC patients would be susceptible to the having additional estrogen-like 
chemicals present in breast tissue as well as compounds that can either have an additive 
(PrP) or antagonistic (MeP) effect. However, parabens have been mostly detected in 
breast tissue as a combination of MeP, PrP, ethylparaben, n-butylparaben and 
isobutylparaben (341). Results from the current study show that when both MeP and PrP 
are present, antagonistic behaviours is the norm for their combination. This suggests that 
combinations of parabens might yield antagonistic behaviour rather than additive. 
However, a similar study by Charles and Darbre (350) with MeP, PrP, ethylparaben, n- 
butylparaben and isobutylparaben showed that in combination these five parabens act 
additively. Nonetheless, findings from Charles and Darbre (350) were obtained using a 
MCF-7 proliferation assay and therefore conflicting results are a possibility. In contrast to 
BC patients, the presence of MeP or PrP in woman could have health and developmental 
effects as their presence together with estrogens could disrupt the delicate key roles 
estrogens play in woman. In children (E2 dominating) MeP could hamper the development 
of secondary sexual characteristics, while PrP would be able to speed up the process. In 
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older woman (E1 dominating) PrP might aggravate menopausal symptoms, while MeP 
could possibly rescue woman from these symptoms. Finally, MeP and PrP could disturb 
the delicate hormone balance in pregnant woman (E3 dominating) and thereby influence 
the development of the unborn foetus. Gestation, pre-puberty and puberty are regarded as 
key windows of susceptibility that can lead to life-long health consequences. Therefore, 
the use of these compounds in products specifically for pregnant woman, toys for children 
and other PCP for infants, children and young adults should be carefully considered. 
Combinations between TCS or TCC and the estrogens showed antagonism and 
synergism for the respective EDCs. TCS has been suspected (329, 390) for some time to 
exhibit anti-proliferative effects in the presence of E2. In this study results confer the 
findings of the previous studies. In addition, results also show that the range can now be 
extended to also include E1 and E3. Like TCS, TCC has also been suspected (329–331) to 
confer the results obtained in this study. Similar to the case with MeP and PrP, the actions 
of TCS and TCC in combinations with estrogens could have dire consequences. However, 
the synergistic effects seen with TCC in combination with estrogens could prove more 
worrisome than that of estrogens combined with PrP. TCC‘s synergistic action when 
combined with estrogens makes this compound a number one threat for BC patients 
battling estrogen-responsive cancers, as the presence of the smallest amount of estrogen 
and TCC could aggravate the current state of the BC by increasing BC cell proliferation. 
Finally, the presence of TCC in pregnant woman, pre-pubertal girls and those going 
through puberty are equally problematic for the same reasons supplied for PrP. 
As a last consideration, the interactions between the different EDCs were 
investigated. First, combinations with TCS and TCC had no noteworthy effects. Second, 
results showed that TCS could suppress the action of MeP, while TCC had mixed results 
indicating either antagonism or synergism. The observation for TCS and MeP comes as a 
relief as its presence in the female body could shield against the actions of MeP when only 
these two are present. However, this is not always the case as other PCPs such as PrP or 
TCC is likely to be present. Third, mixed observations were observed for PrP in 
combination with either TCS or TCC and therefore needs to be confirmed. Finally, of note, 
the response achieved when 10 µM TCC was combined with either MeP or PrP at their 
EC25 potencies, were more than two times the response of MeP or PrP alone. From this it 
can be speculated that higher concentrations of TCC could potentially enhance the action 
of lower concentrations of MeP or PrP and therefore these combinations are a serious 
concern. 
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In conclusion, the results obtained from the mixture results indicate a clear modulatory 
effect on ERα, with some combinations of greater concern than others. However, the 
findings from this study needs to be confirmed with cell models to further elucidate how the 
investigated combinations could affect an organism adversely. 
 
5.4 Materials and methods 
 
5.4.1 Materials 
 
Materials used in this chapter are similar to the ones used in chapter 4 for the YES (See 
section 4.4.1). 
5.4.2 Methods 
 
General experimental preparations. Stocks solutions used in this chapter were prepared 
similar as explained in section 4.4.1. From these the relevant 20x concentrations matching 
the EC25, EC50, and EC75 for E1, E2, E3, MeP and PrP were prepared in MeOH. Stock 
concentration 20-fold higher than 0.1, 1 and 10 µM was prepared for TCS and TCC. E2 at 
a concentration 20-fold 1.5 nM was used as positive control in addition to a standard curve 
prepared from the 20-fold 1.5 nM E2. Furthermore, glassware was treated in the same 
manner as mentioned in section 4.4.1, yeast stored under similar conditions and yeast 
growth medium kept unchanged as layed out in section 4.4.1, while the experimental 
procedure was changed minimally. 
YES protocol. Yeast cultures where started on day one and passaged as previously 
mentioned. On day three, 10 µL of each 20x stock of the first compound was plated in 
combination with 10 µL of the second compound, in sterile 96-well optically flat bottom 
microtitre plates (n = 12), and air dried. In addition, 10 µL of each 20x stock was also 
plated separately. MeOH was used as blank, 1.5 nM (20x) E2 as positive control and the 
E2 dilution series as an assay progression indicator. Finally, the assay medium was 
seeded, plates incubated and readings taken under similar conditions as before. 
Statistical analysis. Statistical analysis was carried out with the statistical package 
GraphPad Prism 5.00, and a one-way ANOVA with Dunnet post-test used to quantify the 
different effects observed between mixtures and the compounds on their own. 
See section 4.4.1 for a detailed description of materials and general assay procedures. 
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CHAPTER 6 
 
 
Conclusions and future studies 
 
6.1 Conclusions 
 
This study was part of a larger project that aims to develop decentralised treatment 
systems, based on biomimicry design, to mitigate the discharge of greywater from informal 
settlements into the Berg and other rivers. The proposed solution, a natural waste water 
treatment system called the TJED Eco-machine, showed to be effective in a pilot scale 
model. However, the actual system still needs to be evaluated at full-scale implementation. 
This study contributed to this evaluation by setting up methods that can be used to monitor 
treatment. Three analytical chemistry methods namely GC-, UPLC- and UPC2-MS/MS 
were investigated as possible instruments for detecting commonly occurring pollutants in 
samples taken from the greywater that will be treated in the Eco-machine once installed. 
The majority of the pollutants selected for monitoring have been shown to play some part 
in disrupting the endocrine system of mammals and therefore pose a great risk to the 
environment. The methods developed on the three instruments were optimized and tested 
for their sensitivity and overall performance towards detecting these pollutants. Method 
validation showed that the UPC2-MS/MS had great potential to be used as the instrument 
of choice for detecting the selected commonly occurring pollutants. However, some of the 
data suggested that the method needed simplification and further optimization before 
finally being used as the analytical instrument of choice. In addition to developing 
analytical techniques for monitoring the levels of pollution and ultimately their removal 
through treatment systems, studies were performed to show how some of the commonly 
occurring pollutants selected for monitoring can possibly influence signal transduction in 
mammals. This is particularly relevant as signal transduction plays a central role in 
regulating homeostasis. In these studies potency values were determined for the 
pollutants E1, E2, E3, MeP and PrP with two bioassays (YES and E-SCREEN) that can 
show ERα modulation. However, the compounds TCS and TCC that was also tested 
showed no dose-response behaviour. Mixture studies, using the YES, between MeP and 
PrP, TCS and TCC, MeP and TCS, PrP and TCS, MeP and TCC, PrP and TCC, and 
between E1, E2, E3 and MeP, PrP, TCS and TCC showed a wide range of mixture 
interaction.  Some  were  additive,  some  antagonistic  and  some  synergistic.  The  most 
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noteworthy and concerning mixtures were that of TCC with E1, E2, E3, MeP and PrP, as 
TCC showed synergistic behaviour that could greatly influence homeostasis and diseases 
such as BC if a mixture of these compounds are found in humans and animals. For a 
detailed overview on the ED effects of the studied compounds and others, chapter 2 
section 2.5.5 provides an in depth discussion. 
In conclusion, this project fulfilled the overall aim of finding the most suitable 
chromatography method that could be used to evaluate the JTED Eco-machine‘s ability to 
remove pollutants such as PPCPs. In addition, the project also fulfilled the aim of showing 
the possible consequences to humans and animals if exposed to contaminated water 
resources containing EDCs. 
 
6.2 Future studies 
 
Method developed for isolating, detecting and quantifying pollutants proved to be complex 
in nature and therefore needs further optimization and simplification. Also, method 
development failed to include the full spectrum of robustness testing as prescribed by 
leading authors in the field. Future studies should therefore investigate other variables 
such as the pH of the eluent, concentration of additives present in the eluent and column 
batch and age that may influence parameters adversely. Alternatively, variables such as 
analyte extraction time and the sample transfer process should be investigated for 
improving process efficiency. On top of that, future studies should also investigate other 
SPE extraction solvents and SPE equilibration buffer conditions such as salt content. 
With regards to mixture studies, results need to be confirmed with a cell model 
such as the E-SCREEN. Additionally, combinations should also be tested on an ERβ bio- 
assay as a growing amount of evidence suggests that ERβ suppresses the function of 
ERα. Alternatively, mixture effects should also be investigated on other NRs considering 
that there exists a complex interplay between NRs. 
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